|
G |
ABCC2 |
ATP binding cassette subfamily C member 2 |
multiple interactions |
EXP |
[Organoselenium Compounds binds to Copper] which results in increased expression of ABCC2 mRNA |
CTD |
PMID:25167922 |
|
NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594
|
|
G |
AKT1 |
AKT serine/threonine kinase 1 |
multiple interactions |
ISO EXP |
Organoselenium Compounds inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased activity of AKT1 protein] [Organoselenium Compounds binds to Copper] which results in decreased expression of AKT1 protein |
CTD |
PMID:18538761 PMID:25167922 |
|
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,751
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
multiple interactions |
ISO |
Organoselenium Compounds inhibits the reaction [Streptozocin results in increased expression of BAX protein] |
CTD |
PMID:25301743 |
|
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
multiple interactions |
ISO |
Organoselenium Compounds inhibits the reaction [Streptozocin results in decreased expression of BCL2 protein] |
CTD |
PMID:25301743 |
|
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
|
|
G |
CASP3 |
caspase 3 |
increases cleavage |
EXP |
Organoselenium Compounds results in increased cleavage of CASP3 protein |
CTD |
PMID:24905917 |
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
CDKN1A |
cyclin dependent kinase inhibitor 1A |
multiple interactions |
ISO |
Organoselenium Compounds inhibits the reaction [Streptozocin results in increased expression of CDKN1A protein] |
CTD |
PMID:25301743 |
|
NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,337
|
|
G |
CYP1A1 |
cytochrome P450 family 1 subfamily A member 1 |
multiple interactions |
EXP |
Organoselenium Compounds binds to and results in decreased activity of CYP1A1 protein |
CTD |
PMID:21732699 |
|
NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
|
|
G |
CYP1A2 |
cytochrome P450 family 1 subfamily A member 2 |
multiple interactions |
EXP |
Organoselenium Compounds binds to and results in decreased activity of CYP1A2 protein |
CTD |
PMID:21732699 |
|
NCBI chr15:74,748,845...74,756,607
Ensembl chr15:74,748,845...74,756,607
|
|
G |
CYP1B1 |
cytochrome P450 family 1 subfamily B member 1 |
multiple interactions |
EXP |
Organoselenium Compounds binds to and results in decreased activity of CYP1B1 protein |
CTD |
PMID:21732699 |
|
NCBI chr 2:38,067,509...38,076,151
Ensembl chr 2:38,066,973...38,109,902
|
|
G |
CYP2A13 |
cytochrome P450 family 2 subfamily A member 13 |
multiple interactions |
EXP |
Organoselenium Compounds binds to and results in decreased activity of CYP2A13 protein |
CTD |
PMID:21732699 |
|
NCBI chr19:41,088,451...41,096,195
Ensembl chr19:41,088,451...41,096,195
|
|
G |
CYP2A6 |
cytochrome P450 family 2 subfamily A member 6 |
multiple interactions |
EXP |
Organoselenium Compounds binds to and results in decreased activity of CYP2A6 protein |
CTD |
PMID:21732699 |
|
NCBI chr19:40,843,541...40,850,447
Ensembl chr19:40,843,541...40,850,447
|
|
G |
DNAJA1 |
DnaJ heat shock protein family (Hsp40) member A1 |
multiple interactions |
EXP |
[Organoselenium Compounds binds to Copper] which results in increased expression of DNAJA1 mRNA |
CTD |
PMID:25167922 |
|
NCBI chr 9:33,025,273...33,039,907
Ensembl chr 9:33,025,273...33,039,907
|
|
G |
DNAJA4 |
DnaJ heat shock protein family (Hsp40) member A4 |
multiple interactions |
EXP |
[Organoselenium Compounds binds to Copper] which results in increased expression of DNAJA4 mRNA |
CTD |
PMID:25167922 |
|
NCBI chr15:78,264,145...78,282,191
Ensembl chr15:78,264,086...78,282,196
|
|
G |
DNAJB1 |
DnaJ heat shock protein family (Hsp40) member B1 |
multiple interactions |
EXP |
[Organoselenium Compounds binds to Copper] which results in increased expression of DNAJB1 mRNA |
CTD |
PMID:25167922 |
|
NCBI chr19:14,514,769...14,560,391
Ensembl chr19:14,514,769...14,560,391
|
|
G |
DNAJB4 |
DnaJ heat shock protein family (Hsp40) member B4 |
multiple interactions |
EXP |
[Organoselenium Compounds binds to Copper] which results in increased expression of DNAJB4 mRNA |
CTD |
PMID:25167922 |
|
NCBI chr 1:77,979,175...78,017,964
Ensembl chr 1:77,979,175...78,017,964
|
|
G |
DNAJB6 |
DnaJ heat shock protein family (Hsp40) member B6 |
multiple interactions |
EXP |
[Organoselenium Compounds binds to Copper] which results in increased expression of DNAJB6 mRNA |
CTD |
PMID:25167922 |
|
NCBI chr 7:157,337,004...157,417,439
Ensembl chr 7:157,335,381...157,417,439
|
|
G |
DNAJB9 |
DnaJ heat shock protein family (Hsp40) member B9 |
multiple interactions |
EXP |
[Organoselenium Compounds binds to Copper] which results in increased expression of DNAJB9 mRNA |
CTD |
PMID:25167922 |
|
NCBI chr 7:108,569,874...108,574,850
Ensembl chr 7:108,569,867...108,574,850
|
|
G |
EGLN3 |
egl-9 family hypoxia inducible factor 3 |
multiple interactions |
EXP |
[Organoselenium Compounds binds to Copper] which results in increased expression of EGLN3 mRNA |
CTD |
PMID:25167922 |
|
NCBI chr14:33,924,227...33,951,074
Ensembl chr14:33,924,227...34,462,774
|
|
G |
EPHX1 |
epoxide hydrolase 1 |
increases activity |
ISO |
Organoselenium Compounds results in increased activity of EPHX1 protein |
CTD |
PMID:17163488 |
|
NCBI chr 1:225,810,124...225,845,563
Ensembl chr 1:225,810,124...225,845,563
|
|
G |
FN1 |
fibronectin 1 |
multiple interactions |
ISO |
Organoselenium Compounds inhibits the reaction [Streptozocin results in increased expression of FN1 protein] |
CTD |
PMID:25301743 |
|
NCBI chr 2:215,360,865...215,436,068
Ensembl chr 2:215,360,440...215,436,073
|
|
G |
FOS |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
EXP |
[Organoselenium Compounds binds to Copper] which results in increased expression of FOS mRNA |
CTD |
PMID:25167922 |
|
NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,282,230
|
|
G |
FOSL1 |
FOS like 1, AP-1 transcription factor subunit |
multiple interactions |
EXP |
[Organoselenium Compounds binds to Copper] which results in increased expression of FOSL1 mRNA |
CTD |
PMID:25167922 |
|
NCBI chr11:65,892,049...65,900,545
Ensembl chr11:65,892,049...65,900,573
|
|
G |
GCLM |
glutamate-cysteine ligase modifier subunit |
multiple interactions |
EXP |
[Organoselenium Compounds binds to Copper] which results in increased expression of GCLM mRNA |
CTD |
PMID:25167922 |
|
NCBI chr 1:93,885,199...93,909,430
Ensembl chr 1:93,885,199...93,909,456
|
|
G |
GPX1 |
glutathione peroxidase 1 |
multiple interactions increases expression |
ISO |
[Organoselenium Compounds co-treated with Lipopolysaccharides] results in increased expression of GPX1 protein Organoselenium Compounds results in increased expression of GPX1 protein |
CTD |
PMID:20883674 |
|
NCBI chr 3:49,357,176...49,358,353
Ensembl chr 3:49,357,174...49,358,605
|
|
G |
HERPUD1 |
homocysteine inducible ER protein with ubiquitin like domain 1 |
multiple interactions |
EXP |
[Organoselenium Compounds binds to Copper] which results in increased expression of HERPUD1 mRNA |
CTD |
PMID:25167922 |
|
NCBI chr16:56,932,142...56,944,864
Ensembl chr16:56,932,142...56,944,864
|
|
G |
HMOX1 |
heme oxygenase 1 |
multiple interactions |
EXP |
[Organoselenium Compounds binds to Copper] which results in increased expression of HMOX1 mRNA |
CTD |
PMID:25167922 |
|
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
|
|
G |
HSP90AA1 |
heat shock protein 90 alpha family class A member 1 |
multiple interactions |
EXP |
[Organoselenium Compounds binds to Copper] which results in decreased expression of HSP90AA1 protein; [Organoselenium Compounds binds to Copper] which results in increased expression of HSP90AA1 mRNA |
CTD |
PMID:25167922 |
|
NCBI chr14:102,080,742...102,139,749
Ensembl chr14:102,080,742...102,139,699
|
|
G |
HSPA1A |
heat shock protein family A (Hsp70) member 1A |
multiple interactions |
EXP |
[Organoselenium Compounds binds to Copper] which results in increased expression of HSPA1A mRNA |
CTD |
PMID:25167922 |
|
NCBI chr 6:31,815,543...31,817,942
Ensembl chr 6:31,815,543...31,817,946
|
|
G |
HSPA1B |
heat shock protein family A (Hsp70) member 1B |
multiple interactions |
EXP |
[Organoselenium Compounds binds to Copper] which results in increased expression of HSPA1B mRNA |
CTD |
PMID:25167922 |
|
NCBI chr 6:31,827,738...31,830,254
Ensembl chr 6:31,827,738...31,830,254
|
|
G |
HSPA1L |
heat shock protein family A (Hsp70) member 1 like |
multiple interactions |
EXP |
[Organoselenium Compounds binds to Copper] which results in increased expression of HSPA1L mRNA |
CTD |
PMID:25167922 |
|
NCBI chr 6:31,809,619...31,815,283
Ensembl chr 6:31,809,619...31,815,283
|
|
G |
HSPA6 |
heat shock protein family A (Hsp70) member 6 |
multiple interactions |
EXP |
[Organoselenium Compounds binds to Copper] which results in increased expression of HSPA6 mRNA |
CTD |
PMID:25167922 |
|
NCBI chr 1:161,524,540...161,526,894
Ensembl chr 1:161,524,540...161,526,894
|
|
G |
HSPB8 |
heat shock protein family B (small) member 8 |
multiple interactions |
EXP |
[Organoselenium Compounds binds to Copper] which results in increased expression of HSPB8 mRNA |
CTD |
PMID:25167922 |
|
NCBI chr12:119,178,931...119,194,746
Ensembl chr12:119,171,555...119,224,855
|
|
G |
HSPH1 |
heat shock protein family H (Hsp110) member 1 |
multiple interactions |
EXP |
[Organoselenium Compounds binds to Copper] which results in increased expression of HSPH1 mRNA |
CTD |
PMID:25167922 |
|
NCBI chr13:31,134,973...31,162,388
Ensembl chr13:31,134,973...31,162,388
|
|
G |
IFNG |
interferon gamma |
multiple interactions |
ISO |
Organoselenium Compounds inhibits the reaction [Freund's Adjuvant results in increased expression of IFNG mRNA] |
CTD |
PMID:31400342 |
|
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
|
|
G |
IL1B |
interleukin 1 beta |
multiple interactions |
ISO |
Organoselenium Compounds inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA] |
CTD |
PMID:18538761 |
|
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
JUN |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
EXP |
[Organoselenium Compounds binds to Copper] which results in increased expression of JUN mRNA |
CTD |
PMID:25167922 |
|
NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048
|
|
G |
JUNB |
JunB proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
EXP |
[Organoselenium Compounds binds to Copper] which results in increased expression of JUNB mRNA |
CTD |
PMID:25167922 |
|
NCBI chr19:12,791,486...12,793,315
Ensembl chr19:12,791,486...12,793,315
|
|
G |
MAFF |
MAF bZIP transcription factor F |
multiple interactions |
EXP |
[Organoselenium Compounds binds to Copper] which results in increased expression of MAFF mRNA |
CTD |
PMID:25167922 |
|
NCBI chr22:38,201,994...38,216,511
Ensembl chr22:38,200,767...38,216,507
|
|
G |
MAFG |
MAF bZIP transcription factor G |
multiple interactions |
EXP |
[Organoselenium Compounds binds to Copper] which results in increased expression of MAFG mRNA |
CTD |
PMID:25167922 |
|
NCBI chr17:81,918,270...81,931,244
Ensembl chr17:81,918,270...81,927,735
|
|
G |
MAP2K6 |
mitogen-activated protein kinase kinase 6 |
multiple interactions |
EXP |
[Organoselenium Compounds binds to Copper] which results in decreased expression of MAP2K6 mRNA |
CTD |
PMID:25167922 |
|
NCBI chr17:69,414,697...69,553,865
Ensembl chr17:69,414,697...69,553,865
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
increases phosphorylation increases activity |
ISO |
Organoselenium Compounds analog results in increased phosphorylation of MAPK1 protein Organoselenium Compounds results in increased activity of MAPK1 protein |
CTD |
PMID:21960664 PMID:22001386 |
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
|
|
G |
MAPK15 |
mitogen-activated protein kinase 15 |
multiple interactions |
EXP |
[Organoselenium Compounds binds to Copper] which results in increased expression of MAPK15 mRNA |
CTD |
PMID:25167922 |
|
NCBI chr 8:143,716,349...143,722,458
Ensembl chr 8:143,716,340...143,722,458
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
increases activity increases phosphorylation |
ISO |
Organoselenium Compounds results in increased activity of MAPK3 protein Organoselenium Compounds analog results in increased phosphorylation of MAPK3 protein |
CTD |
PMID:21960664 PMID:22001386 |
|
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
|
|
G |
MMP1 |
matrix metallopeptidase 1 |
multiple interactions |
EXP |
[Organoselenium Compounds binds to Copper] which results in increased expression of MMP1 mRNA |
CTD |
PMID:25167922 |
|
NCBI chr11:102,789,919...102,798,160
Ensembl chr11:102,789,401...102,798,160
|
|
G |
MMP10 |
matrix metallopeptidase 10 |
multiple interactions |
EXP |
[Organoselenium Compounds binds to Copper] which results in increased expression of MMP10 mRNA |
CTD |
PMID:25167922 |
|
NCBI chr11:102,770,502...102,780,628
Ensembl chr11:102,770,502...102,780,628
|
|
G |
MMP25 |
matrix metallopeptidase 25 |
multiple interactions |
EXP |
[Organoselenium Compounds binds to Copper] which results in increased expression of MMP25 mRNA |
CTD |
PMID:25167922 |
|
NCBI chr16:3,046,561...3,060,726
Ensembl chr16:3,046,062...3,060,726
|
|
G |
MT1B |
metallothionein 1B |
multiple interactions |
EXP |
[Organoselenium Compounds binds to Copper] which results in increased expression of MT1B mRNA |
CTD |
PMID:25167922 |
|
NCBI chr16:56,651,886...56,653,204
Ensembl chr16:56,651,886...56,653,204
|
|
G |
MT1E |
metallothionein 1E |
multiple interactions |
EXP |
[Organoselenium Compounds binds to Copper] which results in increased expression of MT1E mRNA |
CTD |
PMID:25167922 |
|
NCBI chr16:56,625,781...56,627,112
Ensembl chr16:56,625,475...56,627,112
|
|
G |
MT1F |
metallothionein 1F |
multiple interactions |
EXP |
[Organoselenium Compounds binds to Copper] which results in increased expression of MT1F mRNA |
CTD |
PMID:25167922 |
|
NCBI chr16:56,657,959...56,659,303
Ensembl chr16:56,657,731...56,660,698
|
|
G |
MT1G |
metallothionein 1G |
multiple interactions |
EXP |
[Organoselenium Compounds binds to Copper] which results in increased expression of MT1G mRNA |
CTD |
PMID:25167922 |
|
NCBI chr16:56,666,730...56,668,065
Ensembl chr16:56,666,730...56,668,065
|
|
G |
MT1H |
metallothionein 1H |
multiple interactions |
EXP |
[Organoselenium Compounds binds to Copper] which results in increased expression of MT1H mRNA |
CTD |
PMID:25167922 |
|
NCBI chr16:56,669,814...56,671,129
Ensembl chr16:56,669,814...56,671,129
|
|
G |
MT1M |
metallothionein 1M |
multiple interactions |
EXP |
[Organoselenium Compounds binds to Copper] which results in increased expression of MT1M mRNA |
CTD |
PMID:25167922 |
|
NCBI chr16:56,632,659...56,633,981
Ensembl chr16:56,632,659...56,633,981
|
|
G |
MT1X |
metallothionein 1X |
multiple interactions |
EXP |
[Organoselenium Compounds binds to Copper] which results in increased expression of MT1X mRNA |
CTD |
PMID:25167922 |
|
NCBI chr16:56,682,470...56,684,196
Ensembl chr16:56,682,470...56,684,196
|
|
G |
MT2A |
metallothionein 2A |
multiple interactions |
EXP |
[Organoselenium Compounds binds to Copper] which results in increased expression of MT2A mRNA |
CTD |
PMID:25167922 |
|
NCBI chr16:56,608,584...56,609,497
Ensembl chr16:56,608,584...56,609,497
|
|
G |
NOS2 |
nitric oxide synthase 2 |
multiple interactions |
ISO |
Organoselenium Compounds results in decreased susceptibility to [Lipopolysaccharides results in increased expression of NOS2 mRNA]; Organoselenium Compounds results in decreased susceptibility to [Lipopolysaccharides results in increased expression of NOS2 protein] Organoselenium Compounds inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] |
CTD |
PMID:18538761 PMID:20883674 |
|
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|
G |
PARP1 |
poly(ADP-ribose) polymerase 1 |
increases cleavage |
EXP |
Organoselenium Compounds results in increased cleavage of PARP1 protein |
CTD |
PMID:24905917 |
|
NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
|
|
G |
PGF |
placental growth factor |
multiple interactions |
EXP |
[Organoselenium Compounds binds to Copper] which results in increased expression of PGF mRNA |
CTD |
PMID:25167922 |
|
NCBI chr14:74,941,830...74,955,764
Ensembl chr14:74,941,834...74,955,626
|
|
G |
PIK3R5 |
phosphoinositide-3-kinase regulatory subunit 5 |
multiple interactions |
EXP |
[Organoselenium Compounds binds to Copper] which results in increased expression of PIK3R5 mRNA |
CTD |
PMID:25167922 |
|
NCBI chr17:8,878,916...8,965,707
Ensembl chr17:8,878,911...8,965,712
|
|
G |
PIM1 |
Pim-1 proto-oncogene, serine/threonine kinase |
multiple interactions |
EXP |
[Organoselenium Compounds binds to Copper] which results in decreased expression of PIM1 protein; [Organoselenium Compounds binds to Copper] which results in increased expression of PIM1 mRNA |
CTD |
PMID:25167922 |
|
NCBI chr 6:37,170,152...37,175,428
Ensembl chr 6:37,170,152...37,175,428
|
|
G |
PPP1R15A |
protein phosphatase 1 regulatory subunit 15A |
multiple interactions |
EXP |
[Organoselenium Compounds binds to Copper] which results in increased expression of PPP1R15A mRNA |
CTD |
PMID:25167922 |
|
NCBI chr19:48,872,421...48,876,058
Ensembl chr19:48,872,212...48,876,059
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions decreases activity |
ISO EXP |
Organoselenium Compounds inhibits the reaction [Freund's Adjuvant results in increased expression of PTGS2 mRNA]; Organoselenium Compounds results in decreased susceptibility to [Lipopolysaccharides results in increased expression of PTGS2 protein] Organoselenium Compounds inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] Organoselenium Compounds results in decreased activity of PTGS2 protein |
CTD |
PMID:18538761 PMID:20883674 PMID:31400342 |
|
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
|
|
G |
RELA |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
Organoselenium Compounds inhibits the reaction [Lipopolysaccharides results in increased activity of RELA protein] |
CTD |
PMID:18538761 |
|
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
|
|
G |
SGK1 |
serum/glucocorticoid regulated kinase 1 |
multiple interactions |
EXP |
[Organoselenium Compounds binds to Copper] which results in increased expression of SGK1 mRNA |
CTD |
PMID:25167922 |
|
NCBI chr 6:134,169,256...134,318,112
Ensembl chr 6:134,169,248...134,318,112
|
|
G |
SIRT1 |
sirtuin 1 |
multiple interactions |
ISO |
Organoselenium Compounds inhibits the reaction [Streptozocin results in decreased expression of SIRT1 protein] |
CTD |
PMID:25301743 |
|
NCBI chr10:67,884,656...67,918,390
Ensembl chr10:67,884,656...67,918,390
|
|
G |
SLC2A1 |
solute carrier family 2 member 1 |
multiple interactions |
EXP |
[Organoselenium Compounds binds to Copper] which results in increased expression of SLC2A1 mRNA |
CTD |
PMID:25167922 |
|
NCBI chr 1:42,925,353...42,958,868
Ensembl chr 1:42,925,353...42,958,893
|
|
G |
SLC2A3 |
solute carrier family 2 member 3 |
multiple interactions |
EXP |
[Organoselenium Compounds binds to Copper] which results in increased expression of SLC2A3 mRNA |
CTD |
PMID:25167922 |
|
NCBI chr12:7,919,230...7,936,187
Ensembl chr12:7,919,230...7,936,187
|
|
G |
SQSTM1 |
sequestosome 1 |
multiple interactions |
EXP |
[Organoselenium Compounds binds to Copper] which results in increased expression of SQSTM1 mRNA |
CTD |
PMID:25167922 |
|
NCBI chr 5:179,806,393...179,838,078
Ensembl chr 5:179,806,398...179,838,078
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions decreases expression |
ISO |
Organoselenium Compounds results in decreased susceptibility to [Lipopolysaccharides results in increased expression of TNF mRNA] Organoselenium Compounds results in decreased expression of TNF protein Organoselenium Compounds inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; Organoselenium Compounds inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein] |
CTD |
PMID:18538761 PMID:20883674 PMID:31400342 |
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
TRIB3 |
tribbles pseudokinase 3 |
multiple interactions |
EXP |
[Organoselenium Compounds binds to Copper] which results in increased expression of TRIB3 mRNA |
CTD |
PMID:25167922 |
|
NCBI chr20:380,760...397,559
Ensembl chr20:362,835...397,559
|
|
G |
TXNRD1 |
thioredoxin reductase 1 |
multiple interactions |
EXP |
[Organoselenium Compounds binds to Copper] which results in increased expression of TXNRD1 mRNA |
CTD |
PMID:25167922 |
|
NCBI chr12:104,215,779...104,350,307
Ensembl chr12:104,215,779...104,350,307
|
|
G |
VEGFA |
vascular endothelial growth factor A |
multiple interactions |
EXP |
[Organoselenium Compounds binds to Copper] which results in increased expression of VEGFA mRNA |
CTD |
PMID:25167922 |
|
NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
|
|
G |
VEGFC |
vascular endothelial growth factor C |
multiple interactions |
EXP |
[Organoselenium Compounds binds to Copper] which results in decreased expression of VEGFC mRNA |
CTD |
PMID:25167922 |
|
NCBI chr 4:176,683,538...176,792,922
Ensembl chr 4:176,683,538...176,792,922
|
|
|
G |
AAK1 |
AP2 associated kinase 1 |
multiple interactions |
EXP |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of THY1-AS1 mRNA] which results in increased expression of AAK1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 2:69,457,997...69,643,739
Ensembl chr 2:69,457,997...69,674,349
|
|
G |
ACBD3 |
acyl-CoA binding domain containing 3 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of ACBD3-AS1 mRNA] which results in increased expression of ACBD3 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of ACBD3-AS1 mRNA] which results in increased expression of ACBD3 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 1:226,144,679...226,186,741
Ensembl chr 1:226,144,679...226,186,741
|
|
G |
ACBD3-AS1 |
ACBD3 antisense RNA 1 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of ACBD3-AS1 mRNA] which results in increased expression of ACBD3 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of ACBD3-AS1 mRNA] which results in increased expression of ACBD3 mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of ACBD3-AS1 mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in increased expression of ACBD3-AS1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 1:226,148,003...226,154,977
Ensembl chr 1:226,148,003...226,155,071
|
|
G |
ACHE |
acetylcholinesterase (Cartwright blood group) |
multiple interactions |
EXP |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PICART1 mRNA] which results in increased expression of ACHE mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 7:100,889,994...100,896,994
Ensembl chr 7:100,889,994...100,896,974
|
|
G |
ADIRF-AS1 |
ADIRF antisense RNA 1 |
multiple interactions |
EXP |
[[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of ADIRF-AS1 mRNA] which results in increased expression of MMRN2 mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in increased expression of ADIRF-AS1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr10:86,965,287...86,971,240
Ensembl chr10:86,965,345...86,971,311
|
|
G |
ANKAR |
ankyrin and armadillo repeat containing |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of OSGEPL1-AS1 mRNA] which results in increased expression of ANKAR mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 2:189,674,670...189,763,059
Ensembl chr 2:189,674,290...189,761,193
|
|
G |
ARAP1 |
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of ARAP1-AS1 mRNA] which results in increased expression of ARAP1 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of ARAP1-AS1 mRNA] which results in increased expression of ARAP1 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of ARAP1-AS2 mRNA] which results in increased expression of ARAP1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr11:72,685,069...72,752,408
Ensembl chr11:72,685,069...72,793,599
|
|
G |
ARAP1-AS1 |
ARAP1 antisense RNA 1 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of ARAP1-AS1 mRNA] which results in increased expression of ARAP1 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of ARAP1-AS1 mRNA] which results in increased expression of ARAP1 mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of ARAP1-AS1 mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in increased expression of ARAP1-AS1 mRNA |
CTD |
PMID:33656867 |
|
Ensembl chr11:72,685,075...72,693,808
|
|
G |
ARAP1-AS2 |
ARAP1 antisense RNA 2 |
multiple interactions |
EXP |
[[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of ARAP1-AS2 mRNA] which results in increased expression of ARAP1 mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in increased expression of ARAP1-AS2 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr11:72,700,474...72,705,607
Ensembl chr11:72,700,474...72,705,607
|
|
G |
ARHGAP30 |
Rho GTPase activating protein 30 |
multiple interactions |
EXP |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of THY1-AS1 mRNA] which results in increased expression of ARHGAP30 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 1:161,046,946...161,069,891
Ensembl chr 1:161,046,946...161,069,970
|
|
G |
BEX2 |
brain expressed X-linked 2 |
multiple interactions |
EXP |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in increased expression of BEX2 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr X:103,309,346...103,310,990
Ensembl chr X:103,309,346...103,311,007
|
|
G |
C4orf3 |
chromosome 4 open reading frame 3 |
multiple interactions |
EXP |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in decreased expression of C4ORF3 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 4:119,296,419...119,304,445
Ensembl chr 4:119,296,419...119,304,445
|
|
G |
C5AR1 |
complement C5a receptor 1 |
multiple interactions |
EXP |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in increased expression of C5AR1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr19:47,307,477...47,322,066
Ensembl chr19:47,290,023...47,322,066
|
|
G |
CATIP |
ciliogenesis associated TTC17 interacting protein |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of CATIP-AS1 mRNA] which results in increased expression of CATIP mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of CATIP-AS1 mRNA] which results in increased expression of CATIP mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 2:218,356,857...218,368,094
Ensembl chr 2:218,356,857...218,368,099
|
|
G |
CATIP-AS1 |
CATIP antisense RNA 1 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of CATIP-AS1 mRNA] which results in increased expression of CATIP mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of CATIP-AS1 mRNA] which results in increased expression of CATIP mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of CATIP-AS1 mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in increased expression of CATIP-AS1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 2:218,366,665...218,367,902
Ensembl chr 2:218,366,661...218,367,885
|
|
G |
CCDC183 |
coiled-coil domain containing 183 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of CCDC183-AS1 mRNA] which results in increased expression of CCDC183 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of CCDC183-AS1 mRNA] which results in increased expression of CCDC183 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 9:136,796,338...136,807,741
Ensembl chr 9:136,796,338...136,807,741
|
|
G |
CCDC183-AS1 |
CCDC183 antisense RNA 1 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of CCDC183-AS1 mRNA] which results in increased expression of CCDC183 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of CCDC183-AS1 mRNA] which results in increased expression of CCDC183 mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of CCDC183-AS1 mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in increased expression of CCDC183-AS1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 9:136,803,927...136,808,848
Ensembl chr 9:136,803,927...136,808,848
|
|
G |
CDH2 |
cadherin 2 |
multiple interactions |
EXP |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in decreased expression of CDH2 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr18:27,932,879...28,177,130
Ensembl chr18:27,932,879...28,177,946
|
|
G |
CELF3 |
CUGBP Elav-like family member 3 |
multiple interactions |
EXP |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01679 mRNA] which results in increased expression of CELF3 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 1:151,700,058...151,716,803
Ensembl chr 1:151,700,058...151,716,803
|
|
G |
CIMAP1C |
ciliary microtubule associated protein 1C |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of DNM1P35 mRNA] which results in increased expression of ODF3L1 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of DNM1P35 mRNA] which results in increased expression of ODF3L1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr15:75,724,041...75,727,688
Ensembl chr15:75,724,041...75,727,688
|
|
G |
COL4A2 |
collagen type IV alpha 2 chain |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of COL4A2-AS1 mRNA] which results in decreased expression of COL4A2 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of COL4A2-AS2 mRNA] which results in decreased expression of COL4A2 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr13:110,307,284...110,513,209
Ensembl chr13:110,305,812...110,513,209
|
|
G |
COL4A2-AS1 |
COL4A2 antisense RNA 1 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of COL4A2-AS1 mRNA] which results in decreased expression of COL4A2 mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of COL4A2-AS1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr13:110,502,576...110,508,179
Ensembl chr13:110,502,575...110,508,179
|
|
G |
COL4A2-AS2 |
COL4A2 antisense RNA 2 |
multiple interactions |
EXP |
[[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of COL4A2-AS2 mRNA] which results in decreased expression of COL4A2 mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of COL4A2-AS2 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr13:110,456,397...110,463,287
Ensembl chr13:110,456,396...110,463,287
|
|
G |
COL7A1 |
collagen type VII alpha 1 chain |
multiple interactions |
EXP |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PINCR mRNA] which results in increased expression of COL7A1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 3:48,564,073...48,595,329
Ensembl chr 3:48,564,073...48,595,329
|
|
G |
CORO1A |
coronin 1A |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of CORO1A-AS1 mRNA] which results in decreased expression of CORO1A mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of CORO1A-AS1 mRNA] which results in decreased expression of CORO1A mRNA |
CTD |
PMID:33656867 |
|
NCBI chr16:30,183,602...30,189,076
Ensembl chr16:30,182,827...30,189,076
|
|
G |
CORO1A-AS1 |
CORO1A antisense RNA 1 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of CORO1A-AS1 mRNA] which results in decreased expression of CORO1A mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of CORO1A-AS1 mRNA] which results in decreased expression of CORO1A mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of CORO1A-AS1 mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of CORO1A-AS1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr16:30,183,393...30,185,202
|
|
G |
CSRP3-AS1 |
CSRP3 and E2F8 antisense RNA 1 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of CSRP3-AS1 mRNA] which results in increased expression of E2F8 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of CSRP3-AS1 mRNA] which results in increased expression of E2F8 mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of CSRP3-AS1 mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in increased expression of CSRP3-AS1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr11:19,196,713...19,313,258
Ensembl chr11:19,196,775...19,281,426
|
|
G |
DDIT4 |
DNA damage inducible transcript 4 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in decreased expression of DDIT4 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in decreased expression of DDIT4 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr10:72,273,924...72,276,036
Ensembl chr10:72,273,919...72,276,036
|
|
G |
DDIT4-AS1 |
DDIT4 antisense RNA 1 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in decreased expression of DDIT4 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in decreased expression of DDIT4 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in decreased expression of NPR3 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in decreased expression of ZNF385D mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in increased expression of HOXB9 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in increased expression of KCNC4 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in increased expression of PGPEP1 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in increased expression of POPDC2 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in increased expression of PSMB11 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in increased expression of RIIAD1 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in increased expression of SSTR5 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in increased expression of TP53I11 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in increased expression of WNT9A mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in increased expression of ZBTB5 mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA; [Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA |
CTD |
PMID:33656867 |
|
Ensembl chr10:72,274,915...72,275,980
|
|
G |
DDX59 |
DEAD-box helicase 59 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of DDX59-AS1 mRNA] which results in increased expression of DDX59 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of DDX59-AS1 mRNA] which results in increased expression of DDX59 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 1:200,640,805...200,669,907
Ensembl chr 1:200,623,896...200,669,907
|
|
G |
DDX59-AS1 |
DDX59 antisense RNA 1 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of DDX59-AS1 mRNA] which results in increased expression of DDX59 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of DDX59-AS1 mRNA] which results in increased expression of DDX59 mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of DDX59-AS1 mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in increased expression of DDX59-AS1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 1:200,669,507...200,694,250
Ensembl chr 1:200,669,507...200,694,250
|
|
G |
DLGAP1 |
DLG associated protein 1 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in increased expression of DLGAP1 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in increased expression of DLGAP1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr18:3,496,032...4,455,307
Ensembl chr18:3,496,032...4,455,307
|
|
G |
DLGAP1-AS2 |
DLGAP1 antisense RNA 2 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in increased expression of DLGAP1 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in increased expression of DLGAP1 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in decreased expression of C4ORF3 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in decreased expression of CDH2 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in decreased expression of EGLN3 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in decreased expression of METRN mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in decreased expression of NPR3 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in decreased expression of S100A2 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in increased expression of BEX2 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in increased expression of C5AR1 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in increased expression of INHBA mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in increased expression of IQSEC3 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in increased expression of IRGQ mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in increased expression of KIAA1614 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in increased expression of NYAP1 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in increased expression of SEMA3G mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in increased expression of ZNF114 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in increased expression of ZNF662 mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA; [Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr18:3,603,737...3,610,089
Ensembl chr18:3,603,000...3,610,103
|
|
G |
DNM1P35 |
dynamin 1 pseudogene 35 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of DNM1P35 mRNA] which results in increased expression of ODF3L1 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of DNM1P35 mRNA] which results in increased expression of ODF3L1 mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of DNM1P35 mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in increased expression of DNM1P35 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr15:75,727,670...75,740,077
Ensembl chr15:75,727,670...75,738,629
|
|
G |
DNMT3L |
DNA methyltransferase 3 like |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of DNMT3L-AS1 mRNA] which results in increased expression of DNMT3L mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of DNMT3L-AS1 mRNA] which results in increased expression of DNMT3L mRNA |
CTD |
PMID:33656867 |
|
NCBI chr21:44,246,339...44,261,897
Ensembl chr21:44,246,339...44,262,216
|
|
G |
DNMT3L-AS1 |
DNMT3L antisense RNA 1 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of DNMT3L-AS1 mRNA] which results in increased expression of DNMT3L mRNA; [[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of DNMT3L-AS1 mRNA] which results in increased expression of ICOSLG mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of DNMT3L-AS1 mRNA] which results in increased expression of DNMT3L mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of DNMT3L-AS1 mRNA] which results in increased expression of ICOSLG mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of DNMT3L-AS1 mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in increased expression of DNMT3L-AS1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr21:44,250,813...44,251,521
Ensembl chr21:44,250,813...44,251,520
|
|
G |
DOCK3 |
dedicator of cytokinesis 3 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of LINC02019 mRNA] which results in increased expression of DOCK3 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 3:50,674,927...51,384,198
Ensembl chr 3:50,674,927...51,384,198
|
|
G |
DYNLT2B |
dynein light chain Tctex-type 2B |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of TM4SF19-AS1 mRNA] which results in increased expression of DYNLT2B mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 3:196,291,219...196,318,240
Ensembl chr 3:196,291,219...196,318,299
|
|
G |
E2F8 |
E2F transcription factor 8 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of CSRP3-AS1 mRNA] which results in increased expression of E2F8 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of CSRP3-AS1 mRNA] which results in increased expression of E2F8 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr11:19,224,063...19,241,655
Ensembl chr11:19,224,063...19,241,620
|
|
G |
EGLN3 |
egl-9 family hypoxia inducible factor 3 |
multiple interactions |
EXP |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in decreased expression of EGLN3 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr14:33,924,227...33,951,074
Ensembl chr14:33,924,227...34,462,774
|
|
G |
EPB41L1 |
erythrocyte membrane protein band 4.1 like 1 |
multiple interactions |
EXP |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01629 mRNA] which results in decreased expression of EPB41L1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr20:36,091,414...36,232,799
Ensembl chr20:36,091,504...36,232,799
|
|
G |
FAM83F |
family with sequence similarity 83 member F |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of TNRC6B-DT mRNA] which results in increased expression of FAM83F mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of TNRC6B-DT mRNA] which results in increased expression of FAM83F mRNA |
CTD |
PMID:33656867 |
|
NCBI chr22:39,994,954...40,043,534
Ensembl chr22:39,994,954...40,043,534
|
|
G |
FBXW7 |
F-box and WD repeat domain containing 7 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of FBXW7-AS1 mRNA] which results in increased expression of FBXW7 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of FBXW7-AS1 mRNA] which results in increased expression of FBXW7 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 4:152,320,544...152,536,092
Ensembl chr 4:152,320,544...152,536,092
|
|
G |
FBXW7-AS1 |
FBXW7 antisense RNA 1 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of FBXW7-AS1 mRNA] which results in increased expression of FBXW7 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of FBXW7-AS1 mRNA] which results in increased expression of FBXW7 mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of FBXW7-AS1 mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in increased expression of FBXW7-AS1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 4:152,337,674...152,338,096
Ensembl chr 4:152,337,655...152,338,098
|
|
G |
FHAD1 |
forkhead associated phosphopeptide binding domain 1 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of FHAD1-AS1 mRNA] which results in increased expression of FHAD1 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of FHAD1-AS1 mRNA] which results in increased expression of FHAD1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 1:15,236,521...15,403,010
Ensembl chr 1:15,236,521...15,400,283
|
|
G |
FHAD1-AS1 |
FHAD1 antisense RNA 1 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of FHAD1-AS1 mRNA] which results in increased expression of FHAD1 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of FHAD1-AS1 mRNA] which results in increased expression of FHAD1 mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of FHAD1-AS1 mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in increased expression of FHAD1-AS1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 1:15,326,680...15,343,883
Ensembl chr 1:15,326,680...15,343,876
|
|
G |
FLNB |
filamin B |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of FLNB-AS1 mRNA] which results in decreased expression of FLNB mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of FLNB-AS1 mRNA] which results in decreased expression of FLNB mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 3:58,008,422...58,172,251
Ensembl chr 3:58,008,398...58,172,251
|
|
G |
FLNB-AS1 |
FLNB antisense RNA 1 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of FLNB-AS1 mRNA] which results in decreased expression of FLNB mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of FLNB-AS1 mRNA] which results in decreased expression of FLNB mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of FLNB-AS1 mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of FLNB-AS1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 3:58,162,547...58,170,635
Ensembl chr 3:58,162,547...58,170,636
|
|
G |
FLNC |
filamin C |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of FLNC-AS1 mRNA] which results in increased expression of FLNC mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of FLNC-AS1 mRNA] which results in increased expression of FLNC mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 7:128,830,406...128,859,272
Ensembl chr 7:128,830,406...128,859,274
|
|
G |
FLNC-AS1 |
FLNC antisense RNA 1 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of FLNC-AS1 mRNA] which results in increased expression of FLNC mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of FLNC-AS1 mRNA] which results in increased expression of FLNC mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of FLNC-AS1 mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in increased expression of FLNC-AS1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 7:128,850,162...128,862,626
Ensembl chr 7:128,850,162...128,862,626
|
|
G |
FOXC2 |
forkhead box C2 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of FOXC2-AS1 mRNA] which results in decreased expression of FOXC2 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of FOXC2-AS1 mRNA] which results in decreased expression of FOXC2 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr16:86,566,829...86,569,728
Ensembl chr16:86,566,829...86,569,728
|
|
G |
FOXC2-AS1 |
FOXC2 antisense RNA 1 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of FOXC2-AS1 mRNA] which results in decreased expression of FOXC2 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of FOXC2-AS1 mRNA] which results in decreased expression of FOXC2 mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of FOXC2-AS1 mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of FOXC2-AS1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr16:86,565,145...86,567,761
Ensembl chr16:86,565,145...86,567,847
|
|
G |
FOXL2 |
forkhead box L2 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of LINC01391 mRNA] which results in increased expression of FOXL2 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 3:138,944,224...138,947,137
Ensembl chr 3:138,944,224...138,947,137
|
|
G |
GCC2 |
GRIP and coiled-coil domain containing 2 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of GCC2-AS1 mRNA] which results in increased expression of GCC2 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 2:108,449,206...108,509,415
Ensembl chr 2:108,449,107...108,509,415
|
|
G |
GCC2-AS1 |
GCC2 antisense RNA 1 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of GCC2-AS1 mRNA] which results in increased expression of GCC2 mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of GCC2-AS1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 2:108,507,527...108,534,219
Ensembl chr 2:108,507,515...108,534,196
|
|
G |
GK |
glycerol kinase |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of GK-AS1 mRNA] which results in increased expression of GK mRNA; [[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of GK-IT1 mRNA] which results in increased expression of GK mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of GK-AS1 mRNA] which results in increased expression of GK mRNA |
CTD |
PMID:33656867 |
|
NCBI chr X:30,653,423...30,731,462
Ensembl chr X:30,653,359...30,731,462
|
|
G |
GK-AS1 |
GK antisense RNA 1 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of GK-AS1 mRNA] which results in increased expression of GK mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of GK-AS1 mRNA] which results in increased expression of GK mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of GK-AS1 mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in increased expression of GK-AS1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr X:30,700,064...30,718,099
Ensembl chr X:30,699,998...30,724,174
|
|
G |
GK-IT1 |
GK intronic transcript 1 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of GK-IT1 mRNA] which results in increased expression of GK mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of GK-IT1 mRNA |
CTD |
PMID:33656867 |
|
Ensembl chr X:30,671,635...30,672,166
|
|
G |
GSN |
gelsolin |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of GSN-AS1 mRNA] which results in decreased expression of GSN mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of GSN-AS1 mRNA] which results in decreased expression of GSN mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 9:121,201,483...121,332,842
Ensembl chr 9:121,207,794...121,332,843
|
|
G |
GSN-AS1 |
GSN antisense RNA 1 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of GSN-AS1 mRNA] which results in decreased expression of GSN mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of GSN-AS1 mRNA] which results in decreased expression of GSN mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of GSN-AS1 mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of GSN-AS1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 9:121,280,768...121,285,530
Ensembl chr 9:121,280,768...121,285,530
|
|
G |
HIF1A |
hypoxia inducible factor 1 subunit alpha |
multiple interactions |
EXP |
[[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of HIF1A-AS1 mRNA] which results in decreased expression of HIF1A mRNA |
CTD |
PMID:33656867 |
|
NCBI chr14:61,695,513...61,748,258
Ensembl chr14:61,695,513...61,748,259
|
|
G |
HIF1A-AS1 |
HIF1A antisense RNA 1 |
multiple interactions |
EXP |
[[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of HIF1A-AS1 mRNA] which results in decreased expression of HIF1A mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of HIF1A-AS1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr14:61,681,041...61,695,823
Ensembl chr14:61,680,723...61,695,892
|
|
G |
HK2 |
hexokinase 2 |
multiple interactions |
EXP |
[[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of HK2-DT mRNA] which results in decreased expression of HK2 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 2:74,834,127...74,893,359
Ensembl chr 2:74,834,127...74,893,359
|
|
G |
HK2-DT |
HK2 divergent transcript |
multiple interactions |
EXP |
[[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of HK2-DT mRNA] which results in decreased expression of HK2 mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of HK2-DT mRNA |
CTD |
PMID:33656867 |
|
Ensembl chr 2:74,832,655...74,833,987
|
|
G |
HMGN3 |
high mobility group nucleosomal binding domain 3 |
multiple interactions |
EXP |
[[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of HMGN3-AS1 mRNA] which results in decreased expression of HMGN3 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 6:79,201,245...79,234,682
Ensembl chr 6:79,201,245...79,234,689
|
|
G |
HMGN3-AS1 |
HMGN3 antisense RNA 1 |
multiple interactions |
EXP |
[[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of HMGN3-AS1 mRNA] which results in decreased expression of HMGN3 mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of HMGN3-AS1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 6:79,233,674...79,236,800
Ensembl chr 6:79,233,699...79,236,797
|
|
G |
HMMR |
hyaluronan mediated motility receptor |
multiple interactions |
EXP |
[[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of HMMR-AS1 mRNA] which results in decreased expression of HMMR mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 5:163,460,632...163,491,941
Ensembl chr 5:163,460,203...163,491,941
|
|
G |
HMMR-AS1 |
HMMR antisense RNA 1 |
multiple interactions |
EXP |
[[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of HMMR-AS1 mRNA] which results in decreased expression of HMMR mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of HMMR-AS1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 5:163,482,604...163,494,058
Ensembl chr 5:163,483,065...163,494,058
|
|
G |
HOXA10 |
homeobox A10 |
multiple interactions |
EXP |
[[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of HOXA10-AS mRNA] which results in increased expression of HOXA10 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 7:27,170,605...27,179,861
Ensembl chr 7:27,170,605...27,180,261
|
|
G |
HOXA10-AS |
HOXA10 antisense RNA |
multiple interactions |
EXP |
[[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of HOXA10-AS mRNA] which results in increased expression of HOXA10 mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in increased expression of HOXA10-AS mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 7:27,168,899...27,171,915
Ensembl chr 7:27,168,619...27,171,915
|
|
G |
HOXB-AS4 |
HOXB cluster antisense RNA 4 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of HOXB-AS4 mRNA] which results in increased expression of HOXB9 mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of HOXB-AS4 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr17:48,628,698...48,634,932
Ensembl chr17:48,628,675...48,634,932
|
|
G |
HOXB4 |
homeobox B4 |
multiple interactions |
EXP |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PICART1 mRNA] which results in decreased expression of HOXB4 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr17:48,575,507...48,578,350
Ensembl chr17:48,575,507...48,578,350
|
|
G |
HOXB9 |
homeobox B9 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of HOXB-AS4 mRNA] which results in increased expression of HOXB9 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in increased expression of HOXB9 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr17:48,621,156...48,626,358
Ensembl chr17:48,621,156...48,626,358
|
|
G |
HOXC13 |
homeobox C13 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of HOXC13-AS mRNA] which results in increased expression of HOXC13 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of HOXC13-AS mRNA] which results in increased expression of HOXC13 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr12:53,938,831...53,946,544
Ensembl chr12:53,938,831...53,946,544
|
|
G |
HOXC13-AS |
HOXC13 antisense RNA |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of HOXC13-AS mRNA] which results in increased expression of HOXC13 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of HOXC13-AS mRNA] which results in increased expression of HOXC13 mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of HOXC13-AS mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in increased expression of HOXC13-AS mRNA |
CTD |
PMID:33656867 |
|
NCBI chr12:53,935,328...53,939,643
Ensembl chr12:53,935,328...53,939,643
|
|
G |
ICOSLG |
inducible T cell costimulator ligand |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of DNMT3L-AS1 mRNA] which results in increased expression of ICOSLG mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of DNMT3L-AS1 mRNA] which results in increased expression of ICOSLG mRNA |
CTD |
PMID:33656867 |
|
NCBI chr21:44,216,981...44,240,943
Ensembl chr21:44,215,382...44,241,446
|
|
G |
IL1RL1 |
interleukin 1 receptor like 1 |
multiple interactions |
EXP |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PINCR mRNA] which results in increased expression of IL1RL1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 2:102,311,563...102,352,356
Ensembl chr 2:102,311,502...102,352,037
|
|
G |
INHBA |
inhibin subunit beta A |
multiple interactions |
EXP |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in increased expression of INHBA mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 7:41,685,114...41,705,406
Ensembl chr 7:41,667,168...41,705,834
|
|
G |
INSIG1 |
insulin induced gene 1 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of INSIG1-DT mRNA] which results in decreased expression of INSIG1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 7:155,297,878...155,310,235
Ensembl chr 7:155,297,776...155,310,235
|
|
G |
INSIG1-DT |
INSIG1 divergent transcript |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of INSIG1-DT mRNA] which results in decreased expression of INSIG1 mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of INSIG1-DT mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 7:155,288,596...155,298,980
|
|
G |
IQSEC3 |
IQ motif and Sec7 domain ArfGEF 3 |
multiple interactions |
EXP |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in increased expression of IQSEC3 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr12:66,767...178,455
Ensembl chr12:66,767...178,455
|
|
G |
IRGQ |
immunity related GTPase Q |
multiple interactions |
EXP |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in increased expression of IRGQ mRNA |
CTD |
PMID:33656867 |
|
NCBI chr19:43,584,367...43,596,134
Ensembl chr19:43,584,367...43,596,134
|
|
G |
ITGA3 |
integrin subunit alpha 3 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of PICART1 mRNA] which results in decreased expression of ITGA3 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of PICART1 mRNA] which results in decreased expression of ITGA3 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr17:50,056,110...50,090,481
Ensembl chr17:50,055,968...50,090,481
|
|
G |
KCNA7 |
potassium voltage-gated channel subfamily A member 7 |
multiple interactions |
EXP |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of THY1-AS1 mRNA] which results in increased expression of KCNA7 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PICART1 mRNA] which results in increased expression of KCNA7 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr19:49,067,397...49,072,699
Ensembl chr19:49,067,397...49,072,699
|
|
G |
KCNC4 |
potassium voltage-gated channel subfamily C member 4 |
multiple interactions |
EXP |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in increased expression of KCNC4 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 1:110,210,314...110,284,080
Ensembl chr 1:110,210,314...110,283,100
|
|
G |
KIAA1614 |
KIAA1614 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of KIAA1614-AS1 mRNA] which results in increased expression of KIAA1614 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of KIAA1614-AS1 mRNA] which results in increased expression of KIAA1614 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in increased expression of KIAA1614 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 1:180,912,897...180,951,614
Ensembl chr 1:180,912,897...180,951,614
|
|
G |
KIAA1614-AS1 |
KIAA1614 antisense RNA 1 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of KIAA1614-AS1 mRNA] which results in increased expression of KIAA1614 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of KIAA1614-AS1 mRNA] which results in increased expression of KIAA1614 mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of KIAA1614-AS1 mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in increased expression of KIAA1614-AS1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 1:180,949,690...180,954,887
Ensembl chr 1:180,949,699...180,954,887
|
|
G |
KRT7 |
keratin 7 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of KRT7-AS mRNA] which results in decreased expression of KRT7 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of KRT7-AS mRNA] which results in decreased expression of KRT7 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr12:52,233,243...52,255,853
Ensembl chr12:52,232,520...52,252,186
|
|
G |
KRT7-AS |
KRT7 antisense RNA 1 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of KRT7-AS mRNA] which results in decreased expression of KRT7 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of KRT7-AS mRNA] which results in decreased expression of KRT7 mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of KRT7-AS mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of KRT7-AS mRNA |
CTD |
PMID:33656867 |
|
NCBI chr12:52,245,043...52,247,448
Ensembl chr12:52,245,048...52,247,448
|
|
G |
LBX2 |
ladybird homeobox 2 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of LBX2-AS1 mRNA] which results in increased expression of LBX2 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of LBX2-AS1 mRNA] which results in increased expression of LBX2 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 2:74,497,517...74,503,316
Ensembl chr 2:74,497,517...74,503,316
|
|
G |
LBX2-AS1 |
LBX2 antisense RNA 1 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of LBX2-AS1 mRNA] which results in increased expression of LBX2 mRNA; [[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of LBX2-AS1 mRNA] which results in increased expression of TLX2 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of LBX2-AS1 mRNA] which results in increased expression of LBX2 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of LBX2-AS1 mRNA] which results in increased expression of TLX2 mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of LBX2-AS1 mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in increased expression of LBX2-AS1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 2:74,502,593...74,505,065
Ensembl chr 2:74,502,552...74,505,091
|
|
G |
LIF |
LIF interleukin 6 family cytokine |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of LIF-AS1 mRNA] which results in increased expression of LIF mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of LIF-AS1 mRNA] which results in increased expression of LIF mRNA |
CTD |
PMID:33656867 |
|
NCBI chr22:30,240,453...30,246,759
Ensembl chr22:30,240,453...30,246,759
|
|
G |
LIF-AS1 |
LIF antisense RNA 1 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of LIF-AS1 mRNA] which results in increased expression of LIF mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of LIF-AS1 mRNA] which results in increased expression of LIF mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of LIF-AS1 mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in increased expression of LIF-AS1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr22:30,239,194...30,240,538
Ensembl chr22:30,239,194...30,240,538
|
|
G |
LINC01391 |
long intergenic non-protein coding RNA 1391 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of LINC01391 mRNA] which results in increased expression of FOXL2 mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of LINC01391 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 3:138,935,189...138,944,020
Ensembl chr 3:138,935,189...138,944,020
|
|
G |
LINC01629 |
long intergenic non-protein coding RNA 1629 |
multiple interactions |
EXP |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01629 mRNA] which results in decreased expression of EPB41L1 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01629 mRNA] which results in decreased expression of THY1 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01629 mRNA] which results in increased expression of MEF2A mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01629 mRNA] which results in increased expression of MYPN mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01629 mRNA] which results in increased expression of OTOG mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01629 mRNA] which results in increased expression of STAB1 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01629 mRNA] which results in increased expression of TRIM8 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01629 mRNA] which results in increased expression of ZNF672 mRNA; [Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01629 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr14:76,959,638...76,965,802
Ensembl chr14:76,959,636...76,965,802
|
|
G |
LINC01679 |
long intergenic non-protein coding RNA 1679 |
multiple interactions |
EXP |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01679 mRNA] which results in increased expression of CELF3 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01679 mRNA] which results in increased expression of PGPEP1 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01679 mRNA] which results in increased expression of PSMB11 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01679 mRNA] which results in increased expression of ZNF37A mRNA; [Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01679 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr21:43,358,055...43,362,349
Ensembl chr21:43,358,147...43,362,349
|
|
G |
LINC01786 |
long intergenic non-protein coding RNA 1786 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of LINC01786 mRNA] which results in increased expression of SCNN1D mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of LINC01786 mRNA] which results in increased expression of SCNN1D mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of LINC01786 mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in increased expression of LINC01786 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 1:1,274,002...1,279,447
Ensembl chr 1:1,275,223...1,280,420
|
|
G |
LINC01996 |
long intergenic non-protein coding RNA 1996 |
multiple interactions |
EXP |
[[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of LINC01996 mRNA] which results in increased expression of SMTNL2 mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in increased expression of LINC01996 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr17:4,610,449...4,617,647
Ensembl chr17:4,610,449...4,617,650
|
|
G |
LINC02019 |
long intergenic non-protein coding RNA 2019 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of LINC02019 mRNA] which results in increased expression of DOCK3 mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of LINC02019 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 3:50,669,439...50,672,051
Ensembl chr 3:50,669,989...50,672,048
|
|
G |
LINC02481 |
long intergenic non-protein coding RNA 2481 |
multiple interactions |
EXP |
[[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of LINC02481 mRNA] which results in increased expression of S100P mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in increased expression of LINC02481 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 4:6,687,448...6,690,519
Ensembl chr 4:6,687,448...6,690,544
|
|
G |
LMNB1 |
lamin B1 |
multiple interactions |
EXP |
[[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of LMNB1-DT mRNA] which results in decreased expression of LMNB1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 5:126,776,623...126,837,020
Ensembl chr 5:126,776,623...126,837,020
|
|
G |
LMNB1-DT |
LMNB1 divergent transcript |
multiple interactions |
EXP |
[[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of LMNB1-DT mRNA] which results in decreased expression of LMNB1 mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in increased expression of LMNB1-DT mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 5:126,751,963...126,776,486
Ensembl chr 5:126,751,963...126,776,486
|
|
G |
LRRC8D-DT |
LRRC8D divergent transcript |
multiple interactions |
EXP |
[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of LRRC8D-DT mRNA |
CTD |
PMID:33656867 |
|
|
|
G |
MAFA |
MAF bZIP transcription factor A |
multiple interactions |
EXP |
[[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of MAFA-AS1 mRNA] which results in increased expression of MAFA mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 8:143,428,064...143,430,732
Ensembl chr 8:143,419,182...143,430,732
|
|
G |
MAFA-AS1 |
MAFA antisense RNA 1 |
multiple interactions |
EXP |
[[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of MAFA-AS1 mRNA] which results in increased expression of MAFA mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in increased expression of MAFA-AS1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 8:143,417,679...143,419,150
Ensembl chr 8:143,417,679...143,419,150
|
|
G |
MARVELD1 |
MARVEL domain containing 1 |
multiple interactions |
EXP |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PICART1 mRNA] which results in decreased expression of MARVELD1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr10:97,713,730...97,718,150
Ensembl chr10:97,713,173...97,718,150
|
|
G |
MEF2A |
myocyte enhancer factor 2A |
multiple interactions |
EXP |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01629 mRNA] which results in increased expression of MEF2A mRNA |
CTD |
PMID:33656867 |
|
NCBI chr15:99,565,417...99,716,488
Ensembl chr15:99,565,417...99,716,488
|
|
G |
METRN |
meteorin, glial cell differentiation regulator |
multiple interactions |
EXP |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in decreased expression of METRN mRNA |
CTD |
PMID:33656867 |
|
NCBI chr16:715,118...719,655
Ensembl chr16:715,118...719,655
|
|
G |
MEX3B |
mex-3 RNA binding family member B |
multiple interactions |
EXP |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of THY1-AS1 mRNA] which results in increased expression of MEX3B mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PICART1 mRNA] which results in increased expression of MEX3B mRNA |
CTD |
PMID:33656867 |
|
NCBI chr15:82,041,778...82,046,018
Ensembl chr15:82,041,778...82,046,119
|
|
G |
MID1IP1 |
MID1 interacting protein 1 |
multiple interactions |
EXP |
[[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of MID1IP1-AS1 mRNA] which results in increased expression of MID1IP1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr X:38,801,459...38,806,532
Ensembl chr X:38,801,440...38,806,537
|
|
G |
MID1IP1-AS1 |
MID1IP1 antisense RNA 1 |
multiple interactions |
EXP |
[[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of MID1IP1-AS1 mRNA] which results in increased expression of MID1IP1 mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in increased expression of MID1IP1-AS1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr X:38,801,248...38,803,883
Ensembl chr X:38,801,568...38,803,883
|
|
G |
MMEL1 |
membrane metalloendopeptidase like 1 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of MMEL1-AS1 mRNA] which results in decreased expression of MMEL1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 1:2,590,639...2,633,016
Ensembl chr 1:2,590,639...2,633,016
|
|
G |
MMEL1-AS1 |
MMEL1 antisense RNA 1 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of MMEL1-AS1 mRNA] which results in decreased expression of MMEL1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 1:2,628,756...2,636,620
|
|
G |
MMRN2 |
multimerin 2 |
multiple interactions |
EXP |
[[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of ADIRF-AS1 mRNA] which results in increased expression of MMRN2 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr10:86,935,540...86,957,615
Ensembl chr10:86,935,540...86,969,481
|
|
G |
MYPN |
myopalladin |
multiple interactions |
EXP |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01629 mRNA] which results in increased expression of MYPN mRNA |
CTD |
PMID:33656867 |
|
NCBI chr10:68,087,897...68,212,017
Ensembl chr10:68,087,897...68,212,017
|
|
G |
NGFR |
nerve growth factor receptor |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of NGFR-AS1 mRNA] which results in increased expression of NGFR mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of NGFR-AS1 mRNA] which results in increased expression of NGFR mRNA |
CTD |
PMID:33656867 |
|
NCBI chr17:49,495,293...49,515,008
Ensembl chr17:49,495,293...49,515,008
|
|
G |
NGFR-AS1 |
NGFR antisense RNA 1 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of NGFR-AS1 mRNA] which results in increased expression of NGFR mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of NGFR-AS1 mRNA] which results in increased expression of NGFR mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of NGFR-AS1 mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in increased expression of NGFR-AS1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr17:49,505,657...49,574,064
Ensembl chr17:49,505,657...49,574,064
|
|
G |
NPR3 |
natriuretic peptide receptor 3 |
multiple interactions |
EXP |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in decreased expression of NPR3 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in decreased expression of NPR3 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 5:32,690,872...32,791,720
Ensembl chr 5:32,689,070...32,791,724
|
|
G |
NR4A1 |
nuclear receptor subfamily 4 group A member 1 |
multiple interactions |
EXP |
[[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of NR4A1AS mRNA] which results in increased expression of NR4A1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr12:52,022,832...52,059,503
Ensembl chr12:52,022,832...52,059,507
|
|
G |
NR4A1AS |
NR4A1 antisense RNA |
multiple interactions |
EXP |
[[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of NR4A1AS mRNA] which results in increased expression of NR4A1 mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in increased expression of NR4A1AS mRNA |
CTD |
PMID:33656867 |
|
NCBI chr12:52,058,750...52,059,500
Ensembl chr12:52,058,459...52,059,503
|
|
G |
NUCB1 |
nucleobindin 1 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of NUCB1-AS1 mRNA] which results in decreased expression of NUCB1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr19:48,900,312...48,923,372
Ensembl chr19:48,900,050...48,923,473
|
|
G |
NUCB1-AS1 |
NUCB1 antisense RNA 1 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of NUCB1-AS1 mRNA] which results in decreased expression of NUCB1 mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of NUCB1-AS1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr19:48,910,930...48,918,891
Ensembl chr19:48,910,930...48,918,891
|
|
G |
NYAP1 |
neuronal tyrosine phosphorylated phosphoinositide-3-kinase adaptor 1 |
multiple interactions |
EXP |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in increased expression of NYAP1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 7:100,483,927...100,494,802
Ensembl chr 7:100,483,927...100,494,802
|
|
G |
OSGEPL1 |
O-sialoglycoprotein endopeptidase like 1 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of OSGEPL1-AS1 mRNA] which results in decreased expression of OSGEPL1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 2:189,746,660...189,763,198
Ensembl chr 2:189,746,660...189,763,227
|
|
G |
OSGEPL1-AS1 |
OSGEPL1 antisense RNA 1 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of OSGEPL1-AS1 mRNA] which results in decreased expression of OSGEPL1 mRNA; [[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of OSGEPL1-AS1 mRNA] which results in increased expression of ANKAR mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of OSGEPL1-AS1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 2:189,762,780...189,765,556
Ensembl chr 2:189,762,704...189,765,556
|
|
G |
OTOG |
otogelin |
multiple interactions |
EXP |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01629 mRNA] which results in increased expression of OTOG mRNA |
CTD |
PMID:33656867 |
|
NCBI chr11:17,547,259...17,646,044
Ensembl chr11:17,547,259...17,647,150
|
|
G |
PGPEP1 |
pyroglutamyl-peptidase I |
multiple interactions |
EXP |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in increased expression of PGPEP1 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01679 mRNA] which results in increased expression of PGPEP1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr19:18,340,598...18,369,950
Ensembl chr19:18,340,598...18,369,950
|
|
G |
PICART1 |
p53 inducible cancer associated RNA transcript 1 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of PICART1 mRNA] which results in decreased expression of ITGA3 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of PICART1 mRNA] which results in decreased expression of ITGA3 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PICART1 mRNA] which results in decreased expression of HOXB4 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PICART1 mRNA] which results in decreased expression of MARVELD1 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PICART1 mRNA] which results in increased expression of ACHE mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PICART1 mRNA] which results in increased expression of KCNA7 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PICART1 mRNA] which results in increased expression of MEX3B mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PICART1 mRNA] which results in increased expression of SAMD14 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PICART1 mRNA] which results in increased expression of SHF mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PICART1 mRNA] which results in increased expression of SRCIN1 mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in increased expression of PICART1 mRNA; [Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PICART1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr17:50,050,349...50,055,739
Ensembl chr17:50,050,349...50,055,746
|
|
G |
PINCR |
p53-induced noncoding RNA |
multiple interactions |
EXP |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PINCR mRNA] which results in decreased expression of MPP6 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PINCR mRNA] which results in increased expression of COL7A1 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PINCR mRNA] which results in increased expression of IL1RL1 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PINCR mRNA] which results in increased expression of ZNF503 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PINCR mRNA] which results in increased expression of ZNF662 mRNA; [Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PINCR mRNA |
CTD |
PMID:33656867 |
|
NCBI chr X:43,176,994...43,226,598
Ensembl chr X:43,176,994...43,226,598
|
|
G |
PIWIL2 |
piwi like RNA-mediated gene silencing 2 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of PIWIL2-DT mRNA] which results in increased expression of PIWIL2 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 8:22,275,316...22,357,568
Ensembl chr 8:22,275,316...22,357,568
|
|
G |
PIWIL2-DT |
PIWIL2 divergent transcript |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of PIWIL2-DT mRNA] which results in increased expression of PIWIL2 mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of PIWIL2-DT mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 8:22,254,576...22,275,162
Ensembl chr 8:22,254,576...22,275,162
|
|
G |
PLA2G4E |
phospholipase A2 group IVE |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of PLA2G4E-AS1 mRNA] which results in increased expression of PLA2G4E mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of PLA2G4E-AS1 mRNA] which results in increased expression of PLA2G4E mRNA |
CTD |
PMID:33656867 |
|
NCBI chr15:41,981,582...42,050,703
Ensembl chr15:41,981,394...42,051,190
|
|
G |
PLA2G4E-AS1 |
PLA2G4E antisense RNA 1 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of PLA2G4E-AS1 mRNA] which results in increased expression of PLA2G4E mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of PLA2G4E-AS1 mRNA] which results in increased expression of PLA2G4E mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of PLA2G4E-AS1 mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in increased expression of PLA2G4E-AS1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr15:41,972,763...41,999,094
Ensembl chr15:41,972,763...41,999,094
|
|
G |
PLCL2 |
phospholipase C like 2 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of PLCL2-AS1 mRNA] which results in increased expression of PLCL2 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 3:16,884,955...17,090,606
Ensembl chr 3:16,802,651...17,090,604
|
|
G |
PLCL2-AS1 |
PLCL2 antisense RNA 1 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of PLCL2-AS1 mRNA] which results in increased expression of PLCL2 mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of PLCL2-AS1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 3:17,042,752...17,054,584
Ensembl chr 3:17,042,742...17,044,192
|
|
G |
POLH |
DNA polymerase eta |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of POLH-AS1 mRNA] which results in increased expression of POLH mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of POLH-AS1 mRNA] which results in increased expression of POLH mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 6:43,576,185...43,620,523
Ensembl chr 6:43,576,185...43,620,523
|
|
G |
POLH-AS1 |
POLH antisense RNA 1 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of POLH-AS1 mRNA] which results in increased expression of POLH mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of POLH-AS1 mRNA] which results in increased expression of POLH mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of POLH-AS1 mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in increased expression of POLH-AS1 mRNA |
CTD |
PMID:33656867 |
|
Ensembl chr 6:43,588,230...43,591,362
|
|
G |
POPDC2 |
popeye domain containing 2 |
multiple interactions |
EXP |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in increased expression of POPDC2 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 3:119,642,056...119,660,883
Ensembl chr 3:119,636,457...119,665,324
|
|
G |
PRICKLE2 |
prickle planar cell polarity protein 2 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of PRICKLE2-AS1 mRNA] which results in increased expression of PRICKLE2 mRNA; [[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of PRICKLE2-AS3 mRNA] which results in increased expression of PRICKLE2 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of PRICKLE2-AS1 mRNA] which results in increased expression of PRICKLE2 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of PRICKLE2-AS3 mRNA] which results in increased expression of PRICKLE2 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 3:64,092,236...64,268,173
Ensembl chr 3:64,092,236...64,445,476
|
|
G |
PRICKLE2-AS1 |
PRICKLE2 antisense RNA 1 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of PRICKLE2-AS1 mRNA] which results in increased expression of PRICKLE2 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of PRICKLE2-AS1 mRNA] which results in increased expression of PRICKLE2 mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of PRICKLE2-AS1 mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in increased expression of PRICKLE2-AS1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 3:64,067,964...64,103,131
Ensembl chr 3:64,067,964...64,103,131 Ensembl chr 3:64,067,964...64,103,131
|
|
G |
PRICKLE2-AS3 |
PRICKLE2 antisense RNA 3 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of PRICKLE2-AS3 mRNA] which results in increased expression of PRICKLE2 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of PRICKLE2-AS3 mRNA] which results in increased expression of PRICKLE2 mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of PRICKLE2-AS3 mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in increased expression of PRICKLE2-AS3 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 3:64,187,544...64,201,561
Ensembl chr 3:64,187,544...64,200,965
|
|
G |
PSMB11 |
proteasome subunit beta 11 |
multiple interactions |
EXP |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in increased expression of PSMB11 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01679 mRNA] which results in increased expression of PSMB11 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr14:23,042,212...23,044,060
Ensembl chr14:23,042,212...23,044,060
|
|
G |
RIIAD1 |
regulatory subunit of type II PKA R-subunit domain containing 1 |
multiple interactions |
EXP |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in increased expression of RIIAD1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 1:151,711,551...151,729,805
Ensembl chr 1:151,710,433...151,729,805
|
|
G |
S100A2 |
S100 calcium binding protein A2 |
multiple interactions |
EXP |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in decreased expression of S100A2 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 1:153,561,108...153,565,844
Ensembl chr 1:153,561,108...153,567,890
|
|
G |
S100P |
S100 calcium binding protein P |
multiple interactions |
EXP |
[[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of LINC02481 mRNA] which results in increased expression of S100P mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 4:6,693,878...6,697,170
Ensembl chr 4:6,693,878...6,697,170
|
|
G |
SAMD14 |
sterile alpha motif domain containing 14 |
multiple interactions |
EXP |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PICART1 mRNA] which results in increased expression of SAMD14 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr17:50,110,040...50,130,160
Ensembl chr17:50,110,040...50,130,160
|
|
G |
SCNN1D |
sodium channel epithelial 1 subunit delta |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of LINC01786 mRNA] which results in increased expression of SCNN1D mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of LINC01786 mRNA] which results in increased expression of SCNN1D mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 1:1,280,436...1,292,025
Ensembl chr 1:1,280,436...1,292,029
|
|
G |
SEMA3G |
semaphorin 3G |
multiple interactions |
EXP |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in increased expression of SEMA3G mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 3:52,433,035...52,445,103
Ensembl chr 3:52,433,035...52,445,103
|
|
G |
SH3RF3 |
SH3 domain containing ring finger 3 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of SH3RF3-AS1 mRNA] which results in decreased expression of SH3RF3 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of SH3RF3-AS1 mRNA] which results in decreased expression of SH3RF3 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 2:109,129,205...109,504,634
Ensembl chr 2:109,129,205...109,504,634
|
|
G |
SH3RF3-AS1 |
SH3RF3 antisense RNA 1 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of SH3RF3-AS1 mRNA] which results in decreased expression of SH3RF3 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of SH3RF3-AS1 mRNA] which results in decreased expression of SH3RF3 mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of SH3RF3-AS1 mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of SH3RF3-AS1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 2:109,127,327...109,130,119
Ensembl chr 2:109,127,327...109,128,930
|
|
G |
SHF |
Src homology 2 domain containing F |
multiple interactions |
EXP |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PICART1 mRNA] which results in increased expression of SHF mRNA |
CTD |
PMID:33656867 |
|
NCBI chr15:45,167,214...45,201,116
Ensembl chr15:45,167,214...45,201,175
|
|
G |
SKAP1 |
src kinase associated phosphoprotein 1 |
multiple interactions |
EXP |
[[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of SKAP1-AS1 mRNA] which results in increased expression of SKAP1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr17:48,133,442...48,445,061
Ensembl chr17:48,133,442...48,430,275
|
|
G |
SKAP1-AS1 |
SKAP1 antisense RNA 1 |
multiple interactions |
EXP |
[[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of SKAP1-AS1 mRNA] which results in increased expression of SKAP1 mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in increased expression of SKAP1-AS1 mRNA |
CTD |
PMID:33656867 |
|
Ensembl chr17:48,185,938...48,204,529
|
|
G |
SLC25A34 |
solute carrier family 25 member 34 |
multiple interactions |
EXP |
[[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of SLC25A34-AS1 mRNA] which results in increased expression of SLC25A34 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 1:15,736,258...15,741,392
Ensembl chr 1:15,736,258...15,741,392
|
|
G |
SLC25A34-AS1 |
SLC25A34 and TMEM82 antisense RNA 1 |
multiple interactions |
EXP |
[[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of SLC25A34-AS1 mRNA] which results in increased expression of SLC25A34 mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of SLC25A34-AS1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 1:15,740,051...15,749,890
Ensembl chr 1:15,740,048...15,749,896
|
|
G |
SMAD5 |
SMAD family member 5 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of SMAD5-AS1 mRNA] which results in increased expression of SMAD5 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of SMAD5-AS1 mRNA] which results in increased expression of SMAD5 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 5:136,132,845...136,182,733
Ensembl chr 5:136,132,845...136,188,747
|
|
G |
SMAD5-AS1 |
SMAD5 antisense RNA 1 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of SMAD5-AS1 mRNA] which results in increased expression of SMAD5 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of SMAD5-AS1 mRNA] which results in increased expression of SMAD5 mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of SMAD5-AS1 mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in increased expression of SMAD5-AS1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 5:136,129,513...136,134,890
Ensembl chr 5:136,129,507...136,134,890
|
|
G |
SMTNL2 |
smoothelin like 2 |
multiple interactions |
EXP |
[[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of LINC01996 mRNA] which results in increased expression of SMTNL2 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr17:4,584,007...4,608,319
Ensembl chr17:4,583,999...4,608,319
|
|
G |
SRCIN1 |
SRC kinase signaling inhibitor 1 |
multiple interactions |
EXP |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PICART1 mRNA] which results in increased expression of SRCIN1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr17:38,530,031...38,607,025
Ensembl chr17:38,530,031...38,605,952
|
|
G |
SSTR5 |
somatostatin receptor 5 |
multiple interactions |
EXP |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in increased expression of SSTR5 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr16:1,072,747...1,081,454
Ensembl chr16:1,072,747...1,081,454
|
|
G |
STAB1 |
stabilin 1 |
multiple interactions |
EXP |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01629 mRNA] which results in increased expression of STAB1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 3:52,495,338...52,524,495
Ensembl chr 3:52,495,338...52,524,495
|
|
G |
SYP |
synaptophysin |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of SYP-AS1 mRNA] which results in increased expression of SYP mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of SYP-AS1 mRNA] which results in increased expression of SYP mRNA |
CTD |
PMID:33656867 |
|
NCBI chr X:49,187,815...49,200,193
Ensembl chr X:49,187,815...49,200,218
|
|
G |
SYP-AS1 |
SYP antisense RNA 1 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of SYP-AS1 mRNA] which results in increased expression of SYP mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of SYP-AS1 mRNA] which results in increased expression of SYP mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of SYP-AS1 mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in increased expression of SYP-AS1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr X:49,198,839...49,202,454
Ensembl chr X:49,198,966...49,202,454
|
|
G |
TAB3 |
TGF-beta activated kinase 1 (MAP3K7) binding protein 3 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of TAB3-AS1 mRNA] which results in increased expression of TAB3 mRNA; [[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of TAB3-AS2 mRNA] which results in increased expression of TAB3 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of TAB3-AS1 mRNA] which results in increased expression of TAB3 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of TAB3-AS2 mRNA] which results in increased expression of TAB3 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr X:30,827,442...30,889,254
Ensembl chr X:30,827,442...30,975,084
|
|
G |
TAB3-AS1 |
TAB3 antisense RNA 1 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of TAB3-AS1 mRNA] which results in increased expression of TAB3 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of TAB3-AS1 mRNA] which results in increased expression of TAB3 mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of TAB3-AS1 mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in increased expression of TAB3-AS1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr X:30,834,623...30,839,073
Ensembl chr X:30,834,623...30,835,300
|
|
G |
TAB3-AS2 |
TAB3 antisense RNA 2 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of TAB3-AS2 mRNA] which results in increased expression of TAB3 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of TAB3-AS2 mRNA] which results in increased expression of TAB3 mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of TAB3-AS2 mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in increased expression of TAB3-AS2 mRNA |
CTD |
PMID:33656867 |
|
Ensembl chr X:30,854,321...30,854,707
|
|
G |
THY1 |
Thy-1 cell surface antigen |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of THY1-AS1 mRNA] which results in decreased expression of THY1 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of THY1-AS1 mRNA] which results in decreased expression of THY1 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01629 mRNA] which results in decreased expression of THY1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr11:119,415,476...119,424,985
Ensembl chr11:119,415,476...119,424,985
|
|
G |
THY1-AS1 |
THY1 antisense RNA 1 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of THY1-AS1 mRNA] which results in decreased expression of THY1 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of THY1-AS1 mRNA] which results in decreased expression of THY1 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of THY1-AS1 mRNA] which results in increased expression of AAK1 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of THY1-AS1 mRNA] which results in increased expression of ARHGAP30 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of THY1-AS1 mRNA] which results in increased expression of KCNA7 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of THY1-AS1 mRNA] which results in increased expression of MEX3B mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of THY1-AS1 mRNA] which results in increased expression of ZNF37A mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of THY1-AS1 mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of THY1-AS1 mRNA; [Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of THY1-AS1 mRNA |
CTD |
PMID:33656867 |
|
|
|
G |
TLX2 |
T cell leukemia homeobox 2 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of LBX2-AS1 mRNA] which results in increased expression of TLX2 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of LBX2-AS1 mRNA] which results in increased expression of TLX2 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 2:74,514,450...74,517,148
Ensembl chr 2:74,513,463...74,517,148
|
|
G |
TM4SF19 |
transmembrane 4 L six family member 19 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of TM4SF19-AS1 mRNA] which results in decreased expression of TM4SF19 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of TM4SF19-AS1 mRNA] which results in decreased expression of TM4SF19 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 3:196,323,547...196,338,388
Ensembl chr 3:196,319,342...196,338,503
|
|
G |
TM4SF19-AS1 |
TM4SF19 antisense RNA 1 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of TM4SF19-AS1 mRNA] which results in decreased expression of TM4SF19 mRNA; [[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of TM4SF19-AS1 mRNA] which results in increased expression of DYNLT2B mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of TM4SF19-AS1 mRNA] which results in decreased expression of TM4SF19 mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of TM4SF19-AS1 mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of TM4SF19-AS1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 3:196,318,332...196,325,570
Ensembl chr 3:196,318,330...196,325,570
|
|
G |
TNFRSF10A |
TNF receptor superfamily member 10a |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of TNFRSF10A-AS1 mRNA] which results in increased expression of TNFRSF10A mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of TNFRSF10A-AS1 mRNA] which results in increased expression of TNFRSF10A mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 8:23,190,452...23,225,102
Ensembl chr 8:23,190,452...23,225,102
|
|
G |
TNFRSF10A-AS1 |
TNFRSF10A antisense RNA 1 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of TNFRSF10A-AS1 mRNA] which results in increased expression of TNFRSF10A mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of TNFRSF10A-AS1 mRNA] which results in increased expression of TNFRSF10A mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of TNFRSF10A-AS1 mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in increased expression of TNFRSF10A-AS1 mRNA |
CTD |
PMID:33656867 |
|
Ensembl chr 8:23,189,279...23,190,675
|
|
G |
TNRC6B-DT |
TNRC6B divergent transcript |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of TNRC6B-DT mRNA] which results in increased expression of FAM83F mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of TNRC6B-DT mRNA] which results in increased expression of FAM83F mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of TNRC6B-DT mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in increased expression of TNRC6B-DT mRNA |
CTD |
PMID:33656867 |
|
NCBI chr22:40,043,130...40,044,530
Ensembl chr22:40,043,068...40,044,565
|
|
G |
TP53I11 |
tumor protein p53 inducible protein 11 |
multiple interactions |
EXP |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in increased expression of TP53I11 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr11:44,932,348...44,951,306
Ensembl chr11:44,885,903...44,951,306
|
|
G |
TRIM8 |
tripartite motif containing 8 |
multiple interactions |
EXP |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01629 mRNA] which results in increased expression of TRIM8 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr10:102,644,479...102,658,319
Ensembl chr10:102,644,479...102,658,318
|
|
G |
TTC23L |
tetratricopeptide repeat domain 23 like |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of TTC23L-AS1 mRNA] which results in increased expression of TTC23L mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 5:34,839,164...34,925,682
Ensembl chr 5:34,838,833...34,900,511
|
|
G |
TTC23L-AS1 |
TTC23L antisense RNA 1 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of TTC23L-AS1 mRNA] which results in increased expression of TTC23L mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of TTC23L-AS1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 5:34,837,547...34,839,332
Ensembl chr 5:34,837,549...34,839,278
|
|
G |
UPK1A |
uroplakin 1A |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of UPK1A-AS1 mRNA] which results in increased expression of UPK1A mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of UPK1A-AS1 mRNA] which results in increased expression of UPK1A mRNA |
CTD |
PMID:33656867 |
|
NCBI chr19:35,666,517...35,678,481
Ensembl chr19:35,666,517...35,678,481
|
|
G |
UPK1A-AS1 |
UPK1A antisense RNA 1 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of UPK1A-AS1 mRNA] which results in increased expression of UPK1A mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of UPK1A-AS1 mRNA] which results in increased expression of UPK1A mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of UPK1A-AS1 mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in increased expression of UPK1A-AS1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr19:35,667,948...35,673,291
Ensembl chr19:35,667,948...35,673,304
|
|
G |
WNT9A |
Wnt family member 9A |
multiple interactions |
EXP |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in increased expression of WNT9A mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 1:227,918,656...227,947,932
Ensembl chr 1:227,918,656...227,947,932
|
|
G |
ZBTB5 |
zinc finger and BTB domain containing 5 |
multiple interactions |
EXP |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in increased expression of ZBTB5 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 9:37,438,102...37,465,450
Ensembl chr 9:37,438,102...37,465,450
|
|
G |
ZNF114 |
zinc finger protein 114 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of ZNF114-AS1 mRNA] which results in increased expression of ZNF114 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of ZNF114-AS1 mRNA] which results in increased expression of ZNF114 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in increased expression of ZNF114 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr19:48,270,081...48,287,608
Ensembl chr19:48,270,081...48,287,608
|
|
G |
ZNF114-AS1 |
ZNF114 antisense RNA 1 |
multiple interactions |
EXP |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of ZNF114-AS1 mRNA] which results in increased expression of ZNF114 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of ZNF114-AS1 mRNA] which results in increased expression of ZNF114 mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of ZNF114-AS1 mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in increased expression of ZNF114-AS1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr19:48,262,900...48,271,832
Ensembl chr19:48,262,900...48,271,283
|
|
G |
ZNF37A |
zinc finger protein 37A |
multiple interactions |
EXP |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of THY1-AS1 mRNA] which results in increased expression of ZNF37A mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01679 mRNA] which results in increased expression of ZNF37A mRNA |
CTD |
PMID:33656867 |
|
NCBI chr10:38,094,337...38,150,293
Ensembl chr10:38,094,334...38,150,293
|
|
G |
ZNF385D |
zinc finger protein 385D |
multiple interactions |
EXP |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in decreased expression of ZNF385D mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 3:21,412,218...22,372,763
Ensembl chr 3:21,412,218...22,373,321
|
|
G |
ZNF503 |
zinc finger protein 503 |
multiple interactions |
EXP |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PINCR mRNA] which results in increased expression of ZNF503 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr10:75,279,725...75,401,916
Ensembl chr10:75,397,830...75,401,764
|
|
G |
ZNF662 |
zinc finger protein 662 |
multiple interactions |
EXP |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in increased expression of ZNF662 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PINCR mRNA] which results in increased expression of ZNF662 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 3:42,906,142...42,919,334
Ensembl chr 3:42,906,142...42,919,334
|
|
G |
ZNF672 |
zinc finger protein 672 |
multiple interactions |
EXP |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01629 mRNA] which results in increased expression of ZNF672 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 1:248,838,224...248,849,517
Ensembl chr 1:248,838,210...248,849,517
|
|
|
G |
ACTA2 |
actin alpha 2, smooth muscle |
multiple interactions |
EXP |
ebselen inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein] |
CTD |
PMID:16757516 |
|
NCBI chr10:88,935,074...88,991,337
Ensembl chr10:88,935,074...88,991,339
|
|
G |
ADAM9 |
ADAM metallopeptidase domain 9 |
multiple interactions |
EXP |
ebselen inhibits the reaction [Hydrogen Peroxide results in increased expression of ADAM9 protein] |
CTD |
PMID:17018608 |
|
NCBI chr 8:38,996,973...39,105,261
Ensembl chr 8:38,996,754...39,105,445
|
|
G |
AFP |
alpha fetoprotein |
multiple interactions |
ISO |
ebselen inhibits the reaction [Aflatoxin B1 results in increased expression of AFP mRNA] |
CTD |
PMID:11133813 |
|
NCBI chr 4:73,436,221...73,456,174
Ensembl chr 4:73,431,138...73,456,174
|
|
G |
ALAD |
aminolevulinate dehydratase |
multiple interactions decreases activity |
ISO |
Dithiothreitol inhibits the reaction [ebselen results in decreased activity of ALAD protein] ebselen inhibits the reaction [Cadmium Chloride results in decreased activity of ALAD protein] |
CTD |
PMID:14630126 PMID:17624921 PMID:23933410 |
|
NCBI chr 9:113,386,312...113,401,284
Ensembl chr 9:113,386,312...113,401,290
|
|
G |
ALOX5 |
arachidonate 5-lipoxygenase |
decreases activity |
EXP |
ebselen results in decreased activity of ALOX5 protein |
CTD |
PMID:7590103 |
|
NCBI chr10:45,374,216...45,446,117
Ensembl chr10:45,374,176...45,446,119
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
multiple interactions |
ISO |
ebselen inhibits the reaction [sodium arsenite results in increased expression of BAX protein] |
CTD |
PMID:30558456 |
|
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
multiple interactions |
ISO |
ebselen inhibits the reaction [sodium arsenite results in decreased expression of BCL2 protein] |
CTD |
PMID:30558456 |
|
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
|
|
G |
CASP3 |
caspase 3 |
multiple interactions increases activity |
EXP ISO |
ebselen inhibits the reaction [Mechlorethamine results in increased activity of CASP3 protein] ebselen results in increased activity of CASP3 protein ebselen inhibits the reaction [Methylmercury Compounds results in increased activity of CASP3 protein]; ebselen inhibits the reaction [sodium arsenite results in increased expression of CASP3 protein] |
CTD |
PMID:21300091 PMID:23649643 PMID:25068500 PMID:30558456 |
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
CASP9 |
caspase 9 |
multiple interactions |
EXP ISO |
ebselen inhibits the reaction [Mechlorethamine results in increased activity of CASP9 protein] ebselen inhibits the reaction [Cadmium Chloride results in increased activity of CASP9 protein] |
CTD |
PMID:18629305 PMID:23649643 |
|
NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
|
|
G |
CAT |
catalase |
increases activity multiple interactions |
ISO |
ebselen results in increased activity of CAT protein ebselen inhibits the reaction [sodium arsenite results in decreased activity of CAT protein] |
CTD |
PMID:27282967 PMID:30558456 |
|
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
|
|
G |
COX4I1 |
cytochrome c oxidase subunit 4I1 |
increases expression |
EXP |
ebselen results in increased expression of COX4I1 protein |
CTD |
PMID:27385396 |
|
NCBI chr16:85,799,695...85,807,068
Ensembl chr16:85,798,633...85,807,068
|
|
G |
CS |
citrate synthase |
multiple interactions |
EXP ISO |
ebselen inhibits the reaction [FMR1 5' UTR mutant form results in decreased activity of CS protein] ebselen inhibits the reaction [Cisplatin results in decreased activity of CS protein] |
CTD |
PMID:27385396 PMID:32860823 |
|
NCBI chr12:56,271,699...56,300,330
Ensembl chr12:56,271,699...56,300,391
|
|
G |
CXCL8 |
C-X-C motif chemokine ligand 8 |
multiple interactions |
EXP |
ebselen inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL8 mRNA]; ebselen inhibits the reaction [Lipopolysaccharides results in increased secretion of CXCL8 protein]; ebselen inhibits the reaction [Peroxynitrous Acid results in increased expression of CXCL8 mRNA]; ebselen inhibits the reaction [Peroxynitrous Acid results in increased expression of CXCL8 protein] |
CTD |
PMID:14572605 |
|
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
|
|
G |
CYP2E1 |
cytochrome P450 family 2 subfamily E member 1 |
multiple interactions |
ISO |
ebselen inhibits the reaction [Carbon Tetrachloride results in increased expression of CYP2E1 mRNA] |
CTD |
PMID:11903743 |
|
NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220
|
|
G |
EIF2S1 |
eukaryotic translation initiation factor 2 subunit alpha |
increases phosphorylation |
ISO |
ebselen results in increased phosphorylation of EIF2S1 protein |
CTD |
PMID:27282967 |
|
NCBI chr14:67,360,328...67,386,516
Ensembl chr14:67,360,328...67,386,516
|
|
G |
EPHX2 |
epoxide hydrolase 2 |
multiple interactions |
EXP |
ebselen binds to and results in decreased activity of EPHX2 protein |
CTD |
PMID:23219563 |
|
NCBI chr 8:27,491,143...27,548,626
Ensembl chr 8:27,490,781...27,545,564
|
|
G |
FMR1 |
fragile X messenger ribonucleoprotein 1 |
multiple interactions |
EXP |
ebselen inhibits the reaction [FMR1 5' UTR mutant form results in decreased activity of CS protein] |
CTD |
PMID:27385396 |
|
NCBI chr X:147,911,919...147,951,125
Ensembl chr X:147,911,919...147,951,125
|
|
G |
FOS |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
EXP |
ebselen inhibits the reaction [Lipopolysaccharides affects the localization of and affects the activity of FOS protein]; ebselen inhibits the reaction [Peroxynitrous Acid affects the localization of and affects the activity of FOS protein] |
CTD |
PMID:14572605 |
|
NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,282,230
|
|
G |
G6PC1 |
glucose-6-phosphatase catalytic subunit 1 |
multiple interactions |
ISO |
ebselen inhibits the reaction [Cisplatin results in increased activity of G6PC1 protein] |
CTD |
PMID:32860823 |
|
NCBI chr17:42,900,799...42,914,438
Ensembl chr17:42,900,797...42,914,438
|
|
G |
GCK |
glucokinase |
multiple interactions |
ISO |
[ebselen co-treated with Glucose] results in increased activity of GCK protein |
CTD |
PMID:23795780 |
|
NCBI chr 7:44,143,213...44,189,439
Ensembl chr 7:44,143,213...44,198,170
|
|
G |
GFAP |
glial fibrillary acidic protein |
increases phosphorylation |
ISO |
ebselen results in increased phosphorylation of GFAP protein |
CTD |
PMID:27282967 |
|
NCBI chr17:44,903,159...44,915,500
Ensembl chr17:44,903,159...44,916,937
|
|
G |
GJA1 |
gap junction protein alpha 1 |
multiple interactions |
ISO |
ebselen inhibits the reaction [Oxygen deficiency results in increased expression of GJA1 mRNA]; ebselen inhibits the reaction [Oxygen deficiency results in increased expression of GJA1 protein] |
CTD |
PMID:12958040 |
|
NCBI chr 6:121,435,646...121,449,727
Ensembl chr 6:121,435,595...121,449,727
|
|
G |
GPX1 |
glutathione peroxidase 1 |
multiple interactions |
ISO EXP |
ebselen inhibits the reaction [GPX1 gene mutant form inhibits the reaction [Glucose results in increased secretion of INS1 protein]] ebselen inhibits the reaction [Methylmercury Compounds results in decreased activity of GPX1 protein] |
CTD |
PMID:23795780 PMID:28383113 |
|
NCBI chr 3:49,357,176...49,358,353
Ensembl chr 3:49,357,174...49,358,605
|
|
G |
GSR |
glutathione-disulfide reductase |
increases activity multiple interactions |
ISO |
ebselen results in increased activity of GSR protein ebselen inhibits the reaction [sodium arsenite results in decreased activity of GSR protein] |
CTD |
PMID:27282967 PMID:30558456 |
|
NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846
|
|
G |
GSTA1 |
glutathione S-transferase alpha 1 |
multiple interactions |
ISO |
ebselen binds to and results in decreased activity of [GSTA1 protein binds to GSTA3 protein] |
CTD |
PMID:8147899 |
|
NCBI chr 6:52,791,371...52,803,816
Ensembl chr 6:52,791,371...52,803,860
|
|
G |
GSTM1 |
glutathione S-transferase mu 1 |
multiple interactions |
ISO |
ebselen binds to and results in decreased activity of [GSTM1 protein binds to GSTM2 protein] |
CTD |
PMID:8147899 |
|
NCBI chr 1:109,687,817...109,693,745
Ensembl chr 1:109,687,814...109,709,039
|
|
G |
GSTM2 |
glutathione S-transferase mu 2 |
multiple interactions |
ISO |
ebselen binds to and results in decreased activity of [GSTM1 protein binds to GSTM2 protein] |
CTD |
PMID:8147899 |
|
NCBI chr 1:109,668,057...109,683,997
Ensembl chr 1:109,668,022...109,709,551
|
|
G |
GSTP1 |
glutathione S-transferase pi 1 |
multiple interactions |
ISO |
ebselen binds to and results in decreased activity of GSTP1 protein |
CTD |
PMID:8147899 |
|
NCBI chr11:67,583,812...67,586,653
Ensembl chr11:67,583,742...67,586,656
|
|
G |
HIF1A |
hypoxia inducible factor 1 subunit alpha |
multiple interactions |
EXP |
ebselen inhibits the reaction [Acetylcysteine inhibits the reaction [Oxygen deficiency results in increased activity of HIF1A protein]]; ebselen inhibits the reaction [Acetylcysteine inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A mRNA]]; ebselen inhibits the reaction [glutathione glycylethyl ester inhibits the reaction [Oxygen deficiency results in increased activity of HIF1A protein]]; ebselen inhibits the reaction [glutathione glycylethyl ester inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A mRNA]] |
CTD |
PMID:19374849 |
|
NCBI chr14:61,695,513...61,748,258
Ensembl chr14:61,695,513...61,748,259
|
|
G |
HMOX1 |
heme oxygenase 1 |
multiple interactions |
ISO |
[ebselen affects the abundance of Reactive Oxygen Species] which results in decreased expression of HMOX1 protein; [ebselen affects the abundance of Reactive Oxygen Species] which results in increased activity of HMOX1 protein |
CTD |
PMID:16959961 |
|
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
|
|
G |
HPGDS |
hematopoietic prostaglandin D synthase |
increases expression |
ISO |
ebselen results in increased expression of HPGDS mRNA |
CTD |
PMID:21669866 |
|
NCBI chr 4:94,298,535...94,342,836
Ensembl chr 4:94,298,535...94,342,876
|
|
G |
HSF1 |
heat shock transcription factor 1 |
increases activity |
EXP |
ebselen results in increased activity of HSF1 protein |
CTD |
PMID:34170685 |
|
NCBI chr 8:144,291,604...144,314,720
Ensembl chr 8:144,291,591...144,314,720
|
|
G |
IFNG |
interferon gamma |
multiple interactions |
ISO |
ebselen inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA]; ebselen inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 protein] |
CTD |
PMID:12794164 |
|
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
|
|
G |
IL6 |
interleukin 6 |
multiple interactions |
ISO |
ebselen inhibits the reaction [sodium arsenite results in increased expression of IL6 protein] |
CTD |
PMID:30558456 |
|
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
INS-IGF2 |
INS-IGF2 readthrough |
multiple interactions |
ISO |
ebselen inhibits the reaction [GPX1 gene mutant form inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; ebselen inhibits the reaction [SOD1 gene mutant form inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; ebselen promotes the reaction [Glucose results in increased secretion of INS1 protein] |
CTD |
PMID:23795780 |
|
NCBI chr11:2,129,117...2,161,209
Ensembl chr11:2,132,538...2,161,209
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
multiple interactions increases activity increases phosphorylation |
ISO |
ebselen inhibits the reaction [NGF protein results in increased phosphorylation of and results in increased activity of MAPK1 protein] ebselen results in increased activity of MAPK1 protein ebselen inhibits the reaction [Methylmercury Compounds results in increased phosphorylation of MAPK1 protein]; ebselen inhibits the reaction [SOD2 protein results in increased phosphorylation of and results in increased activity of MAPK1 protein]; ebselen inhibits the reaction [tetrakis(N-methyl-4-pyridiniumyl)porphine manganese(III) complex results in increased phosphorylation of and results in increased activity of MAPK1 protein] ebselen analog results in increased phosphorylation of MAPK1 protein; ebselen results in increased phosphorylation of MAPK1 protein |
CTD |
PMID:20495008 PMID:21300091 PMID:21960664 PMID:22001386 PMID:27282967 |
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
multiple interactions increases activity increases phosphorylation |
ISO |
ebselen inhibits the reaction [NGF protein results in increased phosphorylation of and results in increased activity of MAPK3 protein] ebselen results in increased activity of MAPK3 protein ebselen analog results in increased phosphorylation of MAPK3 protein; ebselen results in increased phosphorylation of MAPK3 protein ebselen inhibits the reaction [Methylmercury Compounds results in increased phosphorylation of MAPK3 protein]; ebselen inhibits the reaction [SOD2 protein results in increased phosphorylation of and results in increased activity of MAPK3 protein]; ebselen inhibits the reaction [tetrakis(N-methyl-4-pyridiniumyl)porphine manganese(III) complex results in increased phosphorylation of and results in increased activity of MAPK3 protein] |
CTD |
PMID:20495008 PMID:21300091 PMID:21960664 PMID:22001386 PMID:27282967 |
|
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
|
|
G |
MAPK9 |
mitogen-activated protein kinase 9 |
increases phosphorylation |
ISO |
ebselen results in increased phosphorylation of MAPK9 protein |
CTD |
PMID:27282967 |
|
NCBI chr 5:180,233,143...180,292,083
Ensembl chr 5:180,233,143...180,292,099
|
|
G |
MMP13 |
matrix metallopeptidase 13 |
multiple interactions |
ISO |
ebselen inhibits the reaction [Carbon Tetrachloride results in decreased expression of MMP13 mRNA] |
CTD |
PMID:11903743 |
|
NCBI chr11:102,942,995...102,955,732
Ensembl chr11:102,942,995...102,955,732
|
|
G |
NGF |
nerve growth factor |
multiple interactions |
ISO |
ebselen inhibits the reaction [NGF protein results in increased phosphorylation of and results in increased activity of MAPK1 protein]; ebselen inhibits the reaction [NGF protein results in increased phosphorylation of and results in increased activity of MAPK3 protein] |
CTD |
PMID:20495008 |
|
NCBI chr 1:115,285,917...115,338,249
Ensembl chr 1:115,285,904...115,338,770
|
|
G |
NOS2 |
nitric oxide synthase 2 |
multiple interactions decreases activity |
ISO |
ebselen inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA]; ebselen inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 protein] ebselen results in decreased activity of NOS2 protein |
CTD |
PMID:7590103 PMID:12794164 |
|
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|
G |
NQO1 |
NAD(P)H quinone dehydrogenase 1 |
decreases activity |
ISO |
ebselen results in decreased activity of NQO1 protein |
CTD |
PMID:7590103 |
|
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
|
|
G |
PDX1 |
pancreatic and duodenal homeobox 1 |
multiple interactions |
ISO |
[ebselen co-treated with Glucose] results in increased expression of PDX1 protein |
CTD |
PMID:23795780 |
|
NCBI chr13:27,920,000...27,926,313
Ensembl chr13:27,920,000...27,926,313
|
|
G |
PHOSPHO1 |
phosphoethanolamine/phosphocholine phosphatase 1 |
decreases activity |
EXP |
ebselen results in decreased activity of PHOSPHO1 protein |
CTD |
PMID:17227223 |
|
NCBI chr17:49,223,366...49,230,787
Ensembl chr17:49,223,366...49,230,787
|
|
G |
RELA |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
EXP |
ebselen inhibits the reaction [Lipopolysaccharides affects the localization of and affects the activity of RELA protein]; ebselen inhibits the reaction [Peroxynitrous Acid affects the localization of and affects the activity of RELA protein] |
CTD |
PMID:14572605 |
|
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
|
|
G |
SLC11A2 |
solute carrier family 11 member 2 |
multiple interactions |
EXP |
ebselen inhibits the reaction [SLC11A2 protein results in increased uptake of Iron] |
CTD |
PMID:16984886 |
|
NCBI chr12:50,952,263...51,028,886
Ensembl chr12:50,979,401...51,028,566
|
|
G |
SLC2A2 |
solute carrier family 2 member 2 |
multiple interactions |
ISO |
[ebselen co-treated with Glucose] results in increased expression of SLC2A2 protein ebselen inhibits the reaction [Cisplatin results in increased expression of SLC2A2 protein] |
CTD |
PMID:23795780 PMID:32860823 |
|
NCBI chr 3:170,996,347...171,026,720
Ensembl chr 3:170,996,347...171,026,743
|
|
G |
SMAD3 |
SMAD family member 3 |
multiple interactions |
EXP |
ebselen inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD3 protein] |
CTD |
PMID:21131394 |
|
NCBI chr15:67,065,602...67,195,169
Ensembl chr15:67,063,763...67,195,173
|
|
G |
SOD1 |
superoxide dismutase 1 |
decreases response to substance multiple interactions |
EXP ISO |
ebselen results in decreased susceptibility to SOD1 protein mutant form ebselen inhibits the reaction [SOD1 gene mutant form inhibits the reaction [Glucose results in increased secretion of INS1 protein]] |
CTD |
PMID:16702190 PMID:23795780 |
|
NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931
|
|
G |
SOD2 |
superoxide dismutase 2 |
multiple interactions |
ISO |
ebselen inhibits the reaction [SOD2 protein results in increased phosphorylation of and results in increased activity of MAPK1 protein]; ebselen inhibits the reaction [SOD2 protein results in increased phosphorylation of and results in increased activity of MAPK3 protein] |
CTD |
PMID:20495008 |
|
NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529
|
|
G |
TAT |
tyrosine aminotransferase |
multiple interactions |
ISO |
ebselen inhibits the reaction [Cisplatin results in increased activity of TAT protein] |
CTD |
PMID:32860823 |
|
NCBI chr16:71,565,660...71,577,092
Ensembl chr16:71,565,660...71,577,092
|
|
G |
TGFB1 |
transforming growth factor beta 1 |
multiple interactions |
ISO EXP |
ebselen inhibits the reaction [Carbon Tetrachloride results in increased expression of TGFB1 mRNA] ebselen inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]; ebselen inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD3 protein] |
CTD |
PMID:11903743 PMID:16757516 PMID:21131394 |
|
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
|
|
G |
TIMP1 |
TIMP metallopeptidase inhibitor 1 |
multiple interactions |
ISO |
ebselen inhibits the reaction [Carbon Tetrachloride results in increased expression of TIMP1 mRNA] |
CTD |
PMID:11903743 |
|
NCBI chr X:47,582,436...47,586,789
Ensembl chr X:47,582,408...47,586,789
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions |
ISO |
ebselen inhibits the reaction [sodium arsenite results in increased expression of TNF protein] |
CTD |
PMID:30558456 |
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
TXNRD1 |
thioredoxin reductase 1 |
multiple interactions |
EXP |
ebselen results in increased expression of and results in increased activity of TXNRD1 protein |
CTD |
PMID:28383113 |
|
NCBI chr12:104,215,779...104,350,307
Ensembl chr12:104,215,779...104,350,307
|
|
G |
UCP2 |
uncoupling protein 2 |
multiple interactions |
ISO |
[ebselen co-treated with Glucose] results in decreased expression of UCP2 protein |
CTD |
PMID:23795780 |
|
NCBI chr11:73,974,672...73,983,202
Ensembl chr11:73,974,672...73,982,843
|
|
G |
XBP1 |
X-box binding protein 1 |
increases phosphorylation |
ISO |
ebselen results in increased phosphorylation of XBP1 protein |
CTD |
PMID:27282967 |
|
NCBI chr22:28,794,560...28,800,569
Ensembl chr22:28,794,555...28,800,597
|
|
G |
XPA |
XPA, DNA damage recognition and repair factor |
multiple interactions |
EXP |
ebselen inhibits the reaction [Zinc binds to XPA protein] |
CTD |
PMID:15265038 |
|
NCBI chr 9:97,654,398...97,697,340
Ensembl chr 9:97,674,909...97,697,340
|
|
|
G |
ABCC4 |
ATP binding cassette subfamily C member 4 |
multiple interactions affects expression decreases expression |
EXP |
AR protein inhibits the reaction [methylselenic acid results in decreased expression of ABCC4 mRNA] methylselenic acid affects the expression of ABCC4 mRNA |
CTD |
PMID:14617803 PMID:16020662 PMID:18548127 |
|
NCBI chr13:95,019,835...95,301,451
Ensembl chr13:95,019,835...95,301,475
|
|
G |
ACP3 |
acid phosphatase 3 |
affects expression |
EXP |
methylselenic acid affects the expression of ACP3 mRNA |
CTD |
PMID:14617803 |
|
NCBI chr 3:132,317,407...132,368,302
Ensembl chr 3:132,317,369...132,368,302
|
|
G |
ACSL3 |
acyl-CoA synthetase long chain family member 3 |
affects expression decreases expression |
EXP |
methylselenic acid affects the expression of ACSL3 mRNA methylselenic acid results in decreased expression of ACSL3 mRNA |
CTD |
PMID:14617803 PMID:18548127 |
|
NCBI chr 2:222,861,036...222,944,639
Ensembl chr 2:222,860,942...222,944,639
|
|
G |
ACTA2 |
actin alpha 2, smooth muscle |
increases expression |
EXP |
methylselenic acid results in increased expression of ACTA2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr10:88,935,074...88,991,337
Ensembl chr10:88,935,074...88,991,339
|
|
G |
ACTG2 |
actin gamma 2, smooth muscle |
increases expression |
EXP |
methylselenic acid results in increased expression of ACTG2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 2:73,893,008...73,919,865
Ensembl chr 2:73,892,314...73,919,865
|
|
G |
ADAM22 |
ADAM metallopeptidase domain 22 |
increases expression |
EXP |
methylselenic acid results in increased expression of ADAM22 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 7:87,934,251...88,202,889
Ensembl chr 7:87,934,143...88,202,889
|
|
G |
ADD3 |
adducin 3 |
increases expression |
EXP |
methylselenic acid results in increased expression of ADD3 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr10:109,996,373...110,135,565
Ensembl chr10:109,996,368...110,135,565
|
|
G |
ADGRL3 |
adhesion G protein-coupled receptor L3 |
increases expression |
EXP |
methylselenic acid results in increased expression of ADGRL3 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 4:61,200,326...62,078,335
Ensembl chr 4:61,200,326...62,078,335
|
|
G |
AHR |
aryl hydrocarbon receptor |
increases expression |
EXP |
methylselenic acid results in increased expression of AHR mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152
|
|
G |
AKAP12 |
A-kinase anchoring protein 12 |
increases expression |
EXP |
methylselenic acid results in increased expression of AKAP12 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 6:151,239,967...151,358,559
Ensembl chr 6:151,239,967...151,358,559
|
|
G |
AKR1B1 |
aldo-keto reductase family 1 member B |
increases expression |
EXP |
methylselenic acid results in increased expression of AKR1B1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 7:134,442,350...134,459,239
Ensembl chr 7:134,442,356...134,459,284
|
|
G |
AKT1 |
AKT serine/threonine kinase 1 |
multiple interactions decreases response to substance decreases phosphorylation |
EXP |
[methylselenic acid results in decreased phosphorylation of AKT1 protein] which results in increased susceptibility to Doxorubicin; AKT1 protein modified form inhibits the reaction [[Doxorubicin co-treated with methylselenic acid] results in increased degradation of PARP1 protein]; methylselenic acid inhibits the reaction [Doxorubicin results in increased phosphorylation of AKT1 protein] AKT1 protein results in decreased susceptibility to methylselenic acid |
CTD |
PMID:15845651 PMID:17339365 |
|
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,751
|
|
G |
AKT2 |
AKT serine/threonine kinase 2 |
decreases expression |
EXP |
methylselenic acid results in decreased expression of AKT2 mRNA |
CTD |
PMID:11830524 |
|
NCBI chr19:40,230,317...40,285,345
Ensembl chr19:40,230,317...40,285,536
|
|
G |
ALAD |
aminolevulinate dehydratase |
increases expression |
EXP |
methylselenic acid results in increased expression of ALAD mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 9:113,386,312...113,401,284
Ensembl chr 9:113,386,312...113,401,290
|
|
G |
ALG3 |
ALG3 alpha-1,3- mannosyltransferase |
decreases expression |
EXP |
methylselenic acid results in decreased expression of ALG3 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 3:184,242,301...184,249,525
Ensembl chr 3:184,242,301...184,249,548
|
|
G |
ALG8 |
ALG8 alpha-1,3-glucosyltransferase |
decreases expression |
EXP |
methylselenic acid results in decreased expression of ALG8 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr11:78,100,946...78,139,626
Ensembl chr11:78,095,244...78,139,660
|
|
G |
AMT |
aminomethyltransferase |
increases expression |
EXP |
methylselenic acid results in increased expression of AMT mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 3:49,416,778...49,422,473
Ensembl chr 3:49,416,778...49,422,685
|
|
G |
ANK2 |
ankyrin 2 |
increases expression |
EXP |
methylselenic acid results in increased expression of ANK2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 4:112,705,622...113,383,736
Ensembl chr 4:112,818,032...113,384,221
|
|
G |
ANK3 |
ankyrin 3 |
decreases expression |
EXP |
methylselenic acid results in decreased expression of ANK3 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr10:60,026,298...60,733,528
Ensembl chr10:60,026,298...60,733,490
|
|
G |
APOD |
apolipoprotein D |
affects expression |
EXP |
methylselenic acid affects the expression of APOD mRNA |
CTD |
PMID:14617803 |
|
NCBI chr 3:195,568,705...195,583,940
Ensembl chr 3:195,568,705...195,584,033
|
|
G |
AR |
androgen receptor |
affects response to substance increases degradation decreases expression decreases activity multiple interactions |
EXP |
AR protein affects the susceptibility to methylselenic acid methylselenic acid results in increased degradation of AR mRNA; methylselenic acid results in increased degradation of AR protein methylselenic acid results in decreased expression of AR mRNA; methylselenic acid results in decreased expression of AR protein methylselenic acid results in decreased activity of AR protein AR protein inhibits the reaction [methylselenic acid results in decreased expression of ABCC4 mRNA]; AR protein inhibits the reaction [methylselenic acid results in decreased expression of DHCR24 mRNA]; AR protein inhibits the reaction [methylselenic acid results in decreased expression of GUCY1A1 mRNA]; AR protein inhibits the reaction [methylselenic acid results in decreased expression of KLK2 mRNA]; AR protein inhibits the reaction [methylselenic acid results in decreased expression of KLK3 mRNA]; methylselenic acid inhibits the reaction [Dihydrotestosterone promotes the reaction [AR protein binds to KLK3 promoter]]; Superoxides promotes the reaction [methylselenic acid results in decreased expression of AR protein] |
CTD |
PMID:14617803 PMID:15141018 PMID:16020662 PMID:16648561 PMID:16928829 |
|
NCBI chr X:67,544,021...67,730,619
Ensembl chr X:67,544,021...67,730,619
|
|
G |
ARHGEF2 |
Rho/Rac guanine nucleotide exchange factor 2 |
increases expression |
EXP |
methylselenic acid results in increased expression of ARHGEF2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 1:155,946,854...155,979,617
Ensembl chr 1:155,946,851...156,007,070
|
|
G |
ARL4A |
ADP ribosylation factor like GTPase 4A |
increases expression |
EXP |
methylselenic acid results in increased expression of ARL4A mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 7:12,686,903...12,690,958
Ensembl chr 7:12,686,856...12,690,958
|
|
G |
ATF2 |
activating transcription factor 2 |
multiple interactions |
EXP |
methylselenic acid results in increased phosphorylation of and results in increased activity of ATF2 protein |
CTD |
PMID:11830524 |
|
NCBI chr 2:175,072,259...175,168,203
Ensembl chr 2:175,072,250...175,168,382
|
|
G |
ATF3 |
activating transcription factor 3 |
affects expression |
EXP |
methylselenic acid affects the expression of ATF3 mRNA |
CTD |
PMID:14617803 |
|
NCBI chr 1:212,565,407...212,620,777
Ensembl chr 1:212,565,334...212,620,777
|
|
G |
ATF5 |
activating transcription factor 5 |
decreases expression |
EXP |
methylselenic acid results in decreased expression of ATF5 mRNA |
CTD |
PMID:12517777 PMID:18548127 |
|
NCBI chr19:49,928,906...49,933,935
Ensembl chr19:49,928,702...49,933,935
|
|
G |
ATF6 |
activating transcription factor 6 |
multiple interactions |
EXP |
methylselenic acid results in increased cleavage of and results in increased activity of ATF6 protein |
CTD |
PMID:16205645 |
|
NCBI chr 1:161,766,320...161,964,070
Ensembl chr 1:161,766,298...161,977,574
|
|
G |
ATP2A2 |
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 |
increases expression |
EXP |
methylselenic acid results in increased expression of ATP2A2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr12:110,280,616...110,351,093
Ensembl chr12:110,280,756...110,351,093
|
|
G |
ATP2B4 |
ATPase plasma membrane Ca2+ transporting 4 |
increases expression |
EXP |
methylselenic acid results in increased expression of ATP2B4 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 1:203,626,832...203,744,081
Ensembl chr 1:203,626,832...203,744,081
|
|
G |
AURKA |
aurora kinase A |
affects expression decreases expression |
EXP |
methylselenic acid affects the expression of AURKA mRNA methylselenic acid results in decreased expression of AURKA mRNA |
CTD |
PMID:12517777 PMID:14617803 |
|
NCBI chr20:56,369,390...56,392,215
Ensembl chr20:56,369,389...56,392,337
|
|
G |
B4GALT1 |
beta-1,4-galactosyltransferase 1 |
affects expression |
EXP |
methylselenic acid affects the expression of B4GALT1 mRNA |
CTD |
PMID:14617803 |
|
NCBI chr 9:33,104,077...33,185,089
Ensembl chr 9:33,104,082...33,167,356
|
|
G |
BACH1 |
BTB domain and CNC homolog 1 |
increases expression |
EXP |
methylselenic acid results in increased expression of BACH1 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr21:29,298,922...29,361,894
Ensembl chr21:29,194,071...29,630,751
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
affects expression |
ISO |
methylselenic acid affects the expression of BAX protein |
CTD |
PMID:12017302 |
|
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
|
|
G |
BBC3 |
BCL2 binding component 3 |
increases expression |
EXP |
methylselenic acid results in increased expression of BBC3 mRNA |
CTD |
PMID:28161410 |
|
NCBI chr19:47,220,824...47,232,860
Ensembl chr19:47,220,822...47,232,766
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
affects expression |
ISO |
methylselenic acid affects the expression of BCL2 protein |
CTD |
PMID:12017302 |
|
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
|
|
G |
BCL2A1 |
BCL2 related protein A1 |
increases expression |
EXP |
methylselenic acid results in increased expression of BCL2A1 mRNA |
CTD |
PMID:11830524 |
|
NCBI chr15:79,960,892...79,971,196
Ensembl chr15:79,960,892...79,971,196
|
|
G |
BCL2L11 |
BCL2 like 11 |
multiple interactions increases cleavage increases expression |
EXP |
BCL2L11 protein affects the susceptibility to [Doxorubicin co-treated with methylselenic acid]; BCL2L11 protein promotes the reaction [[Doxorubicin co-treated with methylselenic acid] results in increased cleavage of and results in increased activity of CASP9 protein]; BCL2L11 protein promotes the reaction [[Doxorubicin co-treated with methylselenic acid] results in increased degradation of PARP1 protein]; Tamoxifen promotes the reaction [methylselenic acid results in increased cleavage of BCL2L11 protein] methylselenic acid results in increased expression of BCL2L11 mRNA; methylselenic acid results in increased expression of BCL2L11 protein |
CTD |
PMID:17339365 PMID:18790785 PMID:28161410 |
|
NCBI chr 2:111,120,914...111,168,445
Ensembl chr 2:111,119,378...111,168,445
|
|
G |
BIRC2 |
baculoviral IAP repeat containing 2 |
affects expression |
EXP |
methylselenic acid affects the expression of BIRC2 mRNA |
CTD |
PMID:14617803 |
|
NCBI chr11:102,347,214...102,378,670
Ensembl chr11:102,347,211...102,378,670
|
|
G |
BIRC3 |
baculoviral IAP repeat containing 3 |
affects expression |
EXP |
methylselenic acid affects the expression of BIRC3 mRNA |
CTD |
PMID:14617803 |
|
NCBI chr11:102,317,484...102,339,403
Ensembl chr11:102,317,450...102,339,403
|
|
G |
BIRC5 |
baculoviral IAP repeat containing 5 |
multiple interactions decreases expression |
EXP |
[2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid co-treated with methylselenic acid co-treated with resveratrol] results in decreased expression of BIRC5 protein; methylselenic acid inhibits the reaction [SP1 protein binds to BIRC5 promoter] methylselenic acid results in decreased expression of BIRC5 mRNA; methylselenic acid results in decreased expression of BIRC5 protein |
CTD |
PMID:12517777 PMID:17876054 PMID:18444175 PMID:18567002 |
|
NCBI chr17:78,214,253...78,225,635
Ensembl chr17:78,214,186...78,225,636
|
|
G |
BMP4 |
bone morphogenetic protein 4 |
increases expression |
EXP |
methylselenic acid results in increased expression of BMP4 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr14:53,949,736...53,956,891
Ensembl chr14:53,949,736...53,958,761
|
|
G |
BRCA2 |
BRCA2 DNA repair associated |
increases expression |
EXP |
methylselenic acid results in increased expression of BRCA2 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr13:32,315,508...32,400,268
Ensembl chr13:32,315,086...32,400,268
|
|
G |
BTG3 |
BTG anti-proliferation factor 3 |
increases expression |
EXP |
methylselenic acid results in increased expression of BTG3 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr21:17,593,653...17,612,901
Ensembl chr21:17,593,653...17,612,945
|
|
G |
BUB1B |
BUB1 mitotic checkpoint serine/threonine kinase B |
affects expression |
EXP |
methylselenic acid affects the expression of BUB1B mRNA |
CTD |
PMID:14617803 |
|
NCBI chr15:40,161,069...40,221,123
Ensembl chr15:40,161,023...40,221,123
|
|
G |
C1QBP |
complement C1q binding protein |
decreases expression |
EXP |
methylselenic acid results in decreased expression of C1QBP mRNA |
CTD |
PMID:18548127 |
|
NCBI chr17:5,432,777...5,439,155
Ensembl chr17:5,432,777...5,448,830
|
|
G |
CADM1 |
cell adhesion molecule 1 |
affects expression |
EXP |
methylselenic acid affects the expression of CADM1 mRNA |
CTD |
PMID:14617803 |
|
NCBI chr11:115,169,236...115,504,415
Ensembl chr11:115,169,218...115,504,957
|
|
G |
CALM1 |
calmodulin 1 |
increases expression |
EXP |
methylselenic acid results in increased expression of CALM1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr14:90,396,502...90,408,268
Ensembl chr14:90,396,502...90,408,268
|
|
G |
CAMK2G |
calcium/calmodulin dependent protein kinase II gamma |
increases expression |
EXP |
methylselenic acid results in increased expression of CAMK2G mRNA |
CTD |
PMID:18548127 |
|
NCBI chr10:73,812,501...73,874,555
Ensembl chr10:73,812,501...73,874,591
|
|
G |
CAMK4 |
calcium/calmodulin dependent protein kinase IV |
increases expression |
EXP |
methylselenic acid results in increased expression of CAMK4 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 5:111,223,583...111,494,886
Ensembl chr 5:111,223,653...111,494,886
|
|
G |
CAPZA1 |
capping actin protein of muscle Z-line subunit alpha 1 |
decreases expression |
EXP |
methylselenic acid results in decreased expression of CAPZA1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 1:112,619,832...112,671,616
Ensembl chr 1:112,619,805...112,671,616
|
|
G |
CASP12 |
caspase 12 (gene/pseudogene) |
multiple interactions increases cleavage |
EXP |
HSPA5 protein inhibits the reaction [methylselenic acid results in increased cleavage of CASP12 protein] |
CTD |
PMID:16204082 |
|
NCBI chr11:104,883,286...104,898,460
Ensembl chr11:104,885,718...104,898,670
|
|
G |
CASP3 |
caspase 3 |
multiple interactions increases cleavage |
ISO EXP |
methylselenic acid results in increased cleavage of and results in increased activity of CASP3 protein methylselenic acid results in increased cleavage of CASP3 protein |
CTD |
PMID:19276161 PMID:28161410 |
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
CASP4 |
caspase 4 |
increases cleavage |
EXP |
methylselenic acid results in increased cleavage of CASP4 protein |
CTD |
PMID:28161410 |
|
NCBI chr11:104,942,866...104,968,574
Ensembl chr11:104,942,866...104,969,366
|
|
G |
CASP7 |
caspase 7 |
increases cleavage multiple interactions |
EXP |
methylselenic acid results in increased cleavage of CASP7 protein Acetylcysteine inhibits the reaction [methylselenic acid results in increased cleavage of CASP7 protein]; HSPA5 protein inhibits the reaction [methylselenic acid results in increased cleavage of CASP7 protein]; methylselenic acid inhibits the reaction [CASP7 protein binds to HSPA5 protein]; Sodium Selenite inhibits the reaction [methylselenic acid results in increased cleavage of CASP7 protein]; Tamoxifen promotes the reaction [methylselenic acid results in increased cleavage of CASP7 protein] |
CTD |
PMID:16204082 PMID:18790785 PMID:28161410 |
|
NCBI chr10:113,679,194...113,730,909
Ensembl chr10:113,679,162...113,730,907
|
|
G |
CASP8 |
caspase 8 |
multiple interactions increases cleavage |
EXP |
[2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid co-treated with methylselenic acid co-treated with resveratrol] results in increased cleavage of CASP8 protein; [[methylselenic acid co-treated with Tamoxifen] results in increased cleavage of CASP9 protein] which results in increased cleavage of CASP8 protein; [methylselenic acid co-treated with Tamoxifen] results in increased cleavage of CASP8 protein [methylselenic acid results in increased cleavage of CASP9 protein] which results in increased cleavage of CASP8 protein; methylselenic acid results in increased cleavage of CASP8 protein |
CTD |
PMID:18444175 PMID:18790785 |
|
NCBI chr 2:201,233,443...201,287,711
Ensembl chr 2:201,233,443...201,361,836
|
|
G |
CASP9 |
caspase 9 |
multiple interactions increases cleavage increases expression |
EXP |
[2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid co-treated with methylselenic acid co-treated with resveratrol] results in increased cleavage of CASP9 protein; [[methylselenic acid co-treated with Tamoxifen] results in increased cleavage of CASP9 protein] which results in increased cleavage of CASP8 protein; [Doxorubicin co-treated with methylselenic acid] results in increased cleavage of and results in increased activity of CASP9 protein; [methylselenic acid co-treated with Tamoxifen] results in increased cleavage of CASP9 protein; BCL2L11 protein promotes the reaction [[Doxorubicin co-treated with methylselenic acid] results in increased cleavage of and results in increased activity of CASP9 protein]; methylselenic acid results in increased cleavage of and results in increased activity of CASP9 protein [methylselenic acid results in increased cleavage of CASP9 protein] which results in increased cleavage of CASP8 protein; methylselenic acid results in increased cleavage of CASP9 protein methylselenic acid results in increased expression of CASP9 mRNA |
CTD |
PMID:12517777 PMID:17339365 PMID:18444175 PMID:18790785 PMID:28161410 |
|
NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
|
|
G |
CAST |
calpastatin |
increases expression |
EXP |
methylselenic acid results in increased expression of CAST mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 5:96,662,037...96,774,683
Ensembl chr 5:96,525,267...96,779,595
|
|
G |
CBX7 |
chromobox 7 |
increases expression |
EXP |
methylselenic acid results in increased expression of CBX7 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr22:39,130,772...39,152,680
Ensembl chr22:39,120,167...39,152,680
|
|
G |
CCK |
cholecystokinin |
increases expression |
EXP |
methylselenic acid results in increased expression of CCK mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 3:42,257,826...42,266,185
Ensembl chr 3:42,257,825...42,266,185
|
|
G |
CCNA2 |
cyclin A2 |
decreases expression |
EXP |
methylselenic acid results in decreased expression of CCNA2 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 4:121,816,444...121,823,883
Ensembl chr 4:121,816,444...121,823,883
|
|
G |
CCNB1 |
cyclin B1 |
decreases expression |
EXP |
methylselenic acid results in decreased expression of CCNB1 mRNA; methylselenic acid results in decreased expression of CCNB1 protein |
CTD |
PMID:11830524 |
|
NCBI chr 5:69,167,150...69,178,245
Ensembl chr 5:69,167,135...69,178,245
|
|
G |
CCND1 |
cyclin D1 |
affects expression decreases expression multiple interactions |
EXP ISO |
methylselenic acid affects the expression of CCND1 mRNA methylselenic acid affects the expression of CCND1 protein methylselenic acid results in decreased expression of CCND1 mRNA [2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid co-treated with methylselenic acid co-treated with resveratrol] results in decreased expression of CCND1 protein; KLF4 protein affects the reaction [methylselenic acid results in decreased expression of CCND1 mRNA]; methylselenic acid promotes the reaction [CDKN2A protein binds to CDK4 protein binds to CCND1 protein]; methylselenic acid results in decreased activity of [CDKN2A protein binds to CDK4 protein binds to CCND1 protein] |
CTD |
PMID:11830524 PMID:12017302 PMID:17847021 PMID:18314491 PMID:18444175 |
|
NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474
|
|
G |
CCNE2 |
cyclin E2 |
decreases expression |
EXP |
methylselenic acid results in decreased expression of CCNE2 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 8:94,880,224...94,896,693
Ensembl chr 8:94,879,770...94,896,678
|
|
G |
CD14 |
CD14 molecule |
decreases expression |
EXP |
methylselenic acid results in decreased expression of CD14 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 5:140,631,732...140,633,701
Ensembl chr 5:140,631,728...140,633,700
|
|
G |
CD44 |
CD44 molecule (Indian blood group) |
decreases expression |
EXP |
methylselenic acid results in decreased expression of CD44 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr11:35,139,171...35,232,402
Ensembl chr11:35,138,882...35,232,402
|
|
G |
CDC14B |
cell division cycle 14B |
affects expression |
EXP |
methylselenic acid affects the expression of CDC14B mRNA |
CTD |
PMID:14617803 |
|
NCBI chr 9:96,490,939...96,619,843
Ensembl chr 9:96,490,241...96,619,843
|
|
G |
CDC20 |
cell division cycle 20 |
affects expression |
EXP |
methylselenic acid affects the expression of CDC20 mRNA |
CTD |
PMID:14617803 |
|
NCBI chr 1:43,358,981...43,363,203
Ensembl chr 1:43,358,981...43,363,203
|
|
G |
CDC25A |
cell division cycle 25A |
affects expression decreases expression |
EXP |
methylselenic acid affects the expression of CDC25A mRNA methylselenic acid results in decreased expression of CDC25A mRNA; methylselenic acid results in decreased expression of CDC25A protein |
CTD |
PMID:11830524 PMID:14617803 |
|
NCBI chr 3:48,157,146...48,188,417
Ensembl chr 3:48,157,146...48,188,417
|
|
G |
CDC25C |
cell division cycle 25C |
decreases expression |
EXP |
methylselenic acid results in decreased expression of CDC25C mRNA |
CTD |
PMID:11830524 |
|
NCBI chr 5:138,285,265...138,338,355
Ensembl chr 5:138,285,269...138,338,355
|
|
G |
CDC42 |
cell division cycle 42 |
decreases expression |
EXP |
methylselenic acid results in decreased expression of CDC42 mRNA |
CTD |
PMID:11830524 |
|
NCBI chr 1:22,052,709...22,101,360
Ensembl chr 1:22,052,627...22,101,360
|
|
G |
CDC42EP3 |
CDC42 effector protein 3 |
increases expression |
EXP |
methylselenic acid results in increased expression of CDC42EP3 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 2:37,641,944...37,672,949
Ensembl chr 2:37,641,882...37,738,468
|
|
G |
CDC6 |
cell division cycle 6 |
decreases expression affects expression |
EXP |
methylselenic acid results in decreased expression of CDC6 mRNA methylselenic acid affects the expression of CDC6 mRNA |
CTD |
PMID:11830524 PMID:14617803 |
|
NCBI chr17:40,287,879...40,304,657
Ensembl chr17:40,287,879...40,304,657
|
|
G |
CDH15 |
cadherin 15 |
increases expression |
EXP |
methylselenic acid results in increased expression of CDH15 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr16:89,171,748...89,195,492
Ensembl chr16:89,171,748...89,195,492
|
|
G |
CDH7 |
cadherin 7 |
increases expression |
EXP |
methylselenic acid results in increased expression of CDH7 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr18:65,750,252...65,890,337
Ensembl chr18:65,750,252...65,890,337
|
|
G |
CDK1 |
cyclin dependent kinase 1 |
multiple interactions decreases expression |
EXP |
HSPA5 protein affects the reaction [methylselenic acid results in decreased expression of CDK1 protein] methylselenic acid results in decreased expression of CDK1 mRNA; methylselenic acid results in decreased expression of CDK1 protein |
CTD |
PMID:11830524 PMID:12517777 PMID:16205645 |
|
NCBI chr10:60,778,331...60,794,852
Ensembl chr10:60,778,331...60,794,852
|
|
G |
CDK10 |
cyclin dependent kinase 10 |
decreases expression |
EXP |
methylselenic acid results in decreased expression of CDK10 mRNA |
CTD |
PMID:11830524 |
|
NCBI chr16:89,686,689...89,696,354
Ensembl chr16:89,680,737...89,696,354
|
|
G |
CDK16 |
cyclin dependent kinase 16 |
decreases expression |
EXP |
methylselenic acid results in decreased expression of CDK16 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr X:47,218,303...47,229,997
Ensembl chr X:47,217,860...47,229,997
|
|
G |
CDK18 |
cyclin dependent kinase 18 |
increases expression |
EXP |
methylselenic acid results in increased expression of CDK18 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 1:205,504,669...205,532,790
Ensembl chr 1:205,504,596...205,532,793
|
|
G |
CDK2 |
cyclin dependent kinase 2 |
multiple interactions decreases expression |
EXP |
HSPA5 protein affects the reaction [methylselenic acid results in decreased expression of CDK2 protein]; methylselenic acid promotes the reaction [CDKN1A protein binds to CDKN1B protein binds to CDK2 protein]; methylselenic acid results in decreased activity of [CDKN1A protein binds to CDKN1B protein binds to CDK2 protein] methylselenic acid results in decreased expression of CDK2 mRNA; methylselenic acid results in decreased expression of CDK2 protein |
CTD |
PMID:12517777 PMID:16205645 PMID:17847021 |
|
NCBI chr12:55,966,830...55,972,789
Ensembl chr12:55,966,781...55,972,789
|
|
G |
CDK4 |
cyclin dependent kinase 4 |
multiple interactions decreases expression |
EXP |
methylselenic acid promotes the reaction [CDKN2A protein binds to CDK4 protein binds to CCND1 protein]; methylselenic acid results in decreased activity of [CDKN2A protein binds to CDK4 protein binds to CCND1 protein] methylselenic acid results in decreased expression of CDK4 mRNA |
CTD |
PMID:11830524 PMID:12517777 PMID:17847021 PMID:18548127 |
|
NCBI chr12:57,747,727...57,752,310
Ensembl chr12:57,747,727...57,756,013
|
|
G |
CDK5 |
cyclin dependent kinase 5 |
increases expression |
EXP |
methylselenic acid results in increased expression of CDK5 mRNA |
CTD |
PMID:11830524 |
|
NCBI chr 7:151,053,815...151,057,897
Ensembl chr 7:151,053,815...151,057,897
|
|
G |
CDK6 |
cyclin dependent kinase 6 |
multiple interactions |
EXP |
methylselenic acid promotes the reaction [CDKN2A protein binds to CDK6 protein]; methylselenic acid results in decreased activity of [CDKN2A protein binds to CDK6 protein] |
CTD |
PMID:17847021 |
|
NCBI chr 7:92,604,921...92,836,573
Ensembl chr 7:92,604,921...92,836,573
|
|
G |
CDKL1 |
cyclin dependent kinase like 1 |
decreases expression |
EXP |
methylselenic acid results in decreased expression of CDKL1 mRNA |
CTD |
PMID:11830524 |
|
NCBI chr14:50,326,265...50,397,298
Ensembl chr14:50,326,265...50,416,461
|
|
G |
CDKN1A |
cyclin dependent kinase inhibitor 1A |
multiple interactions affects expression increases expression |
EXP ISO |
DDIT3 protein affects the reaction [methylselenic acid results in increased expression of CDKN1A mRNA]; DDIT3 protein affects the reaction [methylselenic acid results in increased expression of CDKN1A protein]; HSPA5 protein affects the reaction [methylselenic acid results in increased expression of CDKN1A protein]; KLF4 protein affects the reaction [methylselenic acid results in increased expression of CDKN1A mRNA]; methylselenic acid promotes the reaction [CDKN1A protein binds to CDKN1B protein binds to CDK2 protein]; methylselenic acid results in decreased activity of [CDKN1A protein binds to CDKN1B protein binds to CDK2 protein]; methylselenic acid results in increased expression of and results in decreased degradation of CDKN1A protein methylselenic acid affects the expression of CDKN1A protein methylselenic acid results in increased expression of CDKN1A mRNA; methylselenic acid results in increased expression of CDKN1A protein methylselenic acid affects the expression of CDKN1A mRNA |
CTD |
PMID:12017302 PMID:12517777 PMID:14617803 PMID:16205645 PMID:17847021 PMID:18314491 More...
|
|
NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,337
|
|
G |
CDKN1B |
cyclin dependent kinase inhibitor 1B |
multiple interactions affects expression increases expression |
EXP ISO |
KLF4 protein affects the reaction [methylselenic acid results in increased expression of CDKN1B mRNA]; methylselenic acid promotes the reaction [CDKN1A protein binds to CDKN1B protein binds to CDK2 protein]; methylselenic acid results in decreased activity of [CDKN1A protein binds to CDKN1B protein binds to CDK2 protein] methylselenic acid affects the expression of CDKN1B protein methylselenic acid results in increased expression of CDKN1B mRNA; methylselenic acid results in increased expression of CDKN1B protein |
CTD |
PMID:12017302 PMID:17847021 PMID:18314491 |
|
NCBI chr12:12,717,368...12,722,369
Ensembl chr12:12,685,498...12,722,369
|
|
G |
CDKN1C |
cyclin dependent kinase inhibitor 1C |
increases expression affects expression |
EXP |
methylselenic acid results in increased expression of CDKN1C mRNA methylselenic acid affects the expression of CDKN1C mRNA |
CTD |
PMID:14617803 PMID:18548127 |
|
NCBI chr11:2,883,218...2,885,775
Ensembl chr11:2,883,213...2,885,775
|
|
G |
CDKN2A |
cyclin dependent kinase inhibitor 2A |
multiple interactions increases expression |
EXP |
methylselenic acid promotes the reaction [CDKN2A protein binds to CDK4 protein binds to CCND1 protein]; methylselenic acid promotes the reaction [CDKN2A protein binds to CDK6 protein]; methylselenic acid results in decreased activity of [CDKN2A protein binds to CDK4 protein binds to CCND1 protein]; methylselenic acid results in decreased activity of [CDKN2A protein binds to CDK6 protein] methylselenic acid results in increased expression of CDKN2A protein |
CTD |
PMID:17847021 |
|
NCBI chr 9:21,967,752...21,995,324
Ensembl chr 9:21,967,752...21,995,301
|
|
G |
CDKN2D |
cyclin dependent kinase inhibitor 2D |
increases expression affects expression |
EXP |
methylselenic acid results in increased expression of CDKN2D mRNA methylselenic acid affects the expression of CDKN2D mRNA |
CTD |
PMID:12517777 PMID:14617803 |
|
NCBI chr19:10,566,460...10,568,979
Ensembl chr19:10,566,460...10,569,059
|
|
G |
CENPA |
centromere protein A |
affects expression |
EXP |
methylselenic acid affects the expression of CENPA mRNA |
CTD |
PMID:14617803 |
|
NCBI chr 2:26,786,056...26,794,589
Ensembl chr 2:26,764,289...26,801,067
|
|
G |
CENPF |
centromere protein F |
decreases expression |
EXP |
methylselenic acid results in decreased expression of CENPF mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 1:214,603,195...214,664,571
Ensembl chr 1:214,603,185...214,664,574
|
|
G |
CFLAR |
CASP8 and FADD like apoptosis regulator |
multiple interactions |
EXP |
[2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid co-treated with methylselenic acid co-treated with resveratrol] results in decreased expression of CFLAR protein |
CTD |
PMID:18444175 |
|
NCBI chr 2:201,116,164...201,176,687
Ensembl chr 2:201,116,154...201,176,687
|
|
G |
CHAF1A |
chromatin assembly factor 1 subunit A |
decreases expression |
EXP |
methylselenic acid results in decreased expression of CHAF1A mRNA |
CTD |
PMID:12517777 |
|
NCBI chr19:4,402,640...4,450,830
Ensembl chr19:4,402,640...4,445,018
|
|
G |
CHEK2 |
checkpoint kinase 2 |
increases expression |
EXP |
methylselenic acid results in increased expression of CHEK2 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr22:28,687,743...28,741,834
Ensembl chr22:28,687,743...28,742,422
|
|
G |
CLU |
clusterin |
affects expression |
EXP |
methylselenic acid affects the expression of CLU mRNA |
CTD |
PMID:14617803 |
|
NCBI chr 8:27,596,917...27,614,700
Ensembl chr 8:27,596,917...27,614,700
|
|
G |
CNPY2 |
canopy FGF signaling regulator 2 |
decreases expression |
EXP |
methylselenic acid results in decreased expression of CNPY2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr12:56,309,844...56,316,346
Ensembl chr12:56,309,842...56,316,119
|
|
G |
COL16A1 |
collagen type XVI alpha 1 chain |
increases expression |
EXP |
methylselenic acid results in increased expression of COL16A1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 1:31,652,263...31,704,017
Ensembl chr 1:31,652,263...31,704,319
|
|
G |
COL6A1 |
collagen type VI alpha 1 chain |
increases expression |
EXP |
methylselenic acid results in increased expression of COL6A1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr21:45,981,770...46,005,048
Ensembl chr21:45,981,770...46,005,050
|
|
G |
CORO1A |
coronin 1A |
increases expression |
EXP |
methylselenic acid results in increased expression of CORO1A mRNA |
CTD |
PMID:12517777 |
|
NCBI chr16:30,183,602...30,189,076
Ensembl chr16:30,182,827...30,189,076
|
|
G |
CRABP2 |
cellular retinoic acid binding protein 2 |
increases expression |
EXP |
methylselenic acid results in increased expression of CRABP2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 1:156,699,606...156,705,784
Ensembl chr 1:156,699,606...156,705,816
|
|
G |
CREB1 |
cAMP responsive element binding protein 1 |
increases expression |
EXP |
methylselenic acid results in increased expression of CREB1 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 2:207,529,962...207,605,988
Ensembl chr 2:207,529,737...207,605,988
|
|
G |
CREB3L1 |
cAMP responsive element binding protein 3 like 1 |
decreases expression |
EXP |
methylselenic acid results in decreased expression of CREB3L1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr11:46,277,662...46,321,409
Ensembl chr11:46,277,662...46,321,409
|
|
G |
CREB3L4 |
cAMP responsive element binding protein 3 like 4 |
affects expression |
EXP |
methylselenic acid affects the expression of CREB3L4 mRNA |
CTD |
PMID:14617803 |
|
NCBI chr 1:153,967,487...153,974,359
Ensembl chr 1:153,967,534...153,974,361
|
|
G |
CRYAB |
crystallin alpha B |
increases expression |
EXP |
methylselenic acid results in increased expression of CRYAB mRNA |
CTD |
PMID:18548127 |
|
NCBI chr11:111,908,564...111,923,740
Ensembl chr11:111,908,564...111,923,722
|
|
G |
CSRP1 |
cysteine and glycine rich protein 1 |
increases expression |
EXP |
methylselenic acid results in increased expression of CSRP1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 1:201,483,530...201,507,123
Ensembl chr 1:201,483,530...201,509,456
|
|
G |
CTSK |
cathepsin K |
increases expression |
EXP |
methylselenic acid results in increased expression of CTSK mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 1:150,796,208...150,808,260
Ensembl chr 1:150,794,880...150,809,577
|
|
G |
CUL1 |
cullin 1 |
increases expression |
EXP |
methylselenic acid results in increased expression of CUL1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 7:148,697,756...148,801,110
Ensembl chr 7:148,697,914...148,801,110
|
|
G |
CYLD |
CYLD lysine 63 deubiquitinase |
increases expression |
EXP |
methylselenic acid results in increased expression of CYLD mRNA |
CTD |
PMID:18548127 |
|
NCBI chr16:50,742,086...50,801,935
Ensembl chr16:50,742,050...50,801,935
|
|
G |
DDIT3 |
DNA damage inducible transcript 3 |
multiple interactions increases expression |
EXP |
DDIT3 protein affects the reaction [methylselenic acid results in increased expression of CDKN1A mRNA]; DDIT3 protein affects the reaction [methylselenic acid results in increased expression of CDKN1A protein]; HSPA5 protein inhibits the reaction [methylselenic acid results in increased expression of DDIT3 protein] methylselenic acid results in increased expression of DDIT3 mRNA; methylselenic acid results in increased expression of DDIT3 protein |
CTD |
PMID:11830524 PMID:12517777 PMID:16204082 PMID:16205645 PMID:19276161 PMID:28161410 More...
|
|
NCBI chr12:57,516,588...57,520,517
Ensembl chr12:57,516,588...57,521,737
|
|
G |
DEAF1 |
DEAF1 transcription factor |
decreases expression |
EXP |
methylselenic acid results in decreased expression of DEAF1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr11:644,220...707,083
Ensembl chr11:644,233...707,118
|
|
G |
DHCR24 |
24-dehydrocholesterol reductase |
multiple interactions decreases expression |
EXP |
AR protein inhibits the reaction [methylselenic acid results in decreased expression of DHCR24 mRNA] |
CTD |
PMID:16020662 PMID:18548127 |
|
NCBI chr 1:54,849,627...54,887,195
Ensembl chr 1:54,849,627...54,887,195
|
|
G |
DHFR |
dihydrofolate reductase |
decreases expression |
EXP |
methylselenic acid results in decreased expression of DHFR mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 5:80,626,226...80,654,983
Ensembl chr 5:80,626,226...80,654,983
|
|
G |
DIXDC1 |
DIX domain containing 1 |
increases expression |
EXP |
methylselenic acid results in increased expression of DIXDC1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr11:111,927,315...112,022,653
Ensembl chr11:111,927,144...112,022,653
|
|
G |
DKC1 |
dyskerin pseudouridine synthase 1 |
decreases expression |
EXP |
methylselenic acid results in decreased expression of DKC1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr X:154,762,864...154,777,689
Ensembl chr X:154,762,742...154,777,689
|
|
G |
DLC1 |
DLC1 Rho GTPase activating protein |
increases expression |
EXP |
methylselenic acid results in increased expression of DLC1 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 8:13,083,361...13,604,620
Ensembl chr 8:13,083,361...13,604,610
|
|
G |
DNAJB5 |
DnaJ heat shock protein family (Hsp40) member B5 |
increases expression |
EXP |
methylselenic acid results in increased expression of DNAJB5 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 9:34,989,745...34,998,900
Ensembl chr 9:34,989,641...34,998,900
|
|
G |
DNAJB9 |
DnaJ heat shock protein family (Hsp40) member B9 |
affects expression |
EXP |
methylselenic acid affects the expression of DNAJB9 mRNA |
CTD |
PMID:14617803 |
|
NCBI chr 7:108,569,874...108,574,850
Ensembl chr 7:108,569,867...108,574,850
|
|
G |
DNPH1 |
2'-deoxynucleoside 5'-phosphate N-hydrolase 1 |
decreases expression |
EXP |
methylselenic acid results in decreased expression of DNPH1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 6:43,225,629...43,229,481
Ensembl chr 6:43,225,629...43,229,481
|
|
G |
DPYD |
dihydropyrimidine dehydrogenase |
increases expression |
EXP |
methylselenic acid results in increased expression of DPYD mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 1:97,077,743...97,921,059
Ensembl chr 1:97,077,743...97,995,000
|
|
G |
DPYSL2 |
dihydropyrimidinase like 2 |
increases expression |
EXP |
methylselenic acid results in increased expression of DPYSL2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 8:26,514,031...26,658,175
Ensembl chr 8:26,514,031...26,658,178
|
|
G |
DTNA |
dystrobrevin alpha |
increases expression |
EXP |
methylselenic acid results in increased expression of DTNA mRNA |
CTD |
PMID:18548127 |
|
NCBI chr18:34,493,312...34,891,844
Ensembl chr18:34,493,291...34,891,844
|
|
G |
DTYMK |
deoxythymidylate kinase |
decreases expression |
EXP |
methylselenic acid results in decreased expression of DTYMK mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 2:241,675,747...241,686,815
Ensembl chr 2:241,675,747...241,686,944
|
|
G |
DUSP10 |
dual specificity phosphatase 10 |
increases expression |
EXP |
methylselenic acid results in increased expression of DUSP10 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 1:221,701,424...221,742,089
Ensembl chr 1:221,701,424...221,742,089
|
|
G |
DVL3 |
dishevelled segment polarity protein 3 |
increases expression |
EXP |
methylselenic acid results in increased expression of DVL3 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 3:184,155,377...184,173,614
Ensembl chr 3:184,155,377...184,173,614
|
|
G |
DYNC1I1 |
dynein cytoplasmic 1 intermediate chain 1 |
increases expression |
EXP |
methylselenic acid results in increased expression of DYNC1I1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 7:95,772,554...96,110,322
Ensembl chr 7:95,772,506...96,110,322
|
|
G |
E2F1 |
E2F transcription factor 1 |
affects expression multiple interactions decreases expression |
EXP |
methylselenic acid affects the expression of E2F1 mRNA methylselenic acid promotes the reaction [E2F1 protein binds to RB1 protein] methylselenic acid results in decreased expression of E2F1 mRNA; methylselenic acid results in decreased expression of E2F1 protein |
CTD |
PMID:11830524 PMID:14617803 PMID:17847021 |
|
NCBI chr20:33,675,477...33,686,385
Ensembl chr20:33,675,477...33,686,385
|
|
G |
E2F5 |
E2F transcription factor 5 |
decreases expression |
EXP |
methylselenic acid results in decreased expression of E2F5 mRNA |
CTD |
PMID:11830524 |
|
NCBI chr 8:85,177,154...85,214,518
Ensembl chr 8:85,177,154...85,217,158
|
|
G |
ECI1 |
enoyl-CoA delta isomerase 1 |
decreases expression |
EXP |
methylselenic acid results in decreased expression of ECI1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr16:2,239,402...2,251,587
Ensembl chr16:2,239,402...2,252,300
|
|
G |
ECM2 |
extracellular matrix protein 2 |
increases expression |
EXP |
methylselenic acid results in increased expression of ECM2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 9:92,493,547...92,559,106
Ensembl chr 9:92,493,554...92,536,655
|
|
G |
EDNRA |
endothelin receptor type A |
increases expression |
EXP |
methylselenic acid results in increased expression of EDNRA mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 4:147,481,097...147,544,954
Ensembl chr 4:147,480,917...147,544,954
|
|
G |
EDNRB |
endothelin receptor type B |
increases expression |
EXP |
methylselenic acid results in increased expression of EDNRB mRNA |
CTD |
PMID:18548127 |
|
NCBI chr13:77,895,481...77,975,527
Ensembl chr13:77,895,481...77,975,529
|
|
G |
EFEMP2 |
EGF containing fibulin extracellular matrix protein 2 |
increases expression |
EXP |
methylselenic acid results in increased expression of EFEMP2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr11:65,866,441...65,872,800
Ensembl chr11:65,866,441...65,873,592
|
|
G |
EGR1 |
early growth response 1 |
increases expression |
ISO |
methylselenic acid results in increased expression of EGR1 mRNA |
CTD |
PMID:11172735 |
|
NCBI chr 5:138,465,479...138,469,303
Ensembl chr 5:138,465,479...138,469,303
|
|
G |
EIF2A |
eukaryotic translation initiation factor 2A |
multiple interactions increases phosphorylation |
EXP |
HSPA5 protein inhibits the reaction [methylselenic acid results in increased phosphorylation of EIF2A protein] |
CTD |
PMID:16204082 |
|
NCBI chr 3:150,546,787...150,586,016
Ensembl chr 3:150,546,678...150,586,016
|
|
G |
EIF2AK3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
multiple interactions |
EXP |
HSPA5 protein inhibits the reaction [methylselenic acid results in increased phosphorylation of EIF2AK3 protein]; methylselenic acid results in increased phosphorylation of and results in increased activity of EIF2AK3 protein |
CTD |
PMID:16204082 PMID:16205645 |
|
NCBI chr 2:88,556,741...88,628,145
Ensembl chr 2:88,556,741...88,691,518
|
|
G |
EIF4G2 |
eukaryotic translation initiation factor 4 gamma 2 |
decreases expression |
EXP |
methylselenic acid results in decreased expression of EIF4G2 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr11:10,797,046...10,808,926
Ensembl chr11:10,797,050...10,808,940
|
|
G |
ELF3 |
E74 like ETS transcription factor 3 |
increases expression affects expression |
EXP |
methylselenic acid results in increased expression of ELF3 mRNA methylselenic acid affects the expression of ELF3 mRNA |
CTD |
PMID:12517777 PMID:14617803 |
|
NCBI chr 1:202,010,587...202,017,183
Ensembl chr 1:202,007,945...202,017,183
|
|
G |
ENO2 |
enolase 2 |
increases expression |
EXP |
methylselenic acid results in increased expression of ENO2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr12:6,914,580...6,923,697
Ensembl chr12:6,913,745...6,923,698
|
|
G |
EPB41L2 |
erythrocyte membrane protein band 4.1 like 2 |
increases expression |
EXP |
methylselenic acid results in increased expression of EPB41L2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 6:130,839,347...131,063,245
Ensembl chr 6:130,839,347...131,063,322
|
|
G |
EPS8 |
epidermal growth factor receptor pathway substrate 8 |
increases expression |
EXP |
methylselenic acid results in increased expression of EPS8 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr12:15,620,134...15,789,388
Ensembl chr12:15,620,134...15,882,329
|
|
G |
ERCC1 |
ERCC excision repair 1, endonuclease non-catalytic subunit |
increases expression |
EXP |
methylselenic acid results in increased expression of ERCC1 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr19:45,407,334...45,451,547
Ensembl chr19:45,407,334...45,478,828
|
|
G |
ESR1 |
estrogen receptor 1 |
multiple interactions decreases expression |
EXP |
[methylselenic acid co-treated with afimoxifene] results in decreased expression of ESR1 mRNA; [methylselenic acid co-treated with afimoxifene] results in decreased expression of ESR1 protein; methylselenic acid inhibits the reaction [Estradiol binds to ESR1 protein]; methylselenic acid results in decreased expression of and results in decreased activity of ESR1 protein methylselenic acid results in decreased expression of ESR1 mRNA; methylselenic acid results in decreased expression of ESR1 protein |
CTD |
PMID:15833885 PMID:16093440 PMID:16155795 |
|
NCBI chr 6:151,656,672...152,129,619
Ensembl chr 6:151,656,691...152,129,619
|
|
G |
ESR2 |
estrogen receptor 2 |
increases expression affects expression |
EXP |
methylselenic acid results in increased expression of ESR2 mRNA methylselenic acid affects the expression of ESR2 mRNA |
CTD |
PMID:15833885 PMID:16928829 |
|
NCBI chr14:64,226,707...64,338,613
Ensembl chr14:64,084,232...64,338,112
|
|
G |
ETV5 |
ETS variant transcription factor 5 |
increases expression |
EXP |
methylselenic acid results in increased expression of ETV5 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 3:186,046,314...186,109,089
Ensembl chr 3:186,046,314...186,110,318
|
|
G |
ETV6 |
ETS variant transcription factor 6 |
increases expression |
EXP |
methylselenic acid results in increased expression of ETV6 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr12:11,649,674...11,895,377
Ensembl chr12:11,649,674...11,895,377
|
|
G |
EXT1 |
exostosin glycosyltransferase 1 |
increases expression |
EXP |
methylselenic acid results in increased expression of EXT1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 8:117,794,490...118,111,826
Ensembl chr 8:117,794,490...118,111,826
|
|
G |
FAM107A |
family with sequence similarity 107 member A |
increases expression |
EXP |
methylselenic acid results in increased expression of FAM107A mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 3:58,564,117...58,627,610
Ensembl chr 3:58,564,117...58,627,610
|
|
G |
FBXL8 |
F-box and leucine rich repeat protein 8 |
increases expression |
EXP |
methylselenic acid results in increased expression of FBXL8 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr16:67,159,957...67,164,174
Ensembl chr16:67,159,932...67,164,570
|
|
G |
FERMT2 |
FERM domain containing kindlin 2 |
increases expression |
EXP |
methylselenic acid results in increased expression of FERMT2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr14:52,857,273...52,951,050
Ensembl chr14:52,857,268...52,952,435
|
|
G |
FEZ1 |
fasciculation and elongation protein zeta 1 |
increases expression |
EXP |
methylselenic acid results in increased expression of FEZ1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr11:125,442,881...125,496,265
Ensembl chr11:125,442,881...125,592,568
|
|
G |
FGF2 |
fibroblast growth factor 2 |
decreases expression |
EXP |
methylselenic acid results in decreased expression of FGF2 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 4:122,826,682...122,898,236
Ensembl chr 4:122,826,682...122,898,236
|
|
G |
FHL2 |
four and a half LIM domains 2 |
increases expression |
EXP |
methylselenic acid results in increased expression of FHL2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 2:105,357,712...105,438,529
Ensembl chr 2:105,357,712...105,438,513
|
|
G |
FKBP4 |
FKBP prolyl isomerase 4 |
decreases expression |
EXP |
methylselenic acid results in decreased expression of FKBP4 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr12:2,794,970...2,805,423
Ensembl chr12:2,794,970...2,805,423
|
|
G |
FKBP5 |
FKBP prolyl isomerase 5 |
affects expression |
EXP |
methylselenic acid affects the expression of FKBP5 mRNA |
CTD |
PMID:14617803 |
|
NCBI chr 6:35,573,590...35,728,583
Ensembl chr 6:35,573,585...35,728,583
|
|
G |
FLNC |
filamin C |
increases expression |
EXP |
methylselenic acid results in increased expression of FLNC mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 7:128,830,406...128,859,272
Ensembl chr 7:128,830,406...128,859,274
|
|
G |
FN1 |
fibronectin 1 |
affects expression |
EXP |
methylselenic acid affects the expression of FN1 mRNA |
CTD |
PMID:14617803 |
|
NCBI chr 2:215,360,865...215,436,068
Ensembl chr 2:215,360,440...215,436,073
|
|
G |
FNBP1 |
formin binding protein 1 |
increases expression |
EXP |
methylselenic acid results in increased expression of FNBP1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 9:129,887,187...130,053,879
Ensembl chr 9:129,887,187...130,043,189
|
|
G |
FOXA1 |
forkhead box A1 |
decreases expression |
EXP |
methylselenic acid results in decreased expression of FOXA1 mRNA |
CTD |
PMID:12517777 PMID:18548127 |
|
NCBI chr14:37,589,552...37,595,249
Ensembl chr14:37,589,552...37,596,059
|
|
G |
FOXO3 |
forkhead box O3 |
multiple interactions |
EXP |
methylselenic acid results in decreased phosphorylation of and results in increased activity of FOXO3 protein |
CTD |
PMID:17339365 |
|
NCBI chr 6:108,559,825...108,684,774
Ensembl chr 6:108,559,835...108,684,774
|
|
G |
FYN |
FYN proto-oncogene, Src family tyrosine kinase |
increases expression |
EXP |
methylselenic acid results in increased expression of FYN mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 6:111,660,332...111,873,452
Ensembl chr 6:111,660,332...111,873,452
|
|
G |
GABARAPL1 |
GABA type A receptor associated protein like 1 |
increases expression |
EXP |
methylselenic acid results in increased expression of GABARAPL1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr12:10,212,877...10,223,128
Ensembl chr12:10,212,458...10,223,128
|
|
G |
GADD45A |
growth arrest and DNA damage inducible alpha |
increases expression |
EXP |
methylselenic acid results in increased expression of GADD45A mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 1:67,685,201...67,688,334
Ensembl chr 1:67,685,201...67,688,334
|
|
G |
GALNT1 |
polypeptide N-acetylgalactosaminyltransferase 1 |
decreases expression |
EXP |
methylselenic acid results in decreased expression of GALNT1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr18:35,580,922...35,711,834
Ensembl chr18:35,581,117...35,711,834
|
|
G |
GAS1 |
growth arrest specific 1 |
increases expression |
EXP |
methylselenic acid results in increased expression of GAS1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 9:86,944,362...86,947,506
Ensembl chr 9:86,944,362...86,947,506
|
|
G |
GATD3 |
glutamine amidotransferase class 1 domain containing 3 |
decreases expression |
EXP |
methylselenic acid results in decreased expression of GATD3 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr21:44,133,683...44,145,711
Ensembl chr21:44,133,610...44,210,114
|
|
G |
GBP2 |
guanylate binding protein 2 |
increases expression |
EXP |
methylselenic acid results in increased expression of GBP2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 1:89,106,132...89,126,114
Ensembl chr 1:89,106,132...89,150,456
|
|
G |
GJA1 |
gap junction protein alpha 1 |
increases expression |
EXP |
methylselenic acid results in increased expression of GJA1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 6:121,435,646...121,449,727
Ensembl chr 6:121,435,595...121,449,727
|
|
G |
GPR161 |
G protein-coupled receptor 161 |
increases expression |
EXP |
methylselenic acid results in increased expression of GPR161 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 1:168,079,542...168,137,667
Ensembl chr 1:168,079,542...168,137,667
|
|
G |
GPR37 |
G protein-coupled receptor 37 |
increases expression |
EXP |
methylselenic acid results in increased expression of GPR37 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 7:124,743,885...124,765,792
Ensembl chr 7:124,743,885...124,765,792
|
|
G |
GRK5 |
G protein-coupled receptor kinase 5 |
increases expression |
EXP |
methylselenic acid results in increased expression of GRK5 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr10:119,207,571...119,459,745
Ensembl chr10:119,207,571...119,459,745
|
|
G |
GSK3B |
glycogen synthase kinase 3 beta |
multiple interactions decreases phosphorylation |
EXP |
methylselenic acid inhibits the reaction [Doxorubicin results in increased phosphorylation of GSK3B protein] methylselenic acid results in decreased phosphorylation of GSK3B protein |
CTD |
PMID:17339365 |
|
NCBI chr 3:119,821,321...120,094,447
Ensembl chr 3:119,821,321...120,094,994
|
|
G |
GSN |
gelsolin |
increases expression |
EXP |
methylselenic acid results in increased expression of GSN mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 9:121,201,483...121,332,842
Ensembl chr 9:121,207,794...121,332,843
|
|
G |
GTF3C1 |
general transcription factor IIIC subunit 1 |
decreases expression |
EXP |
methylselenic acid results in decreased expression of GTF3C1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr16:27,460,613...27,549,913
Ensembl chr16:27,459,555...27,549,913
|
|
G |
GUCY1A1 |
guanylate cyclase 1 soluble subunit alpha 1 |
affects expression decreases expression multiple interactions |
EXP |
methylselenic acid affects the expression of GUCY1A1 mRNA methylselenic acid results in decreased expression of GUCY1A1 mRNA AR protein inhibits the reaction [methylselenic acid results in decreased expression of GUCY1A1 mRNA] |
CTD |
PMID:14617803 PMID:16020662 PMID:18548127 |
|
NCBI chr 4:155,666,848...155,737,059
Ensembl chr 4:155,666,726...155,737,059
|
|
G |
H1-0 |
H1.0 linker histone |
affects expression |
EXP |
methylselenic acid affects the expression of H1-0 mRNA |
CTD |
PMID:14617803 |
|
NCBI chr22:37,805,229...37,807,432
Ensembl chr22:37,805,229...37,807,432
|
|
G |
H2AC18 |
H2A clustered histone 18 |
decreases expression |
EXP |
methylselenic acid results in decreased expression of H2AC18 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 1:149,842,218...149,842,750
Ensembl chr 1:149,842,218...149,842,750
|
|
G |
H2AC8 |
H2A clustered histone 8 |
decreases expression |
EXP |
methylselenic acid results in decreased expression of H2AC8 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 6:26,216,921...26,217,437
Ensembl chr 6:26,216,921...26,217,437
|
|
G |
H4C11 |
H4 clustered histone 11 |
decreases expression |
EXP |
methylselenic acid results in decreased expression of H4C11 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 6:27,824,092...27,824,480
Ensembl chr 6:27,824,092...27,824,480
|
|
G |
HABP4 |
hyaluronan binding protein 4 |
increases expression |
EXP |
methylselenic acid results in increased expression of HABP4 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 9:96,450,102...96,491,336
Ensembl chr 9:96,450,169...96,491,336
|
|
G |
HACD2 |
3-hydroxyacyl-CoA dehydratase 2 |
decreases expression |
EXP |
methylselenic acid results in decreased expression of HACD2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 3:123,491,554...123,585,053
Ensembl chr 3:123,490,820...123,585,053
|
|
G |
HEPH |
hephaestin |
increases expression |
EXP |
methylselenic acid results in increased expression of HEPH mRNA |
CTD |
PMID:18548127 |
|
NCBI chr X:66,162,671...66,268,863
Ensembl chr X:66,162,671...66,268,867
|
|
G |
HMGN4 |
high mobility group nucleosomal binding domain 4 |
increases expression |
EXP |
methylselenic acid results in increased expression of HMGN4 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 6:26,538,366...26,546,933
Ensembl chr 6:26,538,366...26,546,933
|
|
G |
HNRNPAB |
heterogeneous nuclear ribonucleoprotein A/B |
decreases expression |
EXP |
methylselenic acid results in decreased expression of HNRNPAB mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 5:178,204,533...178,211,163
Ensembl chr 5:178,204,533...178,211,163
|
|
G |
HOXA9 |
homeobox A9 |
decreases expression |
EXP |
methylselenic acid results in decreased expression of HOXA9 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 7:27,162,438...27,165,537
Ensembl chr 7:27,162,438...27,175,180
|
|
G |
HOXD8 |
homeobox D8 |
increases expression |
EXP |
methylselenic acid results in increased expression of HOXD8 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 2:176,129,705...176,132,695
Ensembl chr 2:176,129,694...176,132,695
|
|
G |
HPGD |
15-hydroxyprostaglandin dehydrogenase |
increases expression |
ISO |
methylselenic acid results in increased expression of HPGD mRNA; methylselenic acid results in increased expression of HPGD protein |
CTD |
PMID:25187657 |
|
NCBI chr 4:174,490,175...174,522,893
Ensembl chr 4:174,490,175...174,523,154
|
|
G |
HPGDS |
hematopoietic prostaglandin D synthase |
increases expression |
ISO |
methylselenic acid results in increased expression of HPGDS mRNA |
CTD |
PMID:21669866 |
|
NCBI chr 4:94,298,535...94,342,836
Ensembl chr 4:94,298,535...94,342,876
|
|
G |
HSP90B1 |
heat shock protein 90 beta family member 1 |
increases expression multiple interactions |
EXP |
methylselenic acid results in increased expression of HSP90B1 protein HSPA5 protein inhibits the reaction [methylselenic acid results in increased expression of HSP90B1 protein] |
CTD |
PMID:16204082 |
|
NCBI chr12:103,930,410...103,947,926
Ensembl chr12:103,930,107...103,953,931
|
|
G |
HSPA4L |
heat shock protein family A (Hsp70) member 4 like |
increases expression |
EXP |
methylselenic acid results in increased expression of HSPA4L mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 4:127,781,796...127,840,733
Ensembl chr 4:127,781,821...127,840,733
|
|
G |
HSPA5 |
heat shock protein family A (Hsp70) member 5 |
multiple interactions increases expression |
EXP |
HSPA5 protein affects the reaction [methylselenic acid results in decreased expression of CDK1 protein]; HSPA5 protein affects the reaction [methylselenic acid results in decreased expression of CDK2 protein]; HSPA5 protein affects the reaction [methylselenic acid results in increased expression of CDKN1A protein]; HSPA5 protein inhibits the reaction [methylselenic acid results in increased cleavage of CASP12 protein]; HSPA5 protein inhibits the reaction [methylselenic acid results in increased cleavage of CASP7 protein]; HSPA5 protein inhibits the reaction [methylselenic acid results in increased cleavage of PARP1 protein]; HSPA5 protein inhibits the reaction [methylselenic acid results in increased expression of DDIT3 protein]; HSPA5 protein inhibits the reaction [methylselenic acid results in increased expression of HSP90B1 protein]; HSPA5 protein inhibits the reaction [methylselenic acid results in increased expression of HSPA5 protein]; HSPA5 protein inhibits the reaction [methylselenic acid results in increased phosphorylation of EIF2A protein]; HSPA5 protein inhibits the reaction [methylselenic acid results in increased phosphorylation of EIF2AK3 protein]; methylselenic acid inhibits the reaction [CASP7 protein binds to HSPA5 protein] methylselenic acid results in increased expression of HSPA5 mRNA; methylselenic acid results in increased expression of HSPA5 protein |
CTD |
PMID:16204082 PMID:16205645 PMID:28161410 |
|
NCBI chr 9:125,234,853...125,241,343
Ensembl chr 9:125,234,853...125,241,382
|
|
G |
ID1 |
inhibitor of DNA binding 1 |
decreases expression |
EXP |
methylselenic acid results in decreased expression of ID1 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr20:31,605,289...31,606,510
Ensembl chr20:31,605,283...31,606,515
|
|
G |
ID2 |
inhibitor of DNA binding 2 |
affects expression |
EXP |
methylselenic acid affects the expression of ID2 mRNA |
CTD |
PMID:14617803 |
|
NCBI chr 2:8,682,056...8,684,461
Ensembl chr 2:8,678,845...8,684,461
|
|
G |
ID3 |
inhibitor of DNA binding 3 |
decreases expression increases expression |
EXP |
methylselenic acid results in decreased expression of ID3 mRNA methylselenic acid results in increased expression of ID3 mRNA |
CTD |
PMID:12517777 PMID:18548127 |
|
NCBI chr 1:23,557,926...23,559,501
Ensembl chr 1:23,557,926...23,559,501
|
|
G |
IDS |
iduronate 2-sulfatase |
increases expression |
EXP |
methylselenic acid results in increased expression of IDS mRNA |
CTD |
PMID:18548127 |
|
NCBI chr X:149,476,988...149,505,306
Ensembl chr X:149,476,988...149,521,096
|
|
G |
IFI16 |
interferon gamma inducible protein 16 |
increases expression |
EXP |
methylselenic acid results in increased expression of IFI16 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 1:158,999,976...159,055,151
Ensembl chr 1:158,999,968...159,055,155
|
|
G |
IFRD2 |
interferon related developmental regulator 2 |
decreases expression |
EXP |
methylselenic acid results in decreased expression of IFRD2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 3:50,287,732...50,292,429
Ensembl chr 3:50,287,732...50,292,918
|
|
G |
IGF1 |
insulin like growth factor 1 |
increases expression |
EXP |
methylselenic acid results in increased expression of IGF1 mRNA |
CTD |
PMID:11830524 |
|
NCBI chr12:102,395,874...102,481,839
Ensembl chr12:102,395,874...102,481,744
|
|
G |
IGSF3 |
immunoglobulin superfamily member 3 |
affects expression |
EXP |
methylselenic acid affects the expression of IGSF3 mRNA |
CTD |
PMID:14617803 |
|
NCBI chr 1:116,574,398...116,667,755
Ensembl chr 1:116,574,399...116,667,755
|
|
G |
ING1 |
inhibitor of growth family member 1 |
affects expression |
EXP |
methylselenic acid affects the expression of ING1 mRNA |
CTD |
PMID:14617803 |
|
NCBI chr13:110,712,623...110,723,339
Ensembl chr13:110,712,736...110,723,339
|
|
G |
INPP4B |
inositol polyphosphate-4-phosphatase type II B |
affects expression |
EXP |
methylselenic acid affects the expression of INPP4B mRNA |
CTD |
PMID:14617803 |
|
NCBI chr 4:142,023,160...142,846,535
Ensembl chr 4:142,023,160...142,847,432
|
|
G |
IPO8 |
importin 8 |
increases expression |
EXP |
methylselenic acid results in increased expression of IPO8 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr12:30,628,988...30,695,869
Ensembl chr12:30,628,988...30,695,869
|
|
G |
IRF1 |
interferon regulatory factor 1 |
affects expression |
EXP |
methylselenic acid affects the expression of IRF1 mRNA |
CTD |
PMID:14617803 |
|
NCBI chr 5:132,481,609...132,490,773
Ensembl chr 5:132,440,440...132,508,719
|
|
G |
ITGA3 |
integrin subunit alpha 3 |
increases expression |
EXP |
methylselenic acid results in increased expression of ITGA3 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr17:50,056,110...50,090,481
Ensembl chr17:50,055,968...50,090,481
|
|
G |
ITGB1 |
integrin subunit beta 1 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of ITGB1 mRNA |
CTD |
PMID:11172735 |
|
NCBI chr10:32,900,318...32,958,230
Ensembl chr10:32,887,273...33,005,792
|
|
G |
ITGB3BP |
integrin subunit beta 3 binding protein |
decreases expression |
EXP |
methylselenic acid results in decreased expression of ITGB3BP mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 1:63,440,770...63,529,187
Ensembl chr 1:63,440,770...63,593,721
|
|
G |
ITGB4 |
integrin subunit beta 4 |
decreases expression |
EXP |
methylselenic acid results in decreased expression of ITGB4 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr17:75,721,459...75,757,818
Ensembl chr17:75,721,328...75,757,818
|
|
G |
ITGB5 |
integrin subunit beta 5 |
decreases expression |
EXP |
methylselenic acid results in decreased expression of ITGB5 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 3:124,761,948...124,901,418
Ensembl chr 3:124,761,948...124,901,418
|
|
G |
ITPR1 |
inositol 1,4,5-trisphosphate receptor type 1 |
increases expression |
EXP |
methylselenic acid results in increased expression of ITPR1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 3:4,493,348...4,847,506
Ensembl chr 3:4,493,345...4,847,506
|
|
G |
JAK1 |
Janus kinase 1 |
affects expression increases expression |
EXP |
methylselenic acid affects the expression of JAK1 mRNA methylselenic acid results in increased expression of JAK1 mRNA |
CTD |
PMID:14617803 PMID:18548127 |
|
NCBI chr 1:64,833,229...65,067,746
Ensembl chr 1:64,833,223...65,067,754
|
|
G |
JUN |
Jun proto-oncogene, AP-1 transcription factor subunit |
decreases expression affects expression |
EXP |
methylselenic acid results in decreased expression of JUN protein methylselenic acid affects the expression of JUN mRNA |
CTD |
PMID:11830524 |
|
NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048
|
|
G |
JUNB |
JunB proto-oncogene, AP-1 transcription factor subunit |
decreases expression |
EXP |
methylselenic acid results in decreased expression of JUNB mRNA |
CTD |
PMID:12517777 |
|
NCBI chr19:12,791,486...12,793,315
Ensembl chr19:12,791,486...12,793,315
|
|
G |
KCNAB1 |
potassium voltage-gated channel subfamily A regulatory beta subunit 1 |
increases expression |
EXP |
methylselenic acid results in increased expression of KCNAB1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 3:156,118,211...156,539,138
Ensembl chr 3:156,037,701...156,539,138
|
|
G |
KCNH2 |
potassium voltage-gated channel subfamily H member 2 |
increases expression |
EXP |
methylselenic acid results in increased expression of KCNH2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 7:150,944,961...150,978,321
Ensembl chr 7:150,944,961...150,978,321
|
|
G |
KCNJ8 |
potassium inwardly rectifying channel subfamily J member 8 |
increases expression |
EXP |
methylselenic acid results in increased expression of KCNJ8 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr12:21,764,955...21,774,706
Ensembl chr12:21,764,955...21,775,600
|
|
G |
KDELR2 |
KDEL endoplasmic reticulum protein retention receptor 2 |
decreases expression |
EXP |
methylselenic acid results in decreased expression of KDELR2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 7:6,461,089...6,484,152
Ensembl chr 7:6,445,953...6,484,190
|
|
G |
KIF11 |
kinesin family member 11 |
decreases expression |
EXP |
methylselenic acid results in decreased expression of KIF11 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr10:92,593,130...92,655,395
Ensembl chr10:92,574,105...92,655,395
|
|
G |
KIF20B |
kinesin family member 20B |
decreases expression |
EXP |
methylselenic acid results in decreased expression of KIF20B mRNA |
CTD |
PMID:12517777 |
|
NCBI chr10:89,701,590...89,774,934
Ensembl chr10:89,701,590...89,774,939
|
|
G |
KLF4 |
KLF transcription factor 4 |
multiple interactions increases expression increases activity affects expression |
EXP |
KLF4 protein affects the reaction [methylselenic acid results in decreased expression of CCND1 mRNA]; KLF4 protein affects the reaction [methylselenic acid results in increased expression of CDKN1A mRNA]; KLF4 protein affects the reaction [methylselenic acid results in increased expression of CDKN1B mRNA] methylselenic acid results in increased expression of KLF4 mRNA methylselenic acid results in increased activity of KLF4 protein methylselenic acid affects the expression of KLF4 mRNA |
CTD |
PMID:14617803 PMID:18314491 |
|
NCBI chr 9:107,484,852...107,489,769
Ensembl chr 9:107,484,852...107,490,482
|
|
G |
KLHL2 |
kelch like family member 2 |
affects expression |
EXP |
methylselenic acid affects the expression of KLHL2 mRNA |
CTD |
PMID:14617803 |
|
NCBI chr 4:165,207,561...165,323,156
Ensembl chr 4:165,207,561...165,323,156
|
|
G |
KLK2 |
kallikrein related peptidase 2 |
multiple interactions decreases expression affects expression |
EXP |
AR protein inhibits the reaction [methylselenic acid results in decreased expression of KLK2 mRNA] methylselenic acid affects the expression of KLK2 mRNA |
CTD |
PMID:14617803 PMID:16020662 PMID:18548127 |
|
NCBI chr19:50,873,439...50,880,567
Ensembl chr19:50,861,568...50,880,567
|
|
G |
KLK3 |
kallikrein related peptidase 3 |
multiple interactions decreases secretion decreases expression affects expression |
EXP |
AR protein inhibits the reaction [methylselenic acid results in decreased expression of KLK3 mRNA]; methylselenic acid inhibits the reaction [Dihydrotestosterone inhibits the reaction [NCOR1 protein binds to KLK3 promoter]]; methylselenic acid inhibits the reaction [Dihydrotestosterone inhibits the reaction [NCOR2 protein binds to KLK3 promoter]]; methylselenic acid inhibits the reaction [Dihydrotestosterone promotes the reaction [AR protein binds to KLK3 promoter]]; methylselenic acid inhibits the reaction [Dihydrotestosterone promotes the reaction [NCOA1 protein binds to KLK3 promoter]]; methylselenic acid inhibits the reaction [Dihydrotestosterone promotes the reaction [NCOA2 protein binds to KLK3 promoter]]; methylselenic acid inhibits the reaction [mibolerone results in increased expression of KLK3 mRNA]; methylselenic acid results in increased degradation of and results in decreased expression of and results in decreased secretion of KLK3 protein methylselenic acid results in decreased secretion of KLK3 protein methylselenic acid results in decreased expression of KLK3 mRNA; methylselenic acid results in decreased expression of KLK3 protein methylselenic acid affects the expression of KLK3 mRNA |
CTD |
PMID:14617803 PMID:15141018 PMID:16020662 PMID:16648561 PMID:16928829 PMID:18548127 More...
|
|
NCBI chr19:50,854,915...50,860,764
Ensembl chr19:50,854,915...50,860,764
|
|
G |
KRT15 |
keratin 15 |
increases expression |
EXP |
methylselenic acid results in increased expression of KRT15 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr17:41,513,745...41,518,890
Ensembl chr17:41,513,745...41,522,529
|
|
G |
KRT20 |
keratin 20 |
increases expression |
EXP |
methylselenic acid results in increased expression of KRT20 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr17:40,875,889...40,885,242
Ensembl chr17:40,875,889...40,885,242
|
|
G |
LAGE3 |
L antigen family member 3 |
decreases expression |
EXP |
methylselenic acid results in decreased expression of LAGE3 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr X:154,477,775...154,479,281
Ensembl chr X:154,477,775...154,479,281
|
|
G |
LAMA4 |
laminin subunit alpha 4 |
increases expression |
EXP |
methylselenic acid results in increased expression of LAMA4 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 6:112,107,931...112,254,985
Ensembl chr 6:112,107,931...112,254,939
|
|
G |
LAMB3 |
laminin subunit beta 3 |
increases expression |
EXP |
methylselenic acid results in increased expression of LAMB3 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 1:209,614,870...209,652,425
Ensembl chr 1:209,614,870...209,652,425
|
|
G |
LMNB2 |
lamin B2 |
decreases expression |
EXP |
methylselenic acid results in decreased expression of LMNB2 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr19:2,428,166...2,456,959
Ensembl chr19:2,427,638...2,456,959
|
|
G |
LYPLA1 |
lysophospholipase 1 |
decreases expression |
EXP |
methylselenic acid results in decreased expression of LYPLA1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 8:54,046,367...54,101,947
Ensembl chr 8:54,046,367...54,102,017
|
|
G |
MAEA |
macrophage erythroblast attacher, E3 ubiquitin ligase |
decreases expression |
EXP |
methylselenic acid results in decreased expression of MAEA mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 4:1,289,891...1,340,137
Ensembl chr 4:1,289,887...1,340,147
|
|
G |
MAF |
MAF bZIP transcription factor |
increases expression |
EXP |
methylselenic acid results in increased expression of MAF mRNA |
CTD |
PMID:18548127 |
|
NCBI chr16:79,202,622...79,600,737
Ensembl chr16:79,585,843...79,600,737
|
|
G |
MAP1B |
microtubule associated protein 1B |
affects expression increases expression |
EXP |
methylselenic acid affects the expression of MAP1B mRNA methylselenic acid results in increased expression of MAP1B mRNA |
CTD |
PMID:14617803 PMID:18548127 |
|
NCBI chr 5:72,107,475...72,209,565
Ensembl chr 5:72,107,234...72,209,565
|
|
G |
MAP2K1 |
mitogen-activated protein kinase kinase 1 |
decreases expression increases expression |
EXP |
methylselenic acid results in decreased expression of MAP2K1 mRNA methylselenic acid results in increased expression of MAP2K1 mRNA |
CTD |
PMID:11830524 PMID:12517777 |
|
NCBI chr15:66,386,912...66,491,544
Ensembl chr15:66,386,837...66,491,656
|
|
G |
MAP2K5 |
mitogen-activated protein kinase kinase 5 |
increases expression |
EXP |
methylselenic acid results in increased expression of MAP2K5 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr15:67,542,703...67,807,114
Ensembl chr15:67,542,703...67,807,117
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
increases phosphorylation |
EXP |
methylselenic acid results in increased phosphorylation of MAPK1 protein |
CTD |
PMID:15845651 |
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
increases expression increases phosphorylation |
EXP |
methylselenic acid results in increased expression of MAPK3 mRNA methylselenic acid results in increased phosphorylation of MAPK3 protein |
CTD |
PMID:11830524 PMID:15845651 |
|
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
|
|
G |
MAPK8 |
mitogen-activated protein kinase 8 |
increases expression |
EXP |
methylselenic acid results in increased expression of MAPK8 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr10:48,306,677...48,439,360
Ensembl chr10:48,306,639...48,439,360
|
|
G |
MAPK9 |
mitogen-activated protein kinase 9 |
decreases expression |
EXP |
methylselenic acid results in decreased expression of MAPK9 mRNA |
CTD |
PMID:11830524 |
|
NCBI chr 5:180,233,143...180,292,083
Ensembl chr 5:180,233,143...180,292,099
|
|
G |
MAPRE2 |
microtubule associated protein RP/EB family member 2 |
increases expression |
EXP |
methylselenic acid results in increased expression of MAPRE2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr18:34,977,027...35,143,470
Ensembl chr18:34,976,928...35,143,470
|
|
G |
MAPT |
microtubule associated protein tau |
decreases expression |
EXP |
methylselenic acid results in decreased expression of MAPT mRNA |
CTD |
PMID:12517777 |
|
NCBI chr17:45,894,554...46,028,334
Ensembl chr17:45,894,527...46,028,334
|
|
G |
MAZ |
MYC associated zinc finger protein |
decreases expression |
EXP |
methylselenic acid results in decreased expression of MAZ mRNA |
CTD |
PMID:12517777 |
|
NCBI chr16:29,806,124...29,811,164
Ensembl chr16:29,806,106...29,811,164
|
|
G |
MBNL2 |
muscleblind like splicing regulator 2 |
increases expression |
EXP |
methylselenic acid results in increased expression of MBNL2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr13:97,141,834...97,394,120
Ensembl chr13:97,221,434...97,394,120
|
|
G |
MCCC2 |
methylcrotonyl-CoA carboxylase subunit 2 |
decreases expression |
EXP |
methylselenic acid results in decreased expression of MCCC2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 5:71,587,340...71,658,706
Ensembl chr 5:71,579,531...71,658,706
|
|
G |
MCM2 |
minichromosome maintenance complex component 2 |
affects expression |
EXP |
methylselenic acid affects the expression of MCM2 mRNA |
CTD |
PMID:14617803 |
|
NCBI chr 3:127,598,411...127,622,436
Ensembl chr 3:127,598,410...127,622,436
|
|
G |
MCM3 |
minichromosome maintenance complex component 3 |
decreases expression |
EXP |
methylselenic acid results in decreased expression of MCM3 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 6:52,264,015...52,284,742
Ensembl chr 6:52,264,014...52,284,881
|
|
G |
MCM5 |
minichromosome maintenance complex component 5 |
decreases expression |
EXP |
methylselenic acid results in decreased expression of MCM5 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr22:35,400,140...35,455,031
Ensembl chr22:35,400,134...35,425,431
|
|
G |
MCM6 |
minichromosome maintenance complex component 6 |
decreases expression affects expression |
EXP |
methylselenic acid results in decreased expression of MCM6 mRNA methylselenic acid affects the expression of MCM6 mRNA |
CTD |
PMID:12517777 PMID:14617803 |
|
NCBI chr 2:135,839,626...135,876,443
Ensembl chr 2:135,839,626...135,876,443
|
|
G |
MCM7 |
minichromosome maintenance complex component 7 |
decreases expression |
EXP |
methylselenic acid results in decreased expression of MCM7 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 7:100,092,728...100,101,397
Ensembl chr 7:100,092,728...100,101,940
|
|
G |
ME1 |
malic enzyme 1 |
increases expression |
EXP |
methylselenic acid results in increased expression of ME1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 6:83,210,402...83,431,051
Ensembl chr 6:83,210,402...83,431,051
|
|
G |
MEF2C |
myocyte enhancer factor 2C |
increases expression |
EXP |
methylselenic acid results in increased expression of MEF2C mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 5:88,717,117...88,904,105
Ensembl chr 5:88,717,117...88,904,257
|
|
G |
MEN1 |
menin 1 |
affects expression |
EXP |
methylselenic acid affects the expression of MEN1 mRNA |
CTD |
PMID:14617803 |
|
NCBI chr11:64,803,516...64,811,294
Ensembl chr11:64,803,510...64,811,294
|
|
G |
MICU2 |
mitochondrial calcium uptake 2 |
decreases expression |
EXP |
methylselenic acid results in decreased expression of MICU2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr13:21,492,691...21,604,170
Ensembl chr13:21,492,691...21,604,181
|
|
G |
MITF |
melanocyte inducing transcription factor |
increases expression |
EXP |
methylselenic acid results in increased expression of MITF mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 3:69,739,464...69,968,332
Ensembl chr 3:69,739,456...69,968,336
|
|
G |
MKI67 |
marker of proliferation Ki-67 |
decreases expression |
EXP |
methylselenic acid results in decreased expression of MKI67 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr10:128,096,659...128,126,423
Ensembl chr10:128,096,659...128,126,423
|
|
G |
MRPL19 |
mitochondrial ribosomal protein L19 |
decreases expression |
EXP |
methylselenic acid results in decreased expression of MRPL19 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 2:75,646,783...75,662,206
Ensembl chr 2:75,646,783...75,690,851
|
|
G |
MXD1 |
MAX dimerization protein 1 |
affects expression |
EXP |
methylselenic acid affects the expression of MXD1 mRNA |
CTD |
PMID:14617803 |
|
NCBI chr 2:69,915,109...69,942,945
Ensembl chr 2:69,897,688...69,942,945
|
|
G |
MXI1 |
MAX interactor 1, dimerization protein |
increases expression |
EXP |
methylselenic acid results in increased expression of MXI1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr10:110,207,605...110,287,365
Ensembl chr10:110,207,605...110,287,365
|
|
G |
MYBL2 |
MYB proto-oncogene like 2 |
decreases expression |
EXP |
methylselenic acid results in decreased expression of MYBL2 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr20:43,667,114...43,716,482
Ensembl chr20:43,667,019...43,716,495
|
|
G |
MYC |
MYC proto-oncogene, bHLH transcription factor |
affects expression multiple interactions |
EXP |
methylselenic acid affects the expression of MYC mRNA methylselenic acid inhibits the reaction [afimoxifene results in increased expression of MYC mRNA]; methylselenic acid inhibits the reaction [Estradiol results in increased expression of MYC mRNA] |
CTD |
PMID:14617803 PMID:15833885 PMID:16093440 PMID:16155795 |
|
NCBI chr 8:127,735,434...127,742,951
Ensembl chr 8:127,735,434...127,742,951
|
|
G |
MYL9 |
myosin light chain 9 |
increases expression |
EXP |
methylselenic acid results in increased expression of MYL9 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr20:36,541,519...36,551,447
Ensembl chr20:36,541,497...36,551,447
|
|
G |
MYO10 |
myosin X |
decreases expression |
EXP |
methylselenic acid results in decreased expression of MYO10 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 5:16,661,907...16,936,288
Ensembl chr 5:16,661,907...16,936,288
|
|
G |
MYRIP |
myosin VIIA and Rab interacting protein |
decreases expression |
EXP |
methylselenic acid results in decreased expression of MYRIP mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 3:39,808,914...40,260,321
Ensembl chr 3:39,808,914...40,260,321
|
|
G |
NAAA |
N-acylethanolamine acid amidase |
decreases expression |
EXP |
methylselenic acid results in decreased expression of NAAA mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 4:75,910,655...75,941,013
Ensembl chr 4:75,913,660...75,941,013
|
|
G |
NCOA1 |
nuclear receptor coactivator 1 |
multiple interactions |
EXP |
methylselenic acid inhibits the reaction [Dihydrotestosterone promotes the reaction [NCOA1 protein binds to KLK3 promoter]] |
CTD |
PMID:16648561 |
|
NCBI chr 2:24,491,254...24,770,702
Ensembl chr 2:24,491,254...24,770,702
|
|
G |
NCOA2 |
nuclear receptor coactivator 2 |
multiple interactions |
EXP |
methylselenic acid inhibits the reaction [Dihydrotestosterone promotes the reaction [NCOA2 protein binds to KLK3 promoter]] |
CTD |
PMID:16648561 |
|
NCBI chr 8:70,109,782...70,456,446
Ensembl chr 8:70,109,782...70,403,808
|
|
G |
NCOR1 |
nuclear receptor corepressor 1 |
multiple interactions |
EXP |
methylselenic acid inhibits the reaction [Dihydrotestosterone inhibits the reaction [NCOR1 protein binds to KLK3 promoter]] |
CTD |
PMID:16648561 |
|
NCBI chr17:16,029,157...16,215,534
Ensembl chr17:16,029,065...16,218,185
|
|
G |
NCOR2 |
nuclear receptor corepressor 2 |
multiple interactions |
EXP |
methylselenic acid inhibits the reaction [Dihydrotestosterone inhibits the reaction [NCOR2 protein binds to KLK3 promoter]] |
CTD |
PMID:16648561 |
|
NCBI chr12:124,324,415...124,567,612
Ensembl chr12:124,324,415...124,567,612
|
|
G |
NDRG1 |
N-myc downstream regulated 1 |
affects expression |
EXP |
methylselenic acid affects the expression of NDRG1 mRNA |
CTD |
PMID:14617803 |
|
NCBI chr 8:133,237,175...133,297,252
Ensembl chr 8:133,237,175...133,302,022
|
|
G |
NEBL |
nebulette |
increases expression |
EXP |
methylselenic acid results in increased expression of NEBL mRNA |
CTD |
PMID:18548127 |
|
NCBI chr10:20,779,973...21,293,050
Ensembl chr10:20,779,973...21,293,011
|
|
G |
NFIL3 |
nuclear factor, interleukin 3 regulated |
affects expression |
EXP |
methylselenic acid affects the expression of NFIL3 mRNA |
CTD |
PMID:14617803 |
|
NCBI chr 9:91,409,045...91,483,497
Ensembl chr 9:91,409,045...91,423,832
|
|
G |
NFKB1 |
nuclear factor kappa B subunit 1 |
decreases expression |
EXP |
methylselenic acid results in decreased expression of NFKB1 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 4:102,501,359...102,617,302
Ensembl chr 4:102,501,330...102,617,302
|
|
G |
NKX3-1 |
NK3 homeobox 1 |
affects expression |
EXP |
methylselenic acid affects the expression of NKX3-1 mRNA |
CTD |
PMID:14617803 |
|
NCBI chr 8:23,678,693...23,682,938
Ensembl chr 8:23,678,697...23,682,938
|
|
G |
NME1 |
NME/NM23 nucleoside diphosphate kinase 1 |
decreases expression |
EXP |
methylselenic acid results in decreased expression of NME1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr17:51,153,559...51,162,168
Ensembl chr17:51,153,559...51,162,428
|
|
G |
NME4 |
NME/NM23 nucleoside diphosphate kinase 4 |
decreases expression |
EXP |
methylselenic acid results in decreased expression of NME4 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr16:396,729...400,754
Ensembl chr16:396,725...410,367
|
|
G |
NMI |
N-myc and STAT interactor |
decreases expression |
EXP |
methylselenic acid results in decreased expression of NMI mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 2:151,270,470...151,289,668
Ensembl chr 2:151,270,470...151,289,894
|
|
G |
NQO1 |
NAD(P)H quinone dehydrogenase 1 |
increases activity |
EXP |
methylselenic acid results in increased activity of NQO1 protein |
CTD |
PMID:14617803 |
|
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
|
|
G |
NR3C1 |
nuclear receptor subfamily 3 group C member 1 |
affects expression |
EXP |
methylselenic acid affects the expression of NR3C1 mRNA |
CTD |
PMID:16928829 |
|
NCBI chr 5:143,277,931...143,435,512
Ensembl chr 5:143,277,931...143,435,512
|
|
G |
OAT |
ornithine aminotransferase |
increases expression |
EXP |
methylselenic acid results in increased expression of OAT mRNA |
CTD |
PMID:18548127 |
|
NCBI chr10:124,397,303...124,418,923
Ensembl chr10:124,397,303...124,418,976
|
|
G |
OLFML2A |
olfactomedin like 2A |
increases expression |
EXP |
methylselenic acid results in increased expression of OLFML2A mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 9:124,777,133...124,814,882
Ensembl chr 9:124,777,133...124,814,885
|
|
G |
OPTN |
optineurin |
increases expression |
EXP |
methylselenic acid results in increased expression of OPTN mRNA |
CTD |
PMID:18548127 |
|
NCBI chr10:13,100,082...13,138,308
Ensembl chr10:13,099,449...13,138,308
|
|
G |
PALM2AKAP2 |
PALM2 and AKAP2 fusion |
increases expression |
EXP |
methylselenic acid results in increased expression of PALM2AKAP2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 9:109,640,787...110,172,512
Ensembl chr 9:109,498,325...110,172,512
|
|
G |
PARP1 |
poly(ADP-ribose) polymerase 1 |
multiple interactions increases cleavage |
EXP ISO |
[2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid co-treated with methylselenic acid co-treated with resveratrol] results in increased cleavage of PARP1 protein; [Doxorubicin co-treated with methylselenic acid] results in increased degradation of PARP1 protein; AKT1 protein modified form inhibits the reaction [[Doxorubicin co-treated with methylselenic acid] results in increased degradation of PARP1 protein]; BCL2L11 protein promotes the reaction [[Doxorubicin co-treated with methylselenic acid] results in increased degradation of PARP1 protein]; HSPA5 protein inhibits the reaction [methylselenic acid results in increased cleavage of PARP1 protein]; SB 216763 inhibits the reaction [[Doxorubicin co-treated with methylselenic acid] results in increased degradation of PARP1 protein] |
CTD |
PMID:15845651 PMID:16204082 PMID:17339365 PMID:18444175 PMID:19276161 PMID:28161410 More...
|
|
NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
|
|
G |
PATZ1 |
POZ/BTB and AT hook containing zinc finger 1 |
decreases expression |
EXP |
methylselenic acid results in decreased expression of PATZ1 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr22:31,325,804...31,346,346
Ensembl chr22:31,325,804...31,346,346
|
|
G |
PAXIP1 |
PAX interacting protein 1 |
decreases expression |
EXP |
methylselenic acid results in decreased expression of PAXIP1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 7:154,943,690...155,003,411
Ensembl chr 7:154,943,687...155,003,124
|
|
G |
PBX1 |
PBX homeobox 1 |
increases expression |
EXP |
methylselenic acid results in increased expression of PBX1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 1:164,559,184...164,886,047
Ensembl chr 1:164,555,584...164,899,296
|
|
G |
PCBD1 |
pterin-4 alpha-carbinolamine dehydratase 1 |
decreases expression |
EXP |
methylselenic acid results in decreased expression of PCBD1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr10:70,882,280...70,888,565
Ensembl chr10:70,882,280...70,888,565
|
|
G |
PCNA |
proliferating cell nuclear antigen |
affects expression decreases expression |
EXP |
methylselenic acid affects the expression of PCNA mRNA methylselenic acid results in decreased expression of PCNA mRNA |
CTD |
PMID:11830524 PMID:12517777 PMID:14617803 |
|
NCBI chr20:5,114,953...5,126,622
Ensembl chr20:5,114,953...5,126,626
|
|
G |
PEG3 |
paternally expressed 3 |
affects expression |
EXP |
methylselenic acid affects the expression of PEG3 mRNA |
CTD |
PMID:14617803 |
|
NCBI chr19:56,810,082...56,840,726
Ensembl chr19:56,810,077...56,840,728
|
|
G |
PFDN5 |
prefoldin subunit 5 |
decreases expression |
EXP |
methylselenic acid results in decreased expression of PFDN5 mRNA |
CTD |
PMID:11830524 |
|
NCBI chr12:53,295,542...53,299,450
Ensembl chr12:53,295,291...53,299,452
|
|
G |
PGAP2 |
post-GPI attachment to proteins 2 |
decreases expression |
EXP |
methylselenic acid results in decreased expression of PGAP2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr11:3,797,724...3,826,371
Ensembl chr11:3,797,724...3,826,371
|
|
G |
PGM5 |
phosphoglucomutase 5 |
increases expression |
EXP |
methylselenic acid results in increased expression of PGM5 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 9:68,356,611...68,531,061
Ensembl chr 9:68,328,308...68,531,061
|
|
G |
PGR |
progesterone receptor |
affects expression |
EXP |
methylselenic acid affects the expression of PGR mRNA |
CTD |
PMID:16928829 |
|
NCBI chr11:101,029,624...101,129,813
Ensembl chr11:101,029,624...101,129,813
|
|
G |
PJA2 |
praja ring finger ubiquitin ligase 2 |
increases expression |
EXP |
methylselenic acid results in increased expression of PJA2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 5:109,334,722...109,409,974
Ensembl chr 5:109,334,713...109,409,974
|
|
G |
PLA2G4A |
phospholipase A2 group IVA |
increases expression |
EXP |
methylselenic acid results in increased expression of PLA2G4A mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 1:186,828,949...186,988,981
Ensembl chr 1:186,828,949...186,988,981
|
|
G |
PLCB4 |
phospholipase C beta 4 |
increases expression |
EXP |
methylselenic acid results in increased expression of PLCB4 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr20:9,068,678...9,480,808
Ensembl chr20:9,067,825...9,504,593
|
|
G |
PLK1 |
polo like kinase 1 |
decreases expression affects expression |
EXP |
methylselenic acid results in decreased expression of PLK1 mRNA methylselenic acid affects the expression of PLK1 mRNA |
CTD |
PMID:11830524 PMID:14617803 |
|
NCBI chr16:23,678,889...23,690,367
Ensembl chr16:23,677,656...23,690,367
|
|
G |
PMS2 |
PMS1 homolog 2, mismatch repair system component |
increases expression |
EXP |
methylselenic acid results in increased expression of PMS2 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 7:5,970,925...6,009,106
Ensembl chr 7:5,970,925...6,009,130
|
|
G |
POLA1 |
DNA polymerase alpha 1, catalytic subunit |
decreases expression |
EXP |
methylselenic acid results in decreased expression of POLA1 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr X:24,693,918...24,996,986
Ensembl chr X:24,693,873...24,996,986
|
|
G |
POLR2H |
RNA polymerase II, I and III subunit H |
decreases expression |
EXP |
methylselenic acid results in decreased expression of POLR2H mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 3:184,361,710...184,368,591
Ensembl chr 3:184,361,710...184,368,596
|
|
G |
PPFIA1 |
PTPRF interacting protein alpha 1 |
affects expression |
EXP |
methylselenic acid affects the expression of PPFIA1 mRNA |
CTD |
PMID:14617803 |
|
NCBI chr11:70,270,690...70,384,396
Ensembl chr11:70,270,690...70,385,312
|
|
G |
PPIL2 |
peptidylprolyl isomerase like 2 |
decreases expression |
EXP |
methylselenic acid results in decreased expression of PPIL2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr22:21,666,012...21,700,015
Ensembl chr22:21,666,000...21,700,015
|
|
G |
PPM1B |
protein phosphatase, Mg2+/Mn2+ dependent 1B |
increases expression |
EXP |
methylselenic acid results in increased expression of PPM1B mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 2:44,168,875...44,246,928
Ensembl chr 2:44,167,969...44,244,384
|
|
G |
PPP1R15A |
protein phosphatase 1 regulatory subunit 15A |
increases expression |
EXP |
methylselenic acid results in increased expression of PPP1R15A mRNA |
CTD |
PMID:28161410 |
|
NCBI chr19:48,872,421...48,876,058
Ensembl chr19:48,872,212...48,876,059
|
|
G |
PRKAR2B |
protein kinase cAMP-dependent type II regulatory subunit beta |
increases expression |
EXP |
methylselenic acid results in increased expression of PRKAR2B mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 7:107,044,705...107,161,811
Ensembl chr 7:107,044,705...107,161,811
|
|
G |
PRKCA |
protein kinase C alpha |
increases expression |
EXP |
methylselenic acid results in increased expression of PRKCA mRNA |
CTD |
PMID:12517777 |
|
NCBI chr17:66,302,613...66,810,743
Ensembl chr17:66,302,613...66,810,743
|
|
G |
PRKCB |
protein kinase C beta |
increases expression |
EXP |
methylselenic acid results in increased expression of PRKCB mRNA |
CTD |
PMID:18548127 |
|
NCBI chr16:23,835,983...24,220,611
Ensembl chr16:23,835,983...24,220,611
|
|
G |
PRNP |
prion protein |
increases expression |
EXP |
methylselenic acid results in increased expression of PRNP mRNA |
CTD |
PMID:18548127 |
|
NCBI chr20:4,686,456...4,701,588
Ensembl chr20:4,686,350...4,701,590
|
|
G |
PTEN |
phosphatase and tensin homolog |
increases expression |
EXP |
methylselenic acid results in increased expression of PTEN mRNA |
CTD |
PMID:12517777 |
|
NCBI chr10:87,863,625...87,971,930
Ensembl chr10:87,862,563...87,971,930
|
|
G |
PTGES |
prostaglandin E synthase |
decreases expression |
EXP ISO |
methylselenic acid results in decreased expression of PTGES mRNA |
CTD |
PMID:11830524 PMID:21669866 |
|
NCBI chr 9:129,738,349...129,753,042
Ensembl chr 9:129,738,331...129,753,042
|
|
G |
QKI |
QKI, KH domain containing RNA binding |
increases expression |
EXP |
methylselenic acid results in increased expression of QKI mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 6:163,414,718...163,578,592
Ensembl chr 6:163,414,000...163,578,592
|
|
G |
RAB28 |
RAB28, member RAS oncogene family |
increases expression |
EXP |
methylselenic acid results in increased expression of RAB28 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 4:13,367,724...13,484,340
Ensembl chr 4:13,361,354...13,484,365
|
|
G |
RAB31 |
RAB31, member RAS oncogene family |
increases expression affects expression |
EXP |
methylselenic acid results in increased expression of RAB31 mRNA methylselenic acid affects the expression of RAB31 mRNA |
CTD |
PMID:12517777 PMID:14617803 PMID:18548127 |
|
NCBI chr18:9,708,301...9,862,551
Ensembl chr18:9,708,275...9,862,551
|
|
G |
RABAC1 |
Rab acceptor 1 |
decreases expression |
EXP |
methylselenic acid results in decreased expression of RABAC1 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr19:41,956,683...41,959,321
Ensembl chr19:41,956,681...41,959,321
|
|
G |
RAD9A |
RAD9 checkpoint clamp component A |
increases expression |
EXP |
methylselenic acid results in increased expression of RAD9A mRNA |
CTD |
PMID:12517777 |
|
NCBI chr11:67,391,986...67,398,412
Ensembl chr11:67,317,871...67,398,410
|
|
G |
RAPGEF4 |
Rap guanine nucleotide exchange factor 4 |
increases expression |
EXP |
methylselenic acid results in increased expression of RAPGEF4 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 2:172,735,318...173,052,893
Ensembl chr 2:172,735,274...173,052,893
|
|
G |
RB1 |
RB transcriptional corepressor 1 |
multiple interactions |
EXP |
methylselenic acid promotes the reaction [E2F1 protein binds to RB1 protein]; methylselenic acid results in decreased phosphorylation of and results in increased expression of RB1 protein |
CTD |
PMID:17847021 |
|
NCBI chr13:48,303,751...48,481,890
Ensembl chr13:48,303,744...48,599,436
|
|
G |
RDH11 |
retinol dehydrogenase 11 |
affects expression |
EXP |
methylselenic acid affects the expression of RDH11 mRNA |
CTD |
PMID:14617803 |
|
NCBI chr14:67,676,800...67,695,764
Ensembl chr14:67,676,800...67,695,793
|
|
G |
REEP1 |
receptor accessory protein 1 |
increases expression |
EXP |
methylselenic acid results in increased expression of REEP1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 2:86,213,993...86,338,083
Ensembl chr 2:86,213,993...86,338,083
|
|
G |
RFC5 |
replication factor C subunit 5 |
decreases expression |
EXP |
methylselenic acid results in decreased expression of RFC5 mRNA |
CTD |
PMID:11830524 |
|
NCBI chr12:118,016,703...118,041,448
Ensembl chr12:118,013,588...118,033,130
|
|
G |
RGL1 |
ral guanine nucleotide dissociation stimulator like 1 |
increases expression |
EXP |
methylselenic acid results in increased expression of RGL1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 1:183,636,109...183,928,532
Ensembl chr 1:183,636,085...183,928,532
|
|
G |
RGS10 |
regulator of G protein signaling 10 |
increases expression |
EXP |
methylselenic acid results in increased expression of RGS10 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr10:119,499,817...119,542,719
Ensembl chr10:119,499,817...119,542,719
|
|
G |
RHOB |
ras homolog family member B |
affects expression |
EXP |
methylselenic acid affects the expression of RHOB mRNA |
CTD |
PMID:14617803 |
|
NCBI chr 2:20,447,074...20,449,440
Ensembl chr 2:20,447,074...20,449,440
|
|
G |
RIMS3 |
regulating synaptic membrane exocytosis 3 |
increases expression |
EXP |
methylselenic acid results in increased expression of RIMS3 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 1:40,620,680...40,692,066
Ensembl chr 1:40,620,680...40,665,682
|
|
G |
RND3 |
Rho family GTPase 3 |
increases expression |
EXP |
methylselenic acid results in increased expression of RND3 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 2:150,468,193...150,487,695
Ensembl chr 2:150,468,195...150,539,011
|
|
G |
RPA2 |
replication protein A2 |
decreases expression |
EXP |
methylselenic acid results in decreased expression of RPA2 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 1:27,891,524...27,914,797
Ensembl chr 1:27,891,524...27,914,746
|
|
G |
RPIA |
ribose 5-phosphate isomerase A |
decreases expression |
EXP |
methylselenic acid results in decreased expression of RPIA mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 2:88,691,673...88,750,929
Ensembl chr 2:88,691,673...88,750,929
|
|
G |
RPL27A |
ribosomal protein L27a |
decreases expression |
EXP |
methylselenic acid results in decreased expression of RPL27A mRNA |
CTD |
PMID:18548127 |
|
NCBI chr11:8,682,792...8,689,872
Ensembl chr11:8,682,788...8,714,759
|
|
G |
RPSA |
ribosomal protein SA |
decreases expression |
ISO |
methylselenic acid results in decreased expression of RPSA mRNA |
CTD |
PMID:11172735 |
|
NCBI chr 3:39,406,720...39,412,542
Ensembl chr 3:39,406,716...39,426,255
|
|
G |
RRM1 |
ribonucleotide reductase catalytic subunit M1 |
affects expression |
EXP |
methylselenic acid affects the expression of RRM1 mRNA |
CTD |
PMID:14617803 |
|
NCBI chr11:4,094,685...4,138,932
Ensembl chr11:4,094,707...4,138,932
|
|
G |
RRM2 |
ribonucleotide reductase regulatory subunit M2 |
affects expression |
EXP |
methylselenic acid affects the expression of RRM2 mRNA |
CTD |
PMID:14617803 |
|
NCBI chr 2:10,122,568...10,211,010
Ensembl chr 2:10,120,698...10,211,725
|
|
G |
RXYLT1 |
ribitol xylosyltransferase 1 |
decreases expression |
EXP |
methylselenic acid results in decreased expression of RXYLT1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr12:63,779,909...63,809,562
Ensembl chr12:63,779,833...63,809,792
|
|
G |
S100A4 |
S100 calcium binding protein A4 |
increases expression |
EXP |
methylselenic acid results in increased expression of S100A4 mRNA |
CTD |
|